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A b s tr a c t
A b s t r a c t
Numerous chronic lung diseases are characterised by oxidative stress or 
more accurately, perturbations in redox cycling and signalling. Cellular redox 
alterations lead to phenotypic adaptations such as increased cell proliferation, 
altered differentiation and induction of apoptosis. Biomarkers that reflect 
changes in cellular oxidation states as a function of normal redox signalling as 
well as following environmental insults would be extremely useful for studying 
disease processes in the lung in vitro and in vivo. One current area of interest 
in this field is the Peroxiredoxins (Prxs), a family of ubiquitously expressed 
antioxidant (AO) enzymes. The aim of this project was to assess the utility of 
measuring the changes in Prx expression levels and oxidation states as a 
quantitative biomarker of oxidative lung injury.
Utilising normal human bronchial epithelial (NHBE) primary cells, which were 
cultured at an air-liquid interface (ALI), Prx status was analysed throughout 
culture morphogenesis, and following oxidative insult via glucose oxidase 
(GOx) and cigarette smoke (CS) exposures. Human in vivo correlation was 
also undertaken, using lung tissue from COPD (GOLD4) patients. Results 
were analysed using conventional toxicology, Western blotting (WB) and 
immunohistochemistry (IHC) techniques. Preliminary results revealed 
elevated basal levels of oxidative stress within the NHBE model, which was 
alleviated via the addition of AO to the media. Following GOx and CS 
exposures, there was increased Prx hyperoxidation in conjunction with 
variations in expression. A dose-dependant response to GOx and CS was 
observed in the NHBE cultures +AO. Variations in Prx expression levels and 
oxidation state were also detected throughout the in vivo correlation, with 
specific Prx responses observed in the different stages of airway remodelling.
The Prxs were determined to be sensitive and reliable biomarkers of
intracellular oxidative stress, injury severity and epithelial remodelling, thus
indicating a role for the Prxs as an ‘early stage’ biomarker, with disruptions in
redox state occurring in advance of phenotypic or morphological adaptations.
Additionally, by eliminating the issue of interspecies reactivity, there may be a
potential role for the NHBE-Prx system as an in vivo pre-screening tool.
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1.1 S tu d y  In tr o d u c tio n
Numerous chronic lung diseases are characterised by oxidative stress or 
more accurately, perturbations in redox cycling and signalling (Jones, 2006). 
Cellular redox alterations lead to phenotypic adaptations such as increased 
cell proliferation, altered differentiation and induction of apoptosis (Thannickal 
and Fanburg, 2000; Halliwell, 2007a). Biomarkers that reflect changes in 
cellular oxidation states, as a function of normal redox signalling and following 
environmental insults would be extremely useful for studying disease 
processes in the human lung at both the in vitro and in vivo levels.
Peroxiredoxins (Prxs) are a family of ubiquitously expressed antioxidant (AO) 
enzymes that regulate oxidant-dependant signalling through a variety of redox 
dependant pathways (Hofmann et al.t 2002). The principal investigation site of 
this research project was the bronchial epithelium (BE), with the aim being to 
assess the utility of measuring the changes in Prx expression levels and 
oxidation states as a quantitative biomarker of oxidative lung injury, such as 
that observed in chronic obstructive pulmonary disease (COPD).
1.2 T he  H u m a n  R e sp ir a to r y  S y s te m
Respiration in humans can be defined as the exchange of gases between the 
cells of the body and the external environment; the mechanical aspect of 
respiration is the movement of air in and out of the lungs or ventilation. 
Respiration itself can be divided into two types, external and internal. External 
respiration involves gas exchange between the lungs and the blood, whereas 
internal respiration is the exchange of gas between the blood and the cells of 
the body (Shier et a/., 2004).
1.2.1 Str u c tu r e  a n d  F u nc tio n  o f  th e  R esp ir a to r y  Syste m
Anatomically, the human respiratory tract (RpT) can be divided into two
regions: (1) the upper RpT; nose, nasal passages, sinuses and the pharynx,
and (2) the lower RpT; larynx, trachea, bronchi, bronchioles, respiratory
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bronchioles and the alveolar unit (Figure 1.1; Levitsky, 2003). The lower RpT 
can be further divided into the distal RpT, to denote the regions involved in 
gas exchange (i.e. respiratory bronchioles and alveoli). The function of the 
upper airways is mainly to warm and humidify the inspired air, but the nose is 
also a potent filter, using its vibrissae (nasal hairs) and mucous membrane to 
trap and then clear particles larger than 10pm in diameter (Berne et al., 2004). 
Airway mucus protects the airways from any harmful inspired molecules and 
also prevents the desiccation of the airway surfaces (Chilvers and 
O'Callaghan, 2000). The lower RpT conducts the inspired air from the external 
environment to the site of gaseous exchange whilst ensuring that any harmful 
molecules are removed before they reach the alveoli (Hasleton, 1996). The 
distal RpT is the site of gaseous exchange, where the alveoli provide a large 
surface allowing O2 to diffuse into the pulmonary capillaries and C02 to diffuse 
into the alveolus (Gardner, 2006).
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Figure 1.1: Depiction of the anatomy of the respiratory system.
The respiratory system can be divided into the upper and lower RpT. The lower respiratory 
tract can be further divided into the distal RpT, with the latter containing all regions involved in 
gas exchange (Adapted from Sexton, 2009).
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Functionally, the respiratory system is divided into two zones: (1) the 
‘conducting’ and (2) the ‘respiratory’ (Figure 1.2; Hasleton, 1996). The 
conducting zone consists of the trachea, bronchi, bronchioles and terminal 
bronchioles. It is named so as air merely passes through its structures (i.e. 
conducts air) and has no gas exchange with the blood; the volume of air 
within this zone is referred to as anatomic dead space (West, 1995). The 
respiratory zone is the region where gas exchange takes place between the 
lungs and the pulmonary capillaries (Gardner, 2006).
1.2.2 A n a to m y  o f  th e  L ungs
The lungs are divided into five lobes, where the right lung consists of upper, 
middle and lower lobes and the left lung has only an upper and lower lobe 
(Levitsky, 2003). Air enters the lungs via the tracheobronchial system, also 
known as the bronchial tree, which contains up to 23 airway generations 
(Figure 1.2; Hasleton, 1996). The air flows initially through the trachea which 
divides into the two primary bronchi, each penetrating one lung (Berne et al., 
2004). The airway continues to divide producing the bronchioles, terminal 
bronchioles and respiratory bronchioles, unlike the trachea and bronchi, these 
are non-cartilaginous regions (Proud, 2008). The respiratory bronchioles mark 
the end of the conducting zone as they contain alveoli, making them the first 
site of gaseous exchange. The end of this region signifies the beginning of the 
alveolar ducts which lead onto the alveolar sacs. Another noticeable 
difference between the conducting and respiratory zones lies in their blood 
supply, with airways in the conducting zone receiving blood via the bronchial 
circulation and the respiratory zone components from the pulmonary arteries 
(Shier etal., 2004).
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Figure 1.2: Conducting and respiratory zones of the RpT.
The conducting zone consists of the trachea, bronchi and terminal bronchioles, air passes 
through these structures and no gaseous exchange takes place. The respiratory zone 
consists of respiratory bronchioles, the alveolar ducts and alveolar sacs; this is the site of gas 
exchange between the lung and pulmonary capillaries. The branching of the airways form up 
to 23 generations (Z), from the trachea Z = 0 to the alveolar sacs Z = 23 (not shown above 
are the alveolar ducts, Z = 20-22) (Adapted from B6ruB6 et al, 2010b).
5
In t r o d u c t io n
1.3 T he  P u lm o n a r y  E p ith eliu m
As the airway progresses from the conducting to the respiratory zones, the 
cell types alter to accommodate the function of each region (Figure 1.3). At 
the transition from the vestibule (conductive portion following the nostrils) to 
the respiratory region of the nasal cavity, the epithelium becomes first 
stratified squamous and then pseudo-stratified columnar and ciliated (Popp 
and Martin, 1984). This type of epithelium is characteristic for all conductive 
passages dedicated to the respiratory system, and therefore, it is also referred 
to as the ‘respiratory epithelium’. Mucus producing goblet cells (GC) are 
present in the epithelium, along with ciliated and basal cells (BC), all of which 
are firmly attached to the basal membrane (Knight and Holgate, 2003). 
Submucosal glands also line the trachea and bronchi, and contain serous and 
mucous gland cells, that supplement the secretions of the GCs (Meyrick and 
Reid, 1970).
As the airway divides from the bronchioles into the terminal bronchioles, the 
numbers of ciliated cells (CC) decrease and eventually cease before the 
division into respiratory bronchioles (Hasleton, 1996). Clara cells are found in 
the terminal and respiratory bronchioles, whereby they replace the GCs of the 
more proximal airway tract, and secrete proteins used in xenobiotic 
metabolism (Reynolds and Malkinson, 2010).
The gaseous exchange region of the human lung is only 0.2-0.4pM in 
thickness; however, the barrier possesses great strength which is essential in 
order to avoid stress failure (Costello et al.y 1992; West and Mathieu-Costello, 
1999). The alveolar unit contains Type I and II alveolar pneumocyte cells, 
which work in conjunction to ensure effective oxygen delivery to the blood 
stream (Hansel and Barnes, 2004). Type I pneumocytes act to provide a large 
thin surface area where gas exchange occurs, accounting for 95% of the 
alveolar lining but only 40% of pneumocytes. The most important role of the 
Type II pneumocyte is surfactant production; which acts to prevent the 
collapse of the alveoli; they account for only 5% of the alveolar lining but 
make up 60% of pneumocytes (Hasleton, 1996).
6
In tr o d u c tio n
Alveolar
Gas
▲
lell
Q>
Basal Cell
Ciliated C
Intermediate
Cell
Clara Cellw£p0
Goblet Cell
Alveolar Macrophage
Bronchial
Epithelium
Bronchiolar
Epithelium
Respiratory 
Bronchioles
Distal
RT Alveolar Sacs
____
Alveolar
Epithelium
Type I Alveolar 
Epithelial Cell
Type II Alveolar 
Epithelial Cell
2° Bronchi 
3° Bronchi
Small
Bronchi
Bronchioles
Terminal
Bronchioles
T rachea
Lower
RT
1° Bronchi
Figure 1.3 Cells of the pulmonary epithelium.
The more proximal region of the lower RpT consists of a BE, as the airways decrease in size 
the epithelium becomes more characteristically bronchiolar. The distal airways, also know as 
the region of gaseous exchange comprises of alveolar epithelium, which include type I and II 
alveolar epithelial cells and alveolar macrophages (B6ruB6 etal., 2010b, Drawn by C.Job).
1 .4  C e l l s  o f  t h e  B r o n c h ia l  E p it h e l iu m
The BE contained within the lower RpT consists of CCs, BCs, intermediate 
cells (IC) and GCs (Figure 1.3). The epithelium of this region represents the 
focal point of the PhD investigation, and as such, the constituent cells of the 
distal RpT will not be discussed.
1.4.1 C iliated  C ells
CCs are roughly columnar in shape (20pm in length and 10pm in width), and 
are covered with -250 cilia (3-6pm in length and 0.3pm in width). They 
outnumber GCs in the ratio of 5:1 in the BE (Knight and Holgate, 2003) and 
are attached to the basal lamina via desmosomes and interconnected via tight
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junctions (Section 1.5.1.2). The cilia are attached to the cell through a basal 
body (Figure 1.4) via an axoneme, which comprises of nine microtubule 
doublets around a central pair of microtubules (Fliegauf et a/., 2007). The 
differentiation of CCs is thought to be partly regulated by the ciliated bronchial 
epithelium 1 (CBE1) gene, whose expression was discovered by Yoshisue 
and co-workers during the random sequencing of a cDNA library from human 
lung biopsies (Yoshisue et al., 2004). Their primary function is mucociliary 
clearance, which is regulated by ATP concentration (Okada et al., 2006) 
provided by the high mitochondrial content within their cytoplasm. The cilia 
beat unilaterally in a ‘back-and-forth’ motion along the proximal RpT 
(Papadakos and Lachman, 2008). This characteristic motion utilises energy 
from ATP to transport any debris/xenobiotics upward, thus, preventing them 
from entering the lower RpT (Sleigh, 1990; Braiman and Priel, 2008).
Cilium
Figure 1.4: TEM image of cilia on the apical surface of the BE.
Transmission electron micrograph (TEM) image of the NHBE cells (in vitro cell culture) from 
Day 15. Cilia may be seen protruding from the apical surface of the BE. Basal bodies may be 
observed just under the apical surface and the internal microtubules were evident. Scale bar 
represents 500nm (Image courtesy Dr. K. B6ruBe, Cardiff University).
Interspersed among the cilia are microvilli (2pm in height and 0.1pm in width).
Microvilli are particularly abundant on the apical surface of the CCs and
immature CCs (Figure 1.5; Breeze and Wheeldon, 1977). The microvilli are
also associated with mucous cells; either small mucous granule cells (SMGC)
or mucus filled GCs (McDowell et al., 1978).
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Mucus
Microvilli
Figure 1.5: SEM image of the BE apical surface.
Scanning electron micrograph (SEM) image of the NHBE cells (in vitro cell culture) from Day 
27, showing the cilia, microvilli and mucus droplets. Scale bar represents 5pM (Image 
courtesy of Dr. Z. Prytherch, Cardiff University).
1.4.2 G oblet C ells
GCs, named so due to the mucous granules within their cytoplasm creating a 
‘goblet’ shaped cell, are also referred to as mucous cells (Proud, 2008). They 
often appear to be electron-dense in comparison to the other cells of the BE, 
due to their high secretary granule content (Rhodin, 1966). GCs are dispersed 
throughout the BE, primarily in the cartilaginous regions, becoming less 
frequent as the airway becomes smaller in the more distal regions, where they 
are replaced by Clara cells (Davis and Dickey, 2008). The GCs are secretary 
cells that release mucus by merocrine-type secretion (Figure 1.6). The mucus 
serves a protective function by trapping any unwanted particles and removing 
them from the airflow (Rogers, 2003) (Section 1.5.1.3). This protective mucus 
barrier is the primary function of GCs (Chilvers and O'Callaghan, 2000).
GCs are known to be capable of differentiating into CCs when required, 
primarily following injury to the epithelium (Ayers and Jeffery, 1988). 
Conversely, progenitor CCs that contain the CC marker FOXJ1 have been 
shown to differentiate into GCs under pathological conditions (i.e. asthma and 
COPD), leading to mucus overproduction within the airway (Turner et al.,
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2011). In COPD, GC hyperplasia (GCH) and metaplasia (GCM) are common, 
leading to increased mucus secretion and impaired lung function (Section 
1.7.3). The inflammatory conditions observed during pathological situations 
also induce mucous metaplasia, manifested by the up-regulation of mucin 
synthesis in Clara cells (Davis and Dickey, 2008).
Mucus
Secretion
Figure 1.6: TEM image of mucus secretion.
TEM image of the NHBE cells (in vitro cell culture) from Day 30. This image reveals a mucus 
droplet being released from a goblet cell at the apical surface of the BE. Scale bar represents 
2pM (Image courtesy of Dr. K. B6ruBe, Cardiff University).
1.4.3 Basal C ells
BCs are relatively round and small (Figure 1.7) in comparison to 
CCs and GCs (Rhodin, 1966), and are firmly attached to the basement 
membrane via hemidesmosomes (Section 1.5.1.2) (Knight and Holgate,
2003). They cover a large surface area and provide desmosomal attachments 
(Section 1.5.1.2) for CCs and GCs to the basal lamina, creating the pseudo­
stratified appearance (Baldwin, 1994). BC numbers decrease as the 
generations of the RpT increase, with BCs accounting for 31% in the airways 
with a diameter of 4mm or more, but only 6% in airways with a diameter of 
less than 0.5mm (Boers et al., 1998). A unique feature of the BCs is their 
progenitor stem cell-like ability, allowing them to repopulate the BE by 
differentiating into BCs, ICs, CCs and GCs (Breeze and Wheeldon, 1977; 
Ayers and Jeffery, 1988; Engelhardt et al., 1995; Hong et al., 2004).
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1.4.4  In ter m ed ia te  C ells
ICs can be seen throughout the pseudo-stratified BE positioned slightly above 
the BC layer but beneath the GCs and CCs (Figure 1.7). The term 
‘intermediate’ is indicative of cells that are in the process of differentiating into 
surface epithelial cells (Hasleton, 1996), and therefore the ICs are capable of 
differentiating into GCs and CCs (Blenkinsopp, 1967).
Figure 1.7: TEM image of the bronchial epithelium.
TEM image of the NHBE cells (in vitro cell culture) from Day 27. This image reveals the 
intermediate cells (IC) present throughout the pseudo-stratified BE, being positioned slightly 
above the basal cell (BC) layer but beneath the goblet and ciliated cells (CC). Scale bar 
represents 400pM (Image courtesy of Dr. K. B6ruB6, Cardiff University).
1.4.5 C la r a  C ells
As the airway progresses throughout the conducting region toward the 
bronchioles, the GCs are replaced by Cara cells (CIC) (Widdicombe, 2002). 
CIC are non-cilliated, non-mucus, dome-shaped, secretory epithelial cells, that 
contain microvilli on their apical surface. They are renowned for being 
metabolically very active and contain numerous mitochondria for this purpose 
(Boers et al., 1999). CICs are known to secrete a variety of proteins: 10kDa 
protein (CC10 or CCSP); 55kDa protein; tryptase, p-galactoside-binding 
lectin; surfactant proteins A, B and D (SpA, SpB and SpD); and 
phospholipase. CC10 si one of the most prevalent proteins in the airway lining
11
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fluid (Berne et al., 2004) with its main actions thought to be anti-inflammatory 
and immuno-suppressive (Singh and Katyal, 2000) CICs also possess a stem 
cell like ability, where they contribute to cell renewal in normal conducting 
airways (Reynolds and Malkinson, 2010).
1.5 D efen c e  M e c h a n ism s  o f  th e  R pT
The RpT is a prime target for oxidative injury due to its direct exposure to 
harmful compounds. Consequently, it relies on a battery of defence 
mechanisms to remove any potential threat. Initial protection is non-specific 
and provided by ever-present mechanical barriers and components of the 
innate immune system (Medzhitov and Janeway, 1997). Failure of the innate 
system to eliminate any inhaled debris (e.g. solid and gaseous detritus) 
results in the activation of the adaptive immune system; a specific response 
induced by exposure to non-self substrates (Gardner, 2006). The two systems 
are not mutually exclusive; they operate in conjunction with one another to 
protect the lung. The components of the two systems can be divided into non- 
immunological and immunological defence mechanisms.
1.5.1 N o n -Im m u n o lo g ic a l  D efen ce  M ec h a n is m s
Non-immunological processes are the first line of defence against inhaled 
xenobiotics. They include reflexive responses such as coughing or sneezing 
and mechanical barriers, including nasal hairs (i.e. vibrissae) and mucus 
(Korpas and Honda, 1996). Mucociliary clearance is considered to be non- 
immunological; however, many mucus components are, in fact, immunological 
(Section 1.5.1.3).
1.5.1.1 M ech an ic al  Ba rr iers
Inhaled particles are humidified as they enter the upper RpT, with their 
diameter determining their depth of penetration (Bittar, 2002). Nasal hairs act 
as the initial filter, trapping the majority of particles over 20pm in diameter. 
Mouth breathing also acts as a filter with the use of saliva and mucus lined
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walls, dissolving toxic gases (Germann and Stanfield, 2004) and preventing 
most particles over 10pm proceeding to the trachea (Berne et al., 2004). 
However, if particles do avoid capture by the nasal hairs and proceed to the 
nasal cavity, they can stimulate nerve endings, resulting in a cough or sneeze 
reflex. This either propels the particle from the body or allows them to be 
swallowed down the gastrointestinal tract (Hlastala and Berger, 2001).
1.5.1.2 C ell Ju n c tio n s  in th e  BE
Maintenance of the protective barrier between the cells of the BE and the 
airway lumen is essential for sustaining a healthy epithelial phenotype 
(Folkerts and Nijkamp, 1998). The cell-cell junctions present within the BE 
include the tight junctions (i.e. zonula occludens; closely associated areas of 
two cells), adherens junctions (i.e. zonula adherens; protein complexes that 
occur at cell-cell junctions in epithelial tissue), desmosomes (i.e. macula 
adherens; localised spot-like adhesions on lateral side of plasma 
membranes), and the gap junctions, whereby the cytoplasms of neighbouring 
cells are directly inter-connected, which allow ions to pass freely between 
cells. There are also cell-matrix junctions in the form of hemidesmosomes that 
anchor the cells to the basal lamina (Figure 1.8; Alberts et al., 2002).
1.5.1.3 M u c o c ilia r y  E scalator
Epithelial protection is provided by airway mucus, which is a viscoelastic gel 
that forms a thin film overlaying the internal surface of the airway (Chilvers 
and O'Callaghan, 2000). Mucus is a heterogeneous mixture of water, ions, 
proteins, lipids, glycoproteins and a myriad of primary defence mechanisms 
(i.e. inflammatory cells and immunoglobulins), with the major macromolecule 
constituent of mucus being the long, thread-like, high-molecular-weight 
glycoprotein mucin (Rose and Voynow, 2006). The secreted oligomeric mucin 
provides mucus with its Theological properties, by controlling its consistency 
and hence gel formation (Thornton and Sheehan, 2004). MUC5AC, MUC2 
and MUC5B are the major mucins present in airway secretions (Davies et al., 
2002), and recent studies have shown that activation of the epidermal growth
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factor receptor (EGFR) plays a pivotal role in the expression of the MUC 
genes (Takeyama et al., 2001; Rogers, 2003). The mucus functions by 
trapping harmful particles, allowing them to be removed by the cilia towards 
the pharynx for degradation or ‘mucociliary clearance’ (Figure 1.9; Braiman 
and Priel, 2008). Although mucociliary clearance is seen as a non- 
immunological process, numerous mucus components are in fact 
immunological, including, immunoglobulin A, lysozyme, and defensins, 
lactoferrin and collectins (Nicod, 1999; Boyton and Openshaw, 2002).
Airway Lumen
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Figure 1.8: Schematic diagram of the various epithelial cell junctions.
(a) Tight junctions are essential in maintaining the barrier properties of epithelial sheets. 
Adherens junctions are associated with actin filaments, usually forming an adhesion belt 
around the cells. Desmosomes form cell-cell contacts and are associated with intermediate 
filaments. Gap junctions allow the passage of small water-soluble ions and molecules. 
Hemidesomosomes resemble half a desmosomes and form cell-extracellular matrix junctions.
(b) TEM image of the NHBE cells {in vitro cell culture) from Day 9. This apical surface view 
shows microvillus tight junctions (TJ) and adherent junctions (AJ). (c) TEM image of the 
NHBE cells {in vitro cell culture) from Day 9. This image shows a desmosome (D), which is 
found at the mid-basal surface of the BE. Scale bars represent (b) 500nm and (c) 100nm. 
(Adapted from B6ruB6 etal., 2010b).
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Figure 1.9: Schematic diagram of the mucociliary escalator.
This diagram shows the involvement of the cilia in the propulsion of mucus out of the airways 
into the gastrointestinal tract (B6ruB6 et al., 2009).
1.5.2 Im m u n o l o g ic a l  D e f e n c e  M e c h a n is m s
The immunological defence mechanisms include constituents of both the 
innate and adaptive immune systems (Gardner, 2006). Both systems work 
concurrently, with components of the innate immune system generating 
signals that trigger the adaptive immune response (Medzhitov and Janeway, 
1997). Cells of both the innate and adaptive immunity systems recognise 
pathogen-associated molecular patterns (PAMPs) on invading pathogens, 
which are a diverse set of microbial molecules (Janeway and Medzhitov, 
2002). The PAMPs are recognised primarily through the toll-like receptors 
(TLRs) present on the cells of the innate and adaptive immunity systems; this 
activation goes onto to activate signalling pathways including the NF-kB 
pathway. The PAMPs are considered to be a subgroup of the larger damage 
associated molecular patterns (DAMPs) family (Bianchi, 2007).
1.5.2.1 In n ate  Im m u n ity
Innate immunity refers to the non-specific and ever-present components of 
the immune system (Table 1.1). They include the cells and their products that 
act immediately to eliminate inhaled pathogens within minutes to hours 
(Travis et al., 2001). Innate immune components include soluble proteins and
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leukocytes. They recognise a common microbial motif, that provides them 
with a broad specificity (Martin and Frevert, 2005).
Innate immunity 
cell type
Function within the innate immune 
system of the RT
Macrophage
• Non-specific phagocytosis and digestion of antigenic substances
• APC process ingested material for presentation to antigen- 
reactive lymphocytes
Neutrophil
Natural 
killer cell
•  Migrate to site of infection and phagocytise invading particles
• Contain enzymes within their secretary granules, aiding 
destruction of engulfed particles
• Kills infected cell not invading pathogens
• Activation releases perforin and granzyme which causes 
destruction of the infected cell by apoptosis/necrosis
Dendritic
cell
• Non-specific phagocytosis and digestion of antigenic substances
• APC process ingested material for presentation to antigen- 
reactive lymphocytes
• Induce T-lymphocyte proliferation
• The main link between innate and adaptive immunity
Table 1.1: Components of the innate immune system within the RT.
Innate immunity refers to the non-specific and ever-present components of the immune 
system. Antigen presenting cell, APC; surfactant protein, SP; leukotriene, LT; interleukin, IL, 
prostaglandin, PG. (White et al., 1995; Travis et al., 2001; Bittar, 2002; Com et al., 2003; 
Prussin and Metcalfe, 2003; Martin and Frevert, 2005; Gardner, 2006; Akuthota et al., 2008).
1.5.2.2 A daptive Immunity
The adaptive immune response is triggered following the failure of the innate 
system to eradicate pathogens (Medzhitov, 2007). The components of the 
innate system play a pivotal role in the activation of the adaptive system, via 
the antigen presenting cells (APC) (e.g. macrophages and dendritic cells) 
(Proud, 2008). Adaptive immunity is antigen specific and lymphocyte 
mediated (Table 1.2), accordingly, the system involves production of 
antibodies specific to sequences present on the invading pathogen in 
conjunction with activation of the T and B lymphocyte cells (Lederer et al.,
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1999). The lymphocytes provide a specific response to pathogens, however, 
the onset is slow with a delay of days compared to minutes for the innate 
components (Travis et al., 2001). The adaptive system involves production of 
antibodies specific to sequences present on the invading pathogen (Martin 
and Frevert, 2005).
Adaptive 
immunity 
cell type
Functions within the adaptive immune 
system of the RT
T-Cells
•  T-cells are activated upon antigen encounter, they continually 
circulate between the blood, tissue and lymph
• Cytotoxic T-cells (CD8+) adhere to cells and release their granule 
content (perforins, serine proteases and granzymes). They mediate 
cell lysis of cells displaying an antigen in conjunction with a class I 
MHC i.e. cells that have been infected
• T helper (TH) cells (CD4+) recognise cells displaying MHC class II in 
conjunction with an antigen
• Th1 cell differentiation is induced by cytokines, upon activation they 
themselves release specific cytokines including IL-2 and INF-y, 
leading to macrophage activation
• Th2 cell differentiation is induced by cytokines, upon activation they 
are involved in humoral immunity, themselves releasing specific 
cytokines including IL-4 and IL-5, leading to, plasma cell 
differentiation/antibody synthesis,
B-Cells
• Activated by direct antigen-antibody contact or by TH2 cell stimulation
• B-cells initially produce IgM which undergoes isotype switch to IgG, 
IgA or memory B-cells
• Ig release leads to neutralisation, opsonisation, complement 
activation and the formation of the ‘membrane attack complex’
Table 1.2: Components of the adaptive immune system within the RT.
The adaptive immune response is triggered following the failure of the innate system to 
eradicate any pathogens. Adaptive immunity is a complex response consisting of B and T 
lymphocytes. Major histocompatibility complex, MHC; Interleukin, IL; interferon-gamma, INF- 
y. (Moore etal., 2001, Bittar, 2002; Gardner, 2006).
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1.6 Lung  D isease
The human respiratory system is precariously balanced between healthy and 
diseased states (Rahman et al., 2006). Its constant exposure to the external 
environment through inhalation of ambient air, containing a myriad of harmful 
compounds, biological components and detritus, puts the defence 
mechanisms under strain, and in the event of these defence mechanisms 
being overwhelmed, lung disease can occur (Decramer et al., 2011).
1.7 C hr o n ic  O b s tr u c tive  P u lm o n a r y  D isea se  (C O P D )
COPD is a complex multifactorial lung disease that has been classified by the 
GOLD (Global Initiative for Chronic Obstructive Lung Disease) committee as 
ua preventable and treatable disease with some significant extrapulmonary 
effects that may contribute to the severity in individual patients. Its pulmonary 
component is characterised by airflow limitation that is not fully reversible. The 
airflow limitation is usually progressive and associated with an abnormal 
inflammatory response of the lungs to noxious particles or gases” (GOLD, 
2006). According to the World Health Organisation, COPD is currently the 
fourth most common cause of death Worldwide and is estimated to rise to 
third by 2020 (Raherison and Girodet, 2009). COPD severity has been 
classified by the GOLD committee using a scale of l-IV (Table 1.1). The least 
severe being Stage I, which represents an individual that is often unaware of 
any abnormal lung function. As the disease severity increases an individual 
forced expiratory volume in one second (FEVi) decreases significantly, 
restricting airflow and lung function (GOLD, 2006).
1.7.1 System ic E f fe c ts  o f  COPD
COPD is a systemic disease, with the pathological effects spreading far
beyond the lungs (Agusti, 2006). The comorbidities associated with COPD
include, cardiovascular disease, muscle wasting, diabetes, osteoporosis and
kidney disease; all of which usually arise once an individual is in the latter
stages of the disease (Langen et al., 2003; Decramer et al., 2005; Sin et al.,
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2006; Mannino and Braman, 2007; Nussbaumer-Ochsner and Rabe, 2011). 
The widespread consequences of COPD arise due to ‘systemic inflammation’, 
which is caused primarily by the elevated levels of endogenous reactive 
oxygen species (ROS) within the pulmonary tissue leaking into the blood 
stream (Oudijk et al., 2003). This was demonstrated by elevated levels of 
superoxide anion (02*') in the peripheral blood neutrophils of COPD patients 
(Morrison et al., 1999). In turn, the elevated levels of ROS within the blood go 
on to activate leukocytes, which themselves produce further ROS, all of which 
perpetuates the systemic inflammatory response (Rennard, 2007).
GOLD Stage FEVVFVC FEVi 
(%  Predicted) Symptoms
I
(Mild) <0.70 >80
• Chronic cough
• Sputum production 
(not always)
II
(Moderate) <0.70 50-80
• Chronic cough
• Sputum production
• Shortness of breath
III
(Severe) <0.70 30-50
• Increased shortness of 
breath
• Reduced exercise capacity
• Fatigue
• Repeated exacerbations
• Impaired quality of life
IV
(Very Severe) <0.70 < 3 0
• Respiratory failure
• Cor pulmonale 
(right heart failure)
• Severely impaired quality 
of life
Table 1.1: Classification of COPD severity.
There are four stages of COPD severity (l-IV), as classified by the GOLD committee. Patients 
with Stage I COPD are often unaware of any abnormal lung function, experiencing only a 
persistent cough. Stage II patients also experience a persistent cough coupled with sputum 
production, by this point medical advice is usually sought. Stage III patients suffer impaired 
quality of life due to repeated exacerbations, fatigue and shortness of breath. By Stage IV 
patient develop respiratory failure, which often leads to cor pulmonale (right heart failure). 
Stage IV patients experience a severely impaired quality of like, with a total lung transplant 
often determined to be the only option for improved quality of life. FEVv forced expiratory 
volume in one second; FVC: forced vital capacity; cor pulmonale, elevation in the jugular 
venous pressure and pitting ankle oedema (Adapted from GOLD, 2006).
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1.7.2 COPD Risk F a c to rs
The main cause of COPD is cigarette smoke (CS), CS contains thousands of 
toxic compounds, (Section 1.8.2) including ROS, which are known to cause 
severe damage to the lung (MacNee and Rahman, 2001). The CS also 
enhances the damage caused by other environmental toxins, through the 
stimulation of neutrophils and macrophages, to release additional ROS 
(Taylor, 2010).
Smokers comprise of over 90% of all COPD sufferers (Boots et al., 2003). 
However, only a small proportion, 15-20%, of smokers go onto develop the 
disease (Snider, 1989); the exact characteristics of a ‘susceptible’ smoker 
remains elusive (Siafakas and Tzortzaki, 2002; Tonello and Poli, 2011). The 
‘susceptibility’ factor indicates that some individuals possess a greater 
resistance to oxidant imbalance than others, which is reinforced by the 
detection of up-regulated AO enzymes within smokers in comparison to non- 
smokers (Hackett et al., 2003).
Other contributing factors include age, with natural lung function beginning to 
decline in healthy individuals after the age of thirty (Fletcher et al., 1976). This 
is greatly accelerated in individuals with COPD, especially in patients who 
continue to smoke (Figure 1.10). Other risk factors include exposure to 
combustion derived particles from solid biomass fuels e.g. diesel exhaust, 
coal fly ash, coal, wood and straw (Lopez et al., 2006). It has also been 
suggested that genetic variations between individuals play a role in disease 
progression (Mannino and Buist, 2007) including a deficiency in a-1 
antitrypsin (ai-AT), which is a serine protease inhibitor. This deficiency has 
been detected in up to 3% of COPD sufferers (Stoller and Aboussouan,
2005).
1.7.3 COPD Diseases
COPD can be divided into three sub-diseases, which include chronic 
bronchitis, obstructive bronchiolitis and emphysema (Szilasi et al., 2006).
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However increasing evidence suggests that COPD is a heterogeneous 
disease that cannot be compartmentalised; and that treatment should be 
unique to each patient in accordance with the breadth of the pathological 
modifications present (Cerveri and Brusasco, 2010). The typical phenotypic 
adaptations within the airways of COPD sufferers include inflammatory cell 
infiltration, smooth muscle hypertrophy, goblet cell hyperplasia (GCH) and 
metaplasia (GCM) and increased wall thickening (Repine et a/., 1997). These 
adaptations lead to mucus hypersecretion in chronic bronchitis, small airway 
obstruction in obstructive bronchiolitis and parenchymal lung damage in 
emphysema (Szilasi et al., 2006).
100
Non-Sm oker or not 
Sensitive to Smoke
75-
Regular Smoker 
and Sensitive to 
Smoke
Cessation at 
***  4 5 y rs
Li.
Disability
25-
Cessation at 
X  65yrsDeath
25 40 8555 70
Age (Yrs)
Figure 1.10: Decrease in FEN  ^ overtime in smokers and non-smokers.
After the age of thirty there is a natural decline in FEV! (forced expiratory volume in 1s) or 
‘lung function’. However, in individuals that regularly smoke the decline is rapidly accelerated, 
this decline can be slowed down by the cessation of smoking. A FEVt of below 30% will 
cause disability, whereas a FEVt of below 10% will lead to death (Adapted from Raherison 
and Girodet, 2009)
1.7.3.1 C h r o n ic  B r o n c h itis
Chronic bronchitis is manifested as a persistent recurrent exasperation and 
bronchial hypersecretion (Fletcher and Pride, 1984), caused by large airway 
mucus gland hyperplasia and inflammation (Figure 1.11; Repine et al., 1997). 
It is clinically defined as a mucus producing cough that lasts 3 months and 
recurred for at least 2 consecutive years (MRC, 1965; Hansel and Barnes,
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2004). Recent work has defined chronic bronchitis as an inflammatory sub- 
type of COPD, with an elevated distribution of eosinophils toward the airway 
lumen (Snoeck-Stroband et al., 2008).
1.7.3.2 O b str uc tive  Br o n ch io litis
The inflammation in COPD causes obstruction of the small and peripheral 
airways, predominantly as a result of smoking. Pathological features of 
obstructive bronchiolitis include: mucus hypersecretion, as a result of GCH 
(Ebert and Hanks, 1981) and collapsing of the lumen, which is due to high 
surface tension produced by the excessive mucus (Szilasi et al., 2006). Other 
pathologies include: fibrosis, loss of alveolar attachments and smooth muscle 
hypertrophy (Figure 1.12; Hansel and Barnes, 2004). The remodelling of the 
small airways is thought to be a consequence of CS inducing an inflammatory 
response followed by a repair process, in conjunction with the direct induction 
of growth factors (Churg et al., 2006).
1.7.3.3 E m ph ysem a
Emphysema has been defined as “the permanent destructive enlargement of 
airspaces distal to the terminal bronchioles, and a loss of alveolar 
attachments due to apoptosis and necrosis of alveolar epithelial cells” 
(Fletcher and Pride, 1984). There are two forms of emphysema, i.e. 
centrilobular and panlobular/panacinar (Kim et al., 1991), both of which are 
associated with a decreased diffusing capacity and appear as reduced lung 
parenchymal density on a chest radiograph (Repine et al., 1997). 
Centrilobular emphysema is most common in smokers, with the respiratory 
bronchioles (RB) being the main site of inflammation; particularly the 3rd order 
RBs. Panacinar emphysema is most common in patients with a a1-AT 
deficiency, and is localised in the lower lung lobes, effecting the RB, alveolar 
ducts and sacs equally (Szilasi et al., 2006).
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Figure 1.11: Normal bronchus and chronic bronchitis.
The normal bronchus has a pseudo-stratified appearance with bands of smooth muscle that 
do not form a complete layer. During chronic bronchitis there is smooth muscle and 
submucosal gland hypertrophy, GCH and increased mucus production and cartilage 
degeneration (Adapted from Hansel and Barnes, 2004).
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Figure 1.12: Normal bronchiole and obstructive bronchiolitis.
The normal bronchiole has a simple cuboidal appearance, with a continuous layer of smooth 
muscle. During obstructive bronchiolitis there is smooth muscle hypertrophy, loss of alveolar 
attachments, GCM leading to increased mucus production (Adapted from Hansel and Barnes, 
2004).
1.7.4 In f l a m m a t io n  in  COPD
The current working definition of COPD (Section 1.3.1) was only recently
amended to acknowledge inflammation as a key process, this sparked
significant interest into the inflammatory responses, which consist of
neutrophils, macrophages and T lymphocytes (Barnes et al., 2003).
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CS is considered to be the major cause of COPD (Section 1.7.2), mainly due 
to the increased oxidant burden it imparts on the lungs (Taylor, 2010). The 
elevated oxidant (ROS) levels imparted by CS propagates abnormal 
inflammation in three ways (Figure 1.13): (1) by increasing the epithelial 
permeability causing an influx of inflammatory cells, which in turn activates 
inflammatory mediators (Morrison et al., 1999); (2) by directly activating the 
epithelial lining to release inflammatory mediators (Takizawa et al., 2000) and
(3) by direct activation of macrophages (Oudijk et al., 2003). In each case, 
there is recruitment of inflammatory cells to the lungs. Inflammatory cell influx 
is measured by an increase in neutrophil (severe inflammation) and 
macrophage (mild inflammation) levels in the bronchoalveolar lavage fluid 
(BALF), which is evident in the BALF of smokers in comparison with non- 
smokers, and also when comparing smokers with and without COPD (Saetta,
1999). The inflammatory process in patients with COPD is characterised by 
an influx of neutrophils, CD8+ lymphocytes, monocytes, and on occasion 
eosinophils (Jeffery, 2000).
The macrophages are components of the innate immune response (Taylor, 
2010), with numbers consistently elevated in the lungs of smokers and COPD 
patients (Tetley, 2002). It has also been stated that macrophage numbers are 
proportionate to the chronicity of the disease (Finkelstein et al., 1995). 
Macrophages have a significant role in driving the inflammatory process by 
generating ROS and inflammatory mediators such as leukocyte 
chemoattractants, e.g. TNF-a and IL-8, which attract a variety of leukocytes, 
such as neutrophils, causing further inflammation (Figure 1.13; Szilasi et al.,
2006).
Neutrophils, like macrophages, form part of the innate immune response. 
They are responsible for producing ROS, and chemoattractants, e.g. IL-8. IL-8 
recruits further neutrophils to the site of inflammation, perpetuating the 
inflammatory response (Szilasi et al., 2006). Neutrophilia is a prominent 
feature of COPD (Figure 1.13; Rytila et al., 2006) with elevated levels of 
neutrophils observed in the induced sputum of COPD sufferers (Keatings et 
al., 1996). A unique way in which neutrophils drive COPD is through the
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production of serine proteases known to stimulate mucus production and 
cause alveolar destruction which contribute to chronic bronchitis and 
emphysema (llumets et al., 2008).
The cytokine TNF-a is secreted by cigarette smoke activated macrophages; it 
can mediate epithelial cell apoptosis, as well as being able to induce both the 
expression of itself and IL-8 (Szilasi et al., 2006). Both TNF-a and IL-8 are 
also regulated by the transcription factor nuclear factor kappa B (NF-kB), 
which itself is known to be activated by oxidants. Thus illustrating that this key 
inflammatory response is redox sensitive (Rahman and MacNee, 1998; 
MacNee, 2001).
C igarette  Sm oke
M acrophage
TN F-a
t  Num bers  
f  Secretions
Epithelial Cells
Em physem a
Neutrophil
IL-8
Figure 1.13: Inflammation in COPD.
CS imparts elevated levels of ROS onto the pulmonary tissue which in turn propagates 
abnormal inflammation in three ways: (1) increases epithelial permeability, to allow 
inflammatory cell influx; (2) directly activates macrophages to release inflammatory mediators 
and; (3) directly activates epithelial cells to release inflammatory mediators. The activated 
macrophages release TNF-a, which in turn causes the release of IL-8. IL-8 attracts 
neutrophils, which themselves secrete IL-8 to perpetuate the response. The activated 
macrophages and neutrophils elicit the pathological responses, which include mucus 
hypersecretion and parenchymal destruction (emphysema). The effects of ROS are 
discussed in more detail below (Adapted from Hansel and Barnes, 2004).
M ucus Hypersecretion
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1.7.5 COPD and O xidative S tre s s
Progression of COPD within an individual coincides with an increase in 
oxidant burden, coupled with insufficient AO capabilities (Rahman, 2006). 
This imbalance was demonstrated by elevated levels of oxidative stress 
indicators within the COPD patients (Boots et al., 2003). The stress indicators 
included: lung inflammation (MacNee, 2001), exhaled hydrogen peroxide 
(H20 2) (Nowak et al., 1996) and 8-isoprostane (Kinnula et al., 2007), lipid 
peroxidation products (LPO) (Nowak etal., 1999), and protein damage (Janoff 
et al., 1983).
Oxidants within the lung, produced by inflammatory cells or via smoke 
inhalation, contribute to the pathogenesis of COPD via several mechanisms 
(Figure 1.14): (1) inactivation of anti-protease mechanisms including secretory 
leukocyte protease inhibitor (SLPI) and OrAT, leading to increased 
proteolysis (Owen, 2005); (2) stimulation of mucus secretion (Cerveri and 
Brusasco, 2010); (3) activation of NF-kB which is known to propagate COPD 
symptoms by activating neutrophil chemoattractants (Szilasi et al., 2006) and;
(4) oxidative stress causes the formation of isoprostanes that cause mucus 
hypersecretion and bronchoconstriction (Kinnula et al., 2007).
There is evidence of increased oxidative stress in the airways of patients with 
COPD that is increased further in severe and very severe exacerbations of 
the disease. This is associated with increased neutrophil influx and IL-8 levels 
during exacerbations (Drost et al., 2005).
1.8 R eactive  O xygen Species
ROS including 0 2#", hydroxyl radical (OH*) and hydrogen peroxide (H20 2), are 
named so as they possess a higher reactivity in comparison to molecular 
oxygen (0 2) (Thannickal and Fanburg, 2000). There are endogenous and 
exogenous sources of ROS within the lungs (Figure 1.15). Both the 
inflammatory response and metabolic by-products are endogenous sources of
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ROS (Halliwell and Gutteridge, 1999), whereas an example of a primary 
exogenous source is CS (Taylor, 2010).
N eutroph il
M acrophage C igarette  S m oke
TN F-a
N F -kB
Anti-Proteases
(o,-AT) ROS
TNF-aIL-8
OH, ONOO-
Proteolysis
Neutrophil
Recruitment
Isoprostane B ron ch o co nstric tion
t  M ucus S ecretion
Figure 1.14: The effect of ROS on COPD pathology.
The ROS, superoxide anion (02*"), hydroxyl radical (OH‘), peroxynitrite (ONOO) and 
hydrogen peroxide (H20 2) are released from cigarette smoke and inflammatory cells. All of 
which mediate several damaging phenotypic adaptations manifested in COPD sufferers e.g. 
increased mucus secretion, bronchoconstriction, increased isoprostane levels, neutrophil 
recruitment and increased proteolysis (Adapted from Hansel and Barnes, 2004).
1.8.1 E ndogenous  ROS Production
The incomplete reduction of O2 to 02*'during cellular respiration is the primary 
source of ROS within the lung (Halliwell and Gutteridge, 1999). Superoxide 
anion is enzymatically or spontaneously dismutated to produce H2O2 (O2*' + 
O2’* +2H' -> H2O2 + O2) (McCord and Fridovich, 1969), which in the presence 
of a transition metal ion forms the extremely reactive and toxic OH* via the 
Fenton reaction (H2O2 + Fe2+ -> Fe3+ + OH' + OH’). It can also react with 
nitric oxide (NO) to produce peroxynitrite (ONOO ) that can go on to form the 
highly reactive OH* via decomposition (Figure 1.15; Halliwell, 1991).
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Other endogenous ROS producers within the lung include eosinophils, 
alveolar macrophages, monocytes and neutrophils (Ciencewicki et a/., 2008). 
These phagocytic cells have O2*' generating plasma membranes (PM), 
utilizing the NADPH oxidase or xanthine/xanthine oxidase systems, which 
function during host defence (Thannickal and Fanburg, 2000). They are 
activated during inflammation causing what is known as a ‘respiratory burst’ 
(Doelman and Bast, 1990), whereby ROS are produced as a result of 
increasing oxidant levels; this positive feed-back mechanism results in 
numerous lung diseases (Halliwell and Gutteridge, 1999). Non-phagocytic 
cells produce ROS, but in lower levels, in response to extracellular stimuli 
such as growth factors (Thannickal et al., 2000) and cytokines (Thannickal 
and Fanburg, 1995). The generation of ROS from these cells utilises the 
NADPH oxidase system (Rhee et a/., 2003).
1.8.2 Exogenous ROS P ro d u c tio n
Due to the location and function of the lung, it is in direct contact with airborne 
oxidants e.g. nitrogen dioxide, ozone, radiation (Janssen et al., 1993) and CS 
(Taylor, 2010), all of which generate ROS, that cause lung damage via 
inflammatory responses. CS, in particular is highly toxic, containing a mixture 
of over 4,700 components (Sexton et al., 2008), including semiquinone 
radicals, 0 2 ", NO and numerous carcinogenic organic compounds; all capable 
of reacting further to produce highly reactive species leading to serious injury 
(Nakayama et al., 1989). The inhalation of air pollutants causes a localised 
inflammatory response, recruiting inflammatory cells (Section 1.7.4) that 
release more ROS, thus enhancing the pathological effects (Ciencewicki et 
al., 2008). Exogenous ROS can also go on to trigger endogenous ROS 
production by inflammatory cells, e.g. neutrophils and macrophages (Rahman 
and Adcock, 2006).
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Figure 1.15: Cellular generation of ROS.
There are numerous exogenous and endogenous sources of ROS, reactions occur 
endogenously that lead to the production of yet more toxic species. Superoxide anion (0 2* ), 
hydroxyl radical (OH*), hydrogen peroxide (H20 2), nitric oxide (NO), peroxinitrite (ONOO ), 
nitrogen dioxide (N02), ferrous ion (Fe2+), superoxide dismutase (SOD) (Adapted from 
Rahman et al., 2006).
1.8.3 O xidative  Stress
Oxidative stress refers to an increased generation of ROS within cells and 
tissues, however, it has recently been argued that the term oxidative stress 
should be redefined as “disruption of redox signalling and cycling”, as this is 
the exact consequence of excessive amounts of ROS, resulting in pulmonary 
damage (Jones, 2006). All the major lung inflammatory diseases share a 
common feature of oxidant/AO imbalance (Rahman et al., 2006), leading to 
‘disrupted redox signalling’, ‘phenotypic adaptation’ and eventual ‘tissue 
remodelling’ (Figure 1.16; Heintz, 2008).
Increased oxidant burden leads to cycles of injury and repair causing 
perturbations that result in increased ROS production (Valko et al., 2007).
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Elevated ROS levels activate redox dependant signalling pathways causing 
changes in gene expression and phenotypic adaptation, with consequent 
compromised cell morphology and function (Genestra, 2007). Disrupted redox 
signalling leads to augmented expression of redox sensitive genes, including 
AO such as the peroxiredoxins (Prxs). This is characteristic of numerous 
pulmonary disorders (Chang et al., 2001; Kinnula et al., 2002a; Kinnula et al., 
2002b; Lehtonen et al., 2004; Park et al., 2006a), including COPD (MacNee,
2000).
Homeostasis Chronic Oxidative Phenotypic Adaptation
Stress
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Redox
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Disrupted Redox 
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Normal Oxidant Increased ROS Augmentation of Redox
Metabolism Production Associated Genes
Figure 1.16: A model for the role of ROS in the pathogenesis of lung disease.
Optimal redox signalling occurs to maintain homeostasis within the lung of a healthy 
individual. Following chronic oxidative stress there is increased ROS production, leading to 
cycles of injury and repair. Over-time the redox signalling within the lung is permanently 
disrupted, leading to phenotypic adaptation through the augmented expression of redox 
associated genes such as antioxidants (Adapted from Heintz, 2008).
1.8.3.1 C ellular Damage Caused by Oxidative  Stress
Chronic oxidative stress causes significant damage to all aspects of the lungs’ 
tissue, structure and function including: (1) lipid peroxidation, which is a direct 
result of oxidative stress, causing cell membrane damage and ultimately cell 
death (Chen et al., 2007); (2) oxidation of the polypeptide backbone within 
proteins, yielding peptide bond cleavage and amino acid side chain 
modification (Kelly and Mudway, 2003); (3) formation of the reactive OH* 
following radiation exposure, which damages DNA and alters gene and 
protein expression (Evans et al., 2004) and; (4) DNA base oxidation, often 
found in malignant tumours. However, the role of ROS in cancer is thought to
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be more complex than this, with it exhibiting additional effects on p53 and cell 
proliferation (Halliwell, 2007b).
1.8.4 ROS S ig n a llin g
Although ROS on the whole are viewed as unwanted and harmful metabolic 
by-products, there is growing evidence of their roles as mediators in cell 
signalling processes (Valko et al., 2007). Non-phagocytic cells can produce 
ROS in response to cytokines and growth factors (Section 1.8.1) but at lower 
levels in comparison to phagocytic cells. These lower levels of ROS are 
thought to be for the purposes of cell signalling and regulation (Winterbourn 
and Hampton, 2008). Numerous cytokines and growth factors have been 
shown to act in ligand-induced ROS production leading to diverse cellular 
functions (Thannickal and Fanburg, 2000). ROS signalling is transduced by 
either the oxidative modification of proteins, i.e. cysteine residues, or by 
intracellular redox state alterations (Janssen-Heininger et al., 2008).
1.8.4.1 H20 2: A n Intracellular  M esse n g er
The toxic effects of H20 2 have been well characterised, therefore, the 
suggestion of cells producing seemingly harmful molecules, to act as signal 
transducers, was met with cynicism (Forman et al., 2004; Rhee, 2006). 
Nevertheless, the role of NO, itself a reactive species (Sections 1.8.1 and 
1.8.2), in signal transduction is unanimously accepted, whereby high levels 
are produced by phagocytic cells during host defence and low levels 
generated by non-phagocytic cells for use in signal transduction; it is in the 
same manner that H20 2 is thought to function (Finkel, 1998). It is now 
accepted that low levels of H20 2, produced by non-phagocytic cells, act as 
intracellular messengers mediating cell proliferation, differentiation and 
migration (Rhee et al., 2000). Until recently, the mechanism by which H20 2 
functioned in signal transduction remained elusive. It has since been revealed 
that H20 2 modifies its target molecules through the oxidation of essential 
cysteine residues, which include protein tyrosine phosphatases and the lipid 
phosphatase PTEN (Rhee etal., 2005b).
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1.8.4.2 Detr im e n ta l  ROS S ig n a llin g
Not all oxidant-mediated signalling is required for normal cellular function, the 
redox-sensitive activation of transcription factors by ROS initiates 
inflammatory responses throughout the lung (Poli et al., 2004; Waris and 
Ahsan, 2006). An example of this is the release of the pro-inflammatory 
cytokine IL-8 in lung epithelial cells following the oxidant-mediated NF-kB 
DNA binding (Antonicelli et al., 2002). Another example is the activation of the 
MAP Kinase and/or redox-sensitive signalling cascades in lung epithelial cells, 
following oxidant inhalation. This leads to the activation of several target 
genes, initiating cell proliferation, differentiation, inflammation and death 
(Figure 1.17; Mossman et al., 2006; Waris and Ahsan, 2006).
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Figure 1.17: Signalling cascades triggered by ROS.
The two mitogen activated protein kinases (MAPK) pathways (i.e. JNK and MEK), and the 
redox sensitive kinase pathway are three pathways through which ROS exert an effect, 
leading to the augmentation of redox sensitive genes and ultimately phenotypic adaptations, 
including, cell proliferation, differentiation and death. JNK: c-Jun N-terminal kinase; MEK: 
mitogen-activeted protein kinase kinase; ATF: activating transcription factor; Erk: extracellular 
signal-regulated kinase; NADPH: nicotinamide adenine dinucleotide phosphate (Adapted from 
Waris and Ahsan, 2006).
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1.9 L ung  A n tio xid a n t  D efen c e  M e c h a n ism s
In broad terms, an AO can be defined as “a substance that when present at 
low concentrations, compared with that of an oxidisable substrate, 
significantly delays or prevents oxidation of that substrate” (Halliwell and 
Gutteridge, 1999). Oxidative stress is detrimental to numerous 
macromolecules (Section 1.8.3.1), therefore the term ‘oxidisable substrate’ 
encompasses the vast majority of intracellular molecules (Halliwell, 1991). 
ROS are produced as by-products of cellular metabolism, in addition to their 
intake via exogenous sources (Section 1.8). Consequently, AO mechanisms 
have evolved to protect the organs most at risk from oxidative damage, 
namely, the lungs (Fridovich and Freeman, 1986; Halliwell, 2006). The 
purpose of these mechanisms is to maintain the precarious balance between 
oxidant and AO levels ensuring healthy lung function (Rahman et al., 2006). 
The AO defence mechanisms can be divided into two categories: (1) the non- 
enzymatic and (2) the enzymatic; both defence mechanisms differ between 
tissues and environment (Kirkham and Rahman, 2006). In addition to the 
endogenous AOs, there have been several studies using AO as therapeutic 
interventions. These include dietary AOs e.g. Vitamin C and E, thiols, e.g. 
GSH, enzyme mimetics e.g. the SOD mimetics M40401 and polyphenols e.g. 
flavenoids (Kirkham and Rahman, 2006).
1.9.1 No n -E n zy m a tic  A n tio xid an ts
Non-enzymatic or ‘scavenger’ AO are low weight compounds that act as 
scavengers, reacting directly with oxidising agents (Rahman et al., 2006). 
They include: p-carotene, uric acid (UA), albumin, vitamin E, vitamin C and 
glutathione. P-carotene and UA both react with peroxyl radicals and 0 2*‘. 
Albumin functions by binding to transition metals and preventing Fenton 
chemistry reactions (Comhair and Erzurum, 2002). Vitamin E reacts with lipid 
peroxyl radicals (Bast et al., 1991) and vitamin C reacts with 0 2*' and HO*, 
forming a free radical that is reduced by reduced glutathione (McCay, 1985). 
GSH reacts non-enzymatically by binding to radicals via its reactive sulphide 
bond (Kelly, 1999).
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1.9.2 E nzymatic  A ntioxidants
There are a host of enzymatic AO that protect the lungs by reacting with 
oxidants to produce less toxic species (Kinnula, 2005). These include 
superoxide dismutases (SODs), catalase, glutathione peroxidase, 
peroxiredoxins (Prx), thioredoxins, glutaredoxins, and heme oxygenase-1 
(Table 1.2). They all act to maintain a healthy oxidant/AO balance. However, 
incorrect functioning and in many cases, AO overexpression has been found 
in a variety of pulmonary diseases (Rahman et al., 2006).
Enzyme M r(KDa) Lung Localisation Function Diseases
Catalase 240 Macrophages, fibroblasts, pneumocytes
H20 2to water Lung parenchymal 
disease, asthma
Cu,Zn SOD 17-28
Bronchial, alveolar 
epithelium, macrophages, 
fibroblasts, pneumocytes
Scavenges 0 2’" Sarcoidosis, COPD, inflammation, hypoxia
EC-SOD 135
Bronchial epithelium, 
macrophages, neutrophils, 
vascular walls, pneumocytes
Scavenges 0 2" COPD, sarcoidosis, alveolitis, lung cancer
Glutathione
Peroxidase 85
Lavage cells, epithelium, 
macrophages, other lung 
cells
Organic 
hydroperoxides 
to organic 
hydroxides
COPD, asthma, CF
Heme
Oxygenase-1 30-33
Alveolar, bronchial 
epithelium, macrophages, 
inflammatory cells of lungs
Heme to carbon 
monoxide, 
billiverdin
Fibrosis, interstitial 
pneumonias, interstitial 
lung disease, COPD, CF
Mn,SOD 88
Bronchial epithelium, 
macrophages, neutrophils, 
vascular walls, pneumocytes
Scavenges 0 2‘* Asthma, sarcoidosis, interstitial lung disease
Thioredoxin 10-12 Bronchial epithelium, macrophages
Prot-S-S-Prot to 
Prot-SH
Idiopathic pulmonary 
fibrosis, CF, COPD
P e ro x ire d o x in 17-28 Alveolar, bronchial epithelium, macrophages
Antioxidant, 
signalling, H20 2 
breakdown
Alveolitis, COPD, 
hyperoxia, lung cancer
Table 1.2: Antioxidant enzymes of the lung.
The function, location and involvement in pulmonary diseases of the enzymatic antioxidants. 
Blue represents a decrease in expression within a given lung disease, green represents both 
an increase and decrease in expression. COPD: chronic obstructive pulmonary disorder;; CF: 
cystic fibrosis; 0 2*': superoxide anion; H20 2: hydrogen peroxide; Cu: copper; Zn: zinc; Mn: 
manganese; EC: extracellular; Prot: protein; S-S: disulpide bond (Adapted from Rahman et 
al., 2006). The peroxiredoxins (red) are the main focus of this research project.
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1 .1 0  P e r o x ir e d o x in s
Peroxiredoxins (Prxs) are a family of ubiquitously expressed AO enzymes, 
that exhibit peroxidase activity by reducing harmful organic peroxides (ROOH 
+ 2e' -> ROH + H20), produced both endogenously and exogenously 
(Hofmann et al.t 2002). In addition to reducing oxidants, the Prxs are capable 
of removing amino acid, peptide and protein hydroperoxides formed as a 
result of oxidative damage (Peskin et al., 2010). Prx family members exist in 
all kingdoms (Chae et al., 1994b) with sizes ranging from 20-30kDa. There 
are currently 6 Prx (Prx l-VI) mammalian isoforms with varied cellular location 
and expression patterns (Seo et al., 2000). There are very few residues that 
are conserved throughout the peroxiredoxin family, with the conserved sites 
located in the catalytic regions (Hofmann et al., 2002).
Prx
Subtype
Polypeptide
Length
Human Chromosomal 
Location
Cellular
Location
Prx I
(Typical 2-Cys)
199aa 1q34.1 Cytosol, Nucleus
Prx II
(Typical 2-Cys)
198aa 13q12 Cytosol,Membrane
Prx III
(Typical 2-Cys)
198aa 10q25-q26 Mitochondria
Prx IV
(Typical 2-Cys)
271 aa (Cleaved 
at 36-37)a
10p22.13 Cytosol, Golgi, 
Secreted
Prx V
(Atypical 2-Cys)
214aa (Cleaved 
at 52-53)a
11 q13
Mitochondria,
Peroxisome,
Cytosol
Prx VI
(1-Cys)
224aa 1q23.3 Cytosol
Table 1.3: Six mammalian Prx isoforms.
The 6 Mammalian Prx isoforms can be further divided into three subgroups regarding their 
catalytic mechanisms; typical and atypical 2-Cys and 1-Cys. Each isoforms varies in size and 
sub-cellular location, allowing diverse functions in addition to their peroxidase activity, aa: 
amino acid;a: these proteins are modified post-translation (Adapted from Wood et al., 2003b).
The 6 mammalian Prx isoforms are divided into three subgroups (Section 
1.10.2), in accordance with their catalytic reaction intermediates (Rhee et al.,
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2005a). It is important to note that the roles of Prxs are not restricted to 
peroxide reduction, with evidence of them participating in cellular functions as 
diverse as basal metabolism, cell cycle progression, cell signalling, 
proliferation, chaperone activity, differentiation and apoptosis (Prosperi et al., 
1993; Kang et al., 1998b; Leyens et al., 2003; Forman et al., 2004; Phalen et 
al., 2006; Kim et al., 2008). In a review by Hoffman and co-workers it was 
stated that ‘Prxs should not be underestimated and thought of only as a back­
up system in the defence against peroxides, but that their discrete regulatory 
roles should be further investigated’ (Hofmann et al., 2002).
1.10.1 P rx  D isc o ver y
Peroxiredoxins were initially discovered in yeast via an observation that yeast 
glutamine synthase was degraded in a purified but not a crude extract. This 
discovery lead to the determination that a mechanism was present within the 
crude extract that provided protection against reactive chemical species (Kim 
et al., 1985). Further investigation by the group lead to the isolation of a 
25KDa protein, thiol-specific antioxidant (TSA), named due to its ability to 
protect cellular components from oxidation systems in which thiols function as 
the reducing equivalent (Kim et al., 1988). Later work deemed thioredoxin 
peroxidase (TPx) to be a more appropriate name than TSA. This was due to 
the thiol-containing donor molecule, thioredoxin (Trx) being identified as the 
electron donor within the catalytic cycle (Chae et al., 1994a). However, 
following the isolation and cloning of the cDNA corresponding to TSA from rat 
brain, TPx was regarded as misleading, with some TPx homologs reducing 
peroxides without Trx. The name Prx was therefore more suitable to 
encompass the entire family (Chae et al., 1994b).
1.10.2 P rx  S u b g r o u p s
Unlike other peroxidases, such as catalase and glutathione peroxidase (GPx), 
Prxs do not contain any redox cofactors (Chae et al., 1994c). Their ability to 
reduce peroxidases stems entirely from conserved redox-active cysteine 
residues, i.e. the N-terminal (N-term) peroxidatic cysteine (Sp) and the C-
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terminal (C-term) resolving cysteine (S r) (Wood et al., 2003b). Prxs were 
initially divided into two subgroups, based on the number of cysteine residues 
required for their catalytic function, 2-Cys Prx (S P and S r required) and 1-Cys 
Prx (Sp only required) (Chae et al., 1994b). The conserved cysteines were 
identified at amino acid positions 47 and 170 in yeast, and mutagenesis 
investigations to replace the conserved cysteines with serine revealed that 
Cys-47 was the primary site of oxidation. This determined that Cys-47 (SP) 
was essential to AO function, with cysteines corresponding to Cys-47 
identified as the conserved residues in both 2-Cys and 1-Cys subgroups. The 
presence of the second conserved cysteine (Cys-170) seemed to be 
dependent on the sequence conservation surrounding the N-term cysteine 
(Chae et al., 1994c). More recent evidence shows a further divide in the 2-Cys 
subgroup, known as the typical and atypical 2-Cys Prxs, with the atypical type 
having only one conserved cysteine but requiring another for its catalytic 
function (Seo et al., 2000; Rhee e ta i, 2001).
The three Prx subgroups undergo a 2-step catalytic cycle, where step one 
involves the reduction of the peroxide leading to the oxidation of the Prx, and 
the second step sees the reduction of the oxidised Prx returning it to its 
original state. The first step in this cycle is common to all three subgroups 
(Choi et al., 1998), in which the peroxide is reduced following a nucleophilic 
attack by the SP, leading to the formation of cysteine sulphenic acid (SPOH) 
(Figure 1.18; Ellis and Poole, 1997). The mechanism by which Prxs are 
recycled distinguish the three subgroups (Wood eta i, 2003b).
1.10.2.1 T ypica l  2 -C ys  Prxs
The typical 2-Cys Prxs (Prx l-IV) are C-term swapping (Hirotsu et al., 1999) 
head-to-tail homodimers (Chae et al., 1994c). They contain conserved SP and 
S r that form an inter-subunit disulphide bond following SP oxidation (Ellis and 
Poole, 1997). The oxidation of the SP causes a conformational rearrangement 
bringing the SP and S r into close enough proximity to form a disulphide bond 
(Hofmann et al., 2002); Trx was identified as the reducing agent (Chae et al., 
1994a). Following the purification of a mammalian Prx (Chae et al., 1994b), a
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database search revealed homologs that were initially characterized without 
reference to their peroxidase activity, and these were later classified as Prx I- 
IV (Table 1.4).
H 2N > ^ - N N krg
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Figure 1.18: Peroxide reduction, the first step in the Prx catalytic cycle.
The first step in the Prx mechanism is common to all subgroups; (i) the initial deprotonation of 
the peroxidatic cysteine (SP) by a catalytic base (B). (ii) The SP reduces the peroxide through 
a nucleophilic attack; a conserved arginine residue stabilizes the thiolate anion, (iii) The RO' 
leaving group is protonated by a catalytic acid (C). (iv) Finally there is formation of a sulphenic 
acid (SPOH) (An intermediate for the 2-Cys Prx subgroups, but more stable in the 1-Cys Prxs) 
(Adapted from Wood et al., 2003b).
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Figure 1.19: Typical 2-Cys Prx catalytic cycle.
The typical 2-Cys Prxs contain conserved peroxidatic (SP) and resolving (SR) cysteines. The 
reduced form of the enzyme (1) (SP-H), reduces hydrogen peroxide leading to the formation 
of the cysteine sulphenic acid intermediate (2) (SP-OH), rearrangement of the homodimer 
allows the SP and SR to form an intersubunit disulphide bond (3) (condensation). Thioredoxin 
acts as a reducing agent, returning the enzyme to its original state (Adapted from D'Autreaux 
and Toledano, 2007).
Characterisation results revealed that Prx I and II are located in the cytosol, 
where they remove H2C>2 generated as a by-product of metabolism and also in 
response to growth factors; thus enforcing their role as cell signalling 
mediators (Chae et al., 1999). Prx III is localised in the mitochondria, it 
contains a much longer amino acid (aa) chain in comparison to Prx I and II, 
which is due to the addition of its mitochondrial targeting sequence (Rhee et 
al., 2001). Recent work suggests that Prx III is a critical regulator of 
mitochondrial H20 2 levels, and hence, a key regulator of apoptotic signalling 
(Chang et al., 2004). Prx IV is a secretory protein initially identified through its 
interaction with Prx I (Jin et al., 1997). It contains an N-term hydrophobic 
sequence, consistent with other secretary proteins and was located in the 
endoplasmic reticulum of COS-1 cells (Matsumoto et al., 1999).
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Prx Subtype Mammalian Homologs
Prx I NKEF-A, PAG1, MSP23, OSF3, HBP23, TPx II
Prx II NKEF-B, TSA, Torin, PrP, TPx I
Prx III MER5, SP-22, Aop1, TPx III
Prx IV AOE 372, TRANK
Table 1.4: Typical 2-Cys Prx mammalian homologs.
The typical 2-Cys Prx mammalian homologues, most were originally identified without 
reference to their peroxidase function in a variety of species including humans (blue), murine 
(red) and bovine (green) NKEF-A: natural killer cell enhancing factor A; NKEF-B: natural killer 
cell enhancing factor B; PAG1: proliferator activated gene 1; MSP23: macrophage 23kDa 
stress-induced protein; OSF3: osteoblast specific factor 3; HBP23: heme binding protein 23; 
TPx: thioredoxin peroxidase; TSA: thiol-specific antioxidant; PrP: prion protein; MER5: murine 
erythroleukemia cells; SP-22: a substrate protein for mitochondrial ATP-dependant protease 
in bovine adrenal cortex; Aop1: antioxidant protein 1; AOE 372: antioxidant enzyme 372; 
TRANK: Tx peroxidase-related activator of natural killer k B and c-Jun N-terminal kinase 
(Harris, 1968; Yamamoto et al., 1989; Ishii et al., 1993; Lim et al., 1993; Prosperi et al., 1993; 
Chae et al., 1994b; Kawai etai., 1994; Shau and Kim, 1994; Watabe etai., 1994; Iwahara et 
al., 1995; Tsuji et al., 1995; Haridas et al., 1998; Mitsumoto et al., 2001).
1.10.2.2 Atypical 2-Cys Prxs
The atypical 2-cys Prxs (Prx V) were located in the cytosol, peroxisomes and 
mitochondria (Knoops et al., 1999). They are the most recently discovered 
members of the Prx family (Seo et al., 2000) and unlike the typical 2-Cys Prx, 
they are functionally monomeric (Declercq et al., 2001). They have only one 
conserved N-term cysteine (Cys-48), however, like the typical 2-Cys Prx, a 
further cysteine is required for catalytic function. Following oxidation to 
cysteine sulphenic acid (SpOH), Prx V forms an intra-molecular disulphide 
bond (Seo et al., 2000), where, like the typical 2-Cys Prxs, Trx is used as a 
reducing agent (Rhee et al., 2001). Prx V has also been shown to possess 
peroxynitrite reductase activity, allowing it to reduce harmful peroxynitrite to 
nitrite, and reducing the damage to cellular components (Dubuisson et al., 
2004).
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Figure 1.20: Atypical 2-Cys Prx catalytic cycle.
The atypical 2-Cys Prxs are functionally monomeric, they contain one conserved peroxidatic 
(SP) cysteine, but require a further non-conserved cysteine (shown here as SR) for their 
catalytic function. The reduced form of the enzyme (1) (SP-H), reduces hydrogen peroxide 
leading to the formation of the cysteine sulphenic acid intermediate (2) (SP-OH), this is 
followed by the formation of an intrasubunit disulphide bond (3) (condensation). Thioredoxin 
acts as a reducing agent, returning the enzyme to its original state (Adapted from D'Autreaux 
and Toledano, 2007).
1.10.2.3 1-Cys Prxs
The Mammalian 1-Cys Prxs were termed Prx VI (Rhee et al., 2001), and like 
the typical 2-Cys Prxs, they formed head to tail homodimers during catalysis. 
This subgroup was identified as a member of the Prx family following random 
cloning and sequence deduction (Nagase et al., 1995). Their subsequent 
characterisation revealed the ability to reduce peroxides but unlike the 2-Cys 
Prx subgroups, the 1-Cys Prxs utilizes only one conserved N-term cysteine for 
catalytic function (Cys-47), and hence, an inter- or intra-molecular disulphide 
bond is not formed during catalysis (Kang et al., 1998a). They are induced by 
oxidative stress, demonstrating their AO function (Kim et al., 2003). However, 
unlike the 2-Cys Prxs, they do not use Trx as a reducing agent and until 
recently, their recycling mechanism remained elusive. Subsequent work by 
Manevich et al. revealed that heterodimerisation between 1-Cys Prx and
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glutathione (GSH)-loaded ttG ST activates the enzyme. There is then a ttG ST  
catalysed glutathionylation of the oxidised cysteine (Sp-OH) allowing GSH 
access to spontaneously reduce the Sp-OH, to return it to an active form 
(Manevich et al., 2004). There are two distinct active sites within the 1-Cys 
Prxs (Chen et al., 2000), allowing them to be bi-functional enzymes with roles 
in lung phospholipid metabolism, in addition to their AO function (Manevich 
and Fisher, 2005).
1
Prx-S
GSSH
Prx-Sp-SG 
3
Figure 1.21: 1-Cys Prx catalytic cycle.
The 1-Cys Prxs (Prx VI) contain and require only one conserved Peroxidatic (SP) cysteine, for 
their catalytic function. The reduced form of the enzyme (1) (Prx-SPH) reduces the peroxide 
and forms cysteine sulphenic acid (2) (Prx-SPOH) in the process. This is followed by 
heterodimerisation of SP and GSH loaded ttGST (3), allowing the glutathiolynation of SP (Prx- 
SP-SG), the GSH is now in a position to act as the reducing agent, returning Prx to its original 
state (Adapted from Manevich and Fisher, 2005).
1.10.3 Prx Active  S ites
The first crystal structure of human Prxs was the 1-Cys Prx hORF6, which 
provided an insight into the active site arrangement and would serve as a 
basis for understanding the biological activities of Prxs (Choi et al., 1998). 
Examples from all Prx subgroups have now been crystallised and they reveal 
great similarities regarding Prx active sites (Choi et al., 1998; Hirotsu et al., 
1999; Declercq et al., 2001). The unusually high efficiency of Prx, when
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considering its catalytically active components suggested that the SP was 
activated. This was confirmed by crystallisation images of hORF6 (Figure 
1.22), revealing that the SP (Cys-47) is in close proximity to the positively 
charged guanidine group of Arg-132 and hydrogen bonded to His-39; both of 
which act to increase its nucleophilicity by stabilizing the thiolate anion (Choi 
et al., 1998).
Figure 1.22: Crystal structure of the hORF6 active site.
Rasmol simulation of the hORF6 active site pocket, SP (Cys 47) exists as Cys-SOH in the 
crystal, the hydrogen bonding (dotted lines) to His-39 and Arg-132 increases the 
nucleophilicity of Cys-47 by stabilising the thiolate anion (Adapted from Choi etai., 1998).
The active site of Prx like many other redox active proteins, is located within a 
thioredoxin-like fold (Choi et al., 1998). Further sequence analysis revealed 
that the SP of Prx and the selenocysteine of GPx are structurally equivalent 
(Schroder and Ponting, 1998). It has since become apparent that this loop- 
helix motif, which is largely hydrophobic, places the reduced SP in a solvent 
accessible narrow pocket. This is a feature of all Prx subgroups, as are the 
highly conserved residues Pro, Thr and Arg surrounding the SP (Hall et al., 
2010), with the exception of Thr being substituted for His in 1-Cys Prxs (Wood 
et al., 2003b).
1.10.4 Prx Regulation
Peroxide accumulation, in particular that of the intracellular messenger 
hydrogen peroxide (Thannickal and Fanburg, 2000), is often required for
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various cellular functions. Regulatory mechanisms are therefore present to 
reversibly inhibit Prxs. There is evidence of Prx regulation, through various 
post-translational modifications including, phosphorylation, truncation, 
oligomerisation and hyperoxidation (Chang et al., 2002; Koo et al., 2002; 
Wood et al., 2002; Yang et al., 2002). The Prx are known to be implicated in 
several signalling pathways, primarily through their ability to regulate 
intracellular concentrations of H2O2 (Rhee et al., 2005b). Accordingly, they 
have been linked to lung diseases including COPD (Chen et al., 2010).
1.10.4.1 Ph osphorylatio n
Prx I contains a consensus site (Thr^-Pro-Lys-Lys) that is phosphorylated 
specifically on Thr90 by cyclin dependant kinases (CDKs) and in particular 
Cdc2. Phosphorylation was shown to reduce peroxidase activity by 80% but 
only during mitosis (Chang et al., 2002), because Prx I is a cytosolic protein 
and its only contact with Cdc2 is following the breakdown of the nuclear 
envelope (Rhee et al., 2005a). This suggests that H2O2 accumulation is 
needed for cell cycle progression (Chang et al., 2002). Further work revealed 
that Prx II was also phosphorylated by Cdc2, with its inactivation speculated 
to occur in the same way (Rhee et al., 2005c). One possible target of the 
accumulated H2O2 is Cdc25C, a dual-specificity phosphatase that is 
inactivated by the increased levels of H2O2 . This action is thought to be part of 
a wider mechanism involving the initial activation of Cdc2 at the onset of 
mitosis (Figure 1.23). Whereby Cdc25C activates the cyclin B bound Cdc2 by 
dephosphorylating its Thr14 and Tyr15 residues (Morgan, 1995), Cdc2 then 
goes on to phosphorylate Prx I and II rendering its peroxidase function 
inactive. However, once H2O2 levels rise, Cdc25C is inactivated which may be 
important to promote exit from mitosis (Rhee et al., 2005c).
1.10.4.2 T runcation
Studies in Schizosaccharomyces pombe revealed that TPx, which is a 
member of the Prx family, displayed C-terminal truncations that affected its 
peroxidase activity and also rendered it less sensitive to peroxide
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overoxidation and subsequent inactivation. The inhibition of peroxidase 
activity resulted from the removal of a positive charge within Lys191, causing a 
loss of affinity to H2O2 , while the corresponding Lys residues are conserved in 
all Prx isoforms except Prx V (Koo et al., 2002). Isolated erythrocyte enzymes 
corresponding to Prx II were also shown to possess a truncated C-term (Cha 
et al., 2 0 0 0 ).
SH
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Figure 1.23: Inactivation of Prx I by Cdc2-dependant Phosphorylation.
The dual-specificity phosphatase Cdc25C activates cyclin B bound Cdc2 through the 
dephosphorylation of Thr14 and Tyr15, the activated Cdc2 goes on to phosphorylate Prx I on 
Thr90, rendering it inactive, allowing H20 2 accumulation which in turn inactivates Cdc25C by 
oxidising its catalytic cysteine residue (Adapted from Rhee etai., 2005c).
1.10.4.3 O l ig o m e r is a t io n
TEM work on torin, a human erythrocyte protein, which is now known as Prx II 
(Harris et al., 2001), revealed complexes resembling decamers (Harris, 1969). 
The typical 2-Cys Prxs are known homodimers (a2), but they are capable of 
existing in two different oligomeric states, dimers 0 2  and doughnut shaped 
decamers (0 2 )5  (Wood et al., 2002), with the dimeric form exhibiting less 
peroxidase activity in comparison to the decemeric form (Kitano et al., 1999). 
The transition between the dimeric and decameric form is thought to be 
regulated by the redox states of the enzyme (Barranco-Medina et al., 2009; 
Rinalducci et al., 2011), with the reduced Sp favouring the decameric form
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and the disulphide bonded Sp preferring the dimeric form (Wood et al., 2002). 
Continued overoxidation causes the decamers to aggregate into high 
molecular weight (HMW) species with chaperone activity (Barranco-Medina et 
al., 2009; Kim et al., 2009). However, it has recently been established that 
glutathionylation of Prx I leads to the dissociation of the HMW complex, and 
hence the loss of chaperone activity (Park et al., 2011).
1.10.4.4 Hyper o xid atio n
Hyperoxidation of the Sp inhibits the peroxidase activity of the 2-Cys Prxs. 
This occurs during catalysis when the cysteine-sulphenic acid (Prx-SpOH) is 
further oxidised to cysteine-sulphinic acid (Prx-Sp0 2 H), this cannot be 
reduced by thioredoxin (Rabilloud et al., 2002; Yang et al., 2002). This Prx 
inhibition was originally thought to be irreversible, yet subsequent research 
showed the reduction of the sulphinic form of Prx I, II and III to the active thiol 
form (Woo et al., 2003a; Woo et al., 2003b), the enzyme responsible for this 
was identified and named sulphiredoxin (Srx), a protein present in eukaryotes 
only (Biteau et al., 2003). The fact that Srx is present in eukaryotes only 
reinforces the findings that eukaryotic 2-Cys Prxs have evolved to become 
much more sensitive to oxidative inactivation in comparison to bacterial 2-Cys 
Prxs. The floodgate hypothesis has therefore been proposed, whereby basal 
levels of H2O2 are kept low, but higher levels are permitted during signal 
transduction (Wood et al., 2003a). Not only does hyperoxidation regulate 
intracellular signalling pathways, it has also been shown to affect cell cycle 
progression, with the hyperoxidation causing structural transitions leading to 
cell cycle arrest by alerting cells to perturbations in peroxide homeostasis 
(Phalen et al., 2006). Often the hyperoxidation caused in vitro is not as 
pertinent in vivo (Lehtonen et al., 2008).
1.11 In  Vitro  C e l l  C u ltu re
Traditionally, animal in vivo studies have been widely used in the field of 
respiratory toxicology; however, seeking viable human in vitro alternatives to 
accurately mimic the in vivo environment, has become increasingly important
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(BgruBg et al., 2009). In addition to the obvious advantages of human end­
point data, provided by the in vitro systems, there is also a need to reduce the 
number of animals used in scientific research (EU Directive 76/68/EEC, 
2003). In light of this, an increasing number of scientists are working towards 
the Three R’s principles, which refers to the “reduction, refinement and 
replacement” of animal experiments (Russell and Burch, 1959).
Whole animal in vivo inhalation studies provide systemic data on a given 
compound (B€ruB6, 2011); however, the task of extrapolating the data to 
predict human responses is complex (Miller et al., 1983). There are significant 
interspecies issues that impact on the reliability of the data, including, 
anatomical variations (Brody, 1984), disparities in cellular composition 
(Thomassen and Nettesheim, 1990) and differences in biotransformation 
(Castell etai., 2005).
To overcome the interspecies discrepancies often encountered with in vivo 
studies (Travis, 1991; Lin, 1998), human cell line cultures have been 
increasingly utilised (Table 1.5). There are two main types of human 
monolayers, carcinoma-derived and virus-transformed cell lines; both of which 
have their limitations (Forbes, 2000). The carcinoma-derived cell lines are 
sourced from human cells that have become carcinogenic, they are 
immortalised and can be passaged indefinitely, which is a great advantage in 
cell culture (Freshney, 2005). One example of a carcinoma-derived cell line is 
the popular Calu-3 cells that are sourced from a human bronchial 
adenocarcinoma. These cells have the ability to form tight junctions, develop 
cilia and produce mucin (Grainger et al., 2006), however due to their 
neoplastic nature they may present an abnormal phenotype and lack 
metabolic activity (Foster et al., 2000). The virally-transformed cell lines have 
been immortalised through the use of viral genes or vectors, examples of 
these commercially available cells lines include the BEAS-2B and 16HBE14o- 
cells (Steimer et al., 2005). The BEAS-2B cells have been transformed using 
the 12-SV40 adenovirus, these cells are able to express AOs (Veranth et al., 
2007) and secrete cytokines (Veranth et al., 2004), but lack the ability to 
secrete mucin and form tight junctions (Steimer et al., 2005). The 16HBE14o-
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cells have been transformed using the SV40 adenovirus (Westmoreland et al., 
1999), form tight junctions and develop cilia (Cozens et al., 1994), but fail to 
secrete mucus (Steimer et al., 2005). Consequently, the reliability of cell line 
data has been scrutinised, with some cell lines reported as containing the 
wrong cell type entirely (Drexler et al., 2003).
Cell Model Derivation Pros
Calu-3 Carcinoma of 
the Bronchus
• Immortalised
• Form Confluent 
Monolayers
• Develop Cilia
• Express Mucin Genes
BEAS-2B
Transformed
Bronchial
Epithelium
• Immortalised
• Form Confluent 
Monolayers
• Secrete Cytokines
• Express Antioxidants
16HBE14o-
Transformed
Bronchial
Epithelium
• Immortalised
• Differentiated & 
Multilayered
• Develop Cilia & Microvilli
• Secrete Cytokines
Table 1.5: Proximal lung cell lines.
The Calu-3 cell line is a carcinoma derived cell line, whereas the BEAS-2B and 16HBE14o- 
cell lines are both virally transformed (Adapted from B6ruB6 et al., 2010b).
An alternative to cell lines are primary cells, which originate from human 
donors, either during surgery or immediately after death. Both alveolar (Elbert 
et al., 1999) and tracheobronchial epithelial (Hill et al., 1998) primary cell 
cultures have been utilised as investigating models. However, monolayers in 
general have their disadvantages, with a wide body of evidence supporting 
the need for three-dimensional (3D) tissue physiology (Griffith and Swartz, 
2006; Pampaloni et al., 2007; BeruBe et al., 2010a; Scotton, 2011). The 
normal human bronchial epithelial (NHBE) cell culture model is derived from 
primary cells that differentiate into a fully-functioning pseudo-stratified BE 
containing ciliated, goblet, Clara, intermediate and basal cells. The model is 
cultured at an air-liquid interface (ALI), thus providing an in vivo like
• Variation in Tight 
Junction Formation
• No Mucin Secretion
• Lack Tight Junctions
• No Mucin Secretion
Cons Micrographs
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environment for chemical exposure (Figure 1.24; BeruBe et al., 2010b; 
Prytherch, 2010).
Phase-Contrast
Photomicrograph
IPNp
C ryo v ia l o f 
N H B E  ce lls
Passage 1
Cultured in
and 2
Flasks
Passage 3
Cultured in Inserts
Phase-Contrast
PhotomicrographBronchialEpithelium
Intermediate 
Cell 
Goblet Cell
Toxicological 
Analysis
T o x ican t/C o n tro l
M o rp h o lo g ic a l^  
A n alys isC la ra  C e llO
Ciliated Cell
Inter-Omic
Analysis
B a s a l C e ll
Figure 1.24: NHBE cells cultured at Air-Liquid Interface.
The Lonza (Basel, Switzerland) NHBE cells were taken from a post-mortem donors. Excision 
of the NHBE cells from donors was followed by maceration and enzyme digestion that 
returned the cells to their undifferentiated progenitor (basal) forms. The NHBE cells then 
underwent two Passages in flasks (T75 and T175), where they remained in their 
undifferentiated form. The cells were then transferred to individual Millipore inserts ® to be 
cultured at an ALI. The differentiated NHBE cell model then consisted of ciliated, goblet, 
Clara, intermediate and basal cells. Once the culture was fully formed and stable (Days 27- 
33) toxicological exposures took place (BeruB6 etai., 2010b, Drawn by C. Job).
1.11.1 NHBE C e l l  C u l t u r e  M o d e l
The natural history of the NHBE cell model during normal growth and 
development, as well as during toxicant challenge has been fully- 
characterised (Prytherch, 2010). The cells were purchased from Lonza 
(Basel, Switzerland) as cryopreserved primary cells (>500,000 cells/cryovial)
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and underwent two Passages in flasks, where they remained as 
undifferentiated basal cells, until transferred to individual Millipore inserts, 
creating an ALI, permitting cells to differentiate (Figure 1.24). An advantage of 
using this in vitro model is that it allowed different epithelial states including 
growth, differentiation and repair responses to be analysed, all of which could 
be used to elucidate the impact of ROS in both normal and diseased states 
(B6ruB6 etai., 2010a).
1 .12 B iom arkers
A biomarker is defined by the Biomarkers Definitions Working Group (BDWG) 
as “a characteristic that is objectively measured and evaluated as an indicator 
of normal biological processes, pathogenic processes, or pharmacologic 
responses to a therapeutic intervention” (BDWG, 2001). There are three 
classes of biomarkers, which include biomarkers of exposure (i.e. exogenous 
substrate or metabolite), biomarkers of susceptibility (i.e. ability of an 
organism to respond to exposure) and biomarkers of effect (i.e. measureable 
biochemical, physiological or other alteration within an organism) (Garban et 
al., 2005). The field of biomarker research is rapidly evolving, providing 
measurable end-points that are invaluable for diagnosis, disease 
management and drug approval (Puntmann, 2009).
1.12.1 B io m a r k e r s  in COPD
Biomarkers of COPD are generally taken from four main pulmonary sources, 
which include, sputum, bronchial biopsies, bronchoalveolar lavage (BAL) and 
exhaled breath (Barnes et al., 2006). Exhaled breath is the simplest form of 
analysis (Montuschi et al., 2010), producing markers such as 8-lsoprostane 
(Makris et al., 2008) and H2O2 (Dekhuijzen et al., 1996). Other common 
markers of COPD include inflammatory markers such as IL-8, increased 
proteases such as the matrix metalloproteinases (MMPs) (Barnes et al., 2006) 
and the acute phase protein, C -reactive protein, which is found in blood 
(Anderson, 2006).
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Oxidative stress has become widely accepted as the earliest pathological 
event, which leads to lung disease (Doelman and Bast, 1990; Valko et a/., 
2007). Therefore, biomarkers that reflect changes in cellular oxidation states 
as a function of normal redox signalling and environmental insults would be 
extremely useful for studying human disease processes in vitro and in vivo.
1.12.2 T he Prxs  as  B io m a r k er s
The Prxs become reversibly inactivated (Woo et al., 2003a; Woo et al., 2003b; 
Wood et al., 2003b; Cox et al., 2010a) and demonstrate altered expression 
levels (Rhee et al., 2001; Immenschuh and Baumgart-Vogt, 2005) during 
times of oxidative stress. They have also been shown to undergo structural 
transitions during the catalytic cycle and as such, may be utilised as 
candidates for biomarkers of oxidative lung injury (Phalen et al., 2006).
To assess the utility of using Prx as biomarkers, their expression levels, 
locations and oxidation states must be determined. These Prx parameters 
would need to be measured during both normal growth conditions and 
following insults, including H2O2 and CS, to allow the significance of any 
changes related to oxidative stress to be fully appreciated.
1.13 A im s  a n d  O b jec tives  of th e  S tu d y
1.13.1 T he  Hy p o th e s is
The hypothesis for this research project was three-fold:
1. Prx status can be used in conjunction with the in vitro NHBE cell 
model, as a biomarker of intracellular oxidative stress.
2. Exposure of the NHBE cell cultures to H2O2 and CS will alter Prx 
status, providing a parameter directly linking the level of oxidative 
stress to the injury severity and repair competency of the cell system.
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3. In vivo correlation analysis, with human lung tissue from COPD 
transplant patients, will substantiate the NHBE in vitro findings by 
confirming that Prx status is a sensitive biomarker of oxidative stress 
and epithelial remodelling.
1.13.2 P r o ject  A im s  a n d  O b jec tives
The overall aim of this project was to determine whether the 2-Cys typical Prx 
isoforms I, II and III could be used as biomarkers of intracellular oxidative 
stress, and hence the level of oxidative damage caused as a result of external 
insults i.e. H2O2 and CS. Furthermore, to determine whether the in vitro NHBE 
cell culture model could provide a system to evaluate the effect of the impact 
of ROS in normal as well as disease pathology phenotypes, using Prx status 
as dosimeters for redox dependant signalling events. Prx I, II and III were 
chosen as they were the three 2-Cys Prx isoforms expressed the strongest 
within the BE, which was the focus of this project.
The clinical application would be to establish whether the NHBE-Prx system 
could be utilised to assess the extent of oxidative damage caused as a result 
of inhaled or systemic drug exposure. The system could inform on the ability 
of pre-clinical compounds to increase intracellular oxidative stress resulting in 
formation of ROS and disruption in redox cycling and signalling. These events 
lead to a perturbation of oxidative metabolism that eventually results in 
pulmonary damage.
The specific aims and objectives for this project were three-fold:
1. To define the expression levels and oxidation states of Prx I, II and III
during NHBE cell model morphogenesis (Figure 1.25):
• Primary NHBE cells will be cultured to produce a fully
differentiated and stable bronchial epithelium (BE) phenotype. 
Trans-epithelial electrical resistance (TEER) will be measured
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throughout the 42 day time-course of the in vitro model to inform 
on junction integrity and culture development.
• Reducing and non-reducing gel electrophoresis followed by 
Western blotting and chemiluminescence detection will be used 
to determine the expression levels and oxidation states of Prx I, 
II and III over a 42 day time-course in the in vitro NHBE model.
• Immunohistochemistry (IHC) at the light microscope (LM) and 
electron microscope (EM) levels will be used to establish the 
levels and specific location of the Prx isoforms and 
hyperoxidised Prx in the in vitro NHBE cell model.
Chapter 2 NHBE Cell Culture
NHBE Cell Types
Millipore* 
Insert-Clara cell Ciliated Cell
Basal Cell
Microporous 
Membrane >
Intermediate
CellGoblet Cell
Chapter 2 Chapter 2 Chapter 3
Reducing Gel Electrophoresis Non-Reducing Gel Electrophoresis Immuno Histochemistry
AP
Secondary Antibody
Prx Antibody
Prx Antigen
Prx I, II and III Form 
S-S Homodimers 
During Catalysis
7  \
Prx rSOH
Prx SH
Streptavidin
Biotin 
Secondary Antibody 
— Prx Antibody 
 Prx Antigen
Figure 1.25: Flow chart of experimental work in Chapters 2 and 3.
Experimental work in Chapters 2 and 3 focused on primary NHBE cell culture and Prx status 
elucidation throughout the morphogenesis of the in vitro model. Reducing and non-reducing 
gel electrophoresis conditions were used to determine Prx expression levels and oxidation 
states, alongside IHC techniques at the LM and EM level.
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2. Define changes in Prx status following exposure to fluxes of H2O2 , 
either directly or via the glucose/glucose oxidase (GOx) system, and 
CS (Figure 1.26):
• The cell cultures will be apically exposed to direct H202i GOx or 
CS.
• Reducing gel electrophoresis will be used to inform on the total 
level of Prx expression and also levels of total hyperoxidation 
within the exposed cultures. IHC at the LM level will also be 
used to inform on Prx levels.
• Non-reducing gel electrophoresis will be used to reveal changes 
in the levels of Prx disulphide bonded dimers, which are formed 
during the catalytic cycle, informing on when the enzymes are 
active but not hyperoxidised.
• Prx status will be quantified relative to cell and tissue markers of 
oxidative stress, including loss of barrier function as measured 
by TEER readings, cell viability via an ATP assay, and activation 
of stress response pathways through measuring levels of 
phosphorylated MAP kinases (e.g. ERK1/2).
3. Correlate in vitro NHBE results with in vivo Prx data using human 
bronchial biopsy tissue (Figure 1.26):
• Bronchial tissue will be obtained by AstraZeneca, with full ethical 
consent, from GOLD4 COPD patients undergoing total lung 
transplants.
• IHC at the LM level will utilise DAB as a chromagen for Prx 
antigen visualisation. This will establish the levels and specific 
cellular locations of the Prx isoforms and hyperoxidised Prx 
within the human tissue samples.
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Figure 1.26: Flow chart of experimental work in Chapters 4, 5 and 6.
The main focus of experimental work in Chapters 4 and 5 involved exposing the NHBE cell 
cultures to toxicants, including H20 2 (directly and utilising the GOX system) and CS. Prx 
expression levels and oxidation states were determined using reducing and non-reducing gel 
electrophoresis conditions, alongside IHC techniques at the LM level. Cell viability and 
junction integrity following exposure was also determined via ATP assays and TEER 
measurements respectively. Chapter 6 focused on in vivo correlation analysis, whereby 
bronchial biopsy samples were taken from COPD patients undergoing double lung 
transplants. IHC techniques at the LM level were utilised to determine Prx levels.
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2.1 In tr o d u c tio n
With the advent of European Union legislation (EU; Directive 76/768/EEC, 
2003) calling for a reduction in animal testing, seeking viable alternatives has 
become increasingly necessary. The NHBE cell model is a 3D cell culture 
platform that aims to alleviate the quantities of animals required for inhalation 
toxicological testing, whilst providing human end-point data. Morphological 
and biochemical characterisation have established that the NHBE model is a 
high throughput system capable of mimicking important aspects of the in situ 
human BE (B6ruB6 etal., 2009; BeruBe etal., 2010b; Prytherch, 2010).
By 2020 COPD is set to rise to the third most common cause of death 
Worldwide (Raherison and Girodet, 2009). In light of this, there is an 
increasing need for early stage biomarkers of injury and repair, and in 
particular, biomarkers identifying perturbations in redox cycling and signalling, 
i.e. oxidative stress (Halliwell and Gutteridge, 1999; Jones, 2006). The 
Peroxiredoxins (Prxs) are a family of ubiquitously expressed AO enzymes that 
are directly affected by levels of intracellular oxidative stress (Wood et a/., 
2003b), rendering them as strong candidates for use as redox sensitive 
biomarkers.
The following work utilised the NHBE cell model in the determination of the 
Prxs as biomarkers of oxidative stress. The basal expression levels and 
oxidation states of Prx I and III during NHBE cell model morphogenesis were 
established. The isoforms had similar properties, formed the same catalytic 
intermediate and underwent the same catalytic cycle (Wood et al., 2003b). 
Previous research showed that Prx I and III were present within the BE 
(Kinnula et al., 2002a). Therefore, a confirmation of the presence of Prxs 
would substantiate the validity of the NHBE model as an in vitro BE 
alternative. In order to assess Prx expression levels and oxidation states, 
reducing and non-reducing gel electrophoresis conditions were used (Cox et 
al., 2010a), followed by Western blotting and chemiluminescent detection. 
Basal levels of hyperoxidised Prx (Prx-S0 3 ) were determined, with increased 
levels indicating elevated intracellular oxidative stress (Phalen etal., 2006)
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2.1.1 R e s e a r c h  A im s
The research aims for experimental work in Chapter 2 (Figure 2.1) were as 
follows:
• Culture the NHBE cell model into a system containing a fully 
differentiated and functioning BE phenotype. Assess the viability of the 
epithelial barrier by measuring the Trans-Epithelial Electrical Resistance 
(TEER) values to determine the integrity of the intercellular junctions.
• Quantify the expression levels and oxidation states of each Prx isoform, 
within the NHBE model during morphogenesis, through utilising reducing 
and non-reducing gel electrophoresis conditions followed by Western 
blotting and chemiluminescence.
NHBE Cell Culture
Millipore Insert
Microporous.
membrane
ALI Media
I
NHBE
Tima-Course
N H B E  C ell Ty p e s  
Basal Coll Intermediate
m  i!" K4Q
o Goblet Cell
Ciliated Cell Clara Cell
TEER M easurem ents
;v o m
Chamber
NHBE
W estern Blot 
Reducing and Non-Reducing Conditions
AP
Secondary Antibody
Prx Antibody
Prx Antigen
Figure 2.1: Flowchart of experimental work in Chapter 2.
Experimental aims included NHBE cell culture followed by Prx status elucidation throughout 
morphogenesis. TEER readings indicated junction integrity and culture differentiation. 
Reducing and non-reducing gel electrophoresis followed by Western blotting and 
chemiluminescent detection determined Prx expression levels and oxidation states. ALI (air 
liquid interface).
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2 .2  M a t e r ia ls  a n d  S t o c k  S o lu t io n s  
2.2.1 M a t e r ia l s  a n d  S u p p l ie r s
M a t e r ia l s : S u p p l ie r :
NHBE Cells, with Retinoic Acid (RA) Lonza Group Ltd, Switzerland
Bronchial Epithelial Basal Medium (BEBM) Lonza Group Ltd, Switzerland
Bronchial Epithelium Growth Medium® 
(BEGM) SingleQuots®
Lonza Group Ltd, Switzerland
Dulbecco’s Modified Eagles Medium 
(DMEM), w/4.5g/L Glucose, L-Glutamine, 
w/out Pyruvate
Lonza Group Ltd, Switzerland
Trypsin-EDTA Lonza Group Ltd, Switzerland
Hank’s Balanced Salt Solution (HBSS) Lonza Group Ltd, Switzerland
RA Sigma-Aldrich
Dimethyl Sulfoxide (DMSO) Sigma-Aldrich
Fetal Calf Serum (FCS) JRH BioScience
RPMI Invitrogen
T75 Cell Culture Flasks Fisher Scientific
T175 Cell Culture Flasks Fisher Scientific
6.5mm (0.4pm pore size) Cell Culture 
Inserts
Millipore
24-Well Plate Grenier Bio-One Ltd.
Rotanta 460R Centrifuge Hettich Zentrifuga, Germany
ENDOHM-6 Endohm Chamber World Percision Instruments
Dulbecco’s Phosphate Buffered Saline 
(PBS)
Sigma-Aldrich
Cell Lysis Buffer x5 Promega
XCell SureLock® Mini-Cell and XCell II™ 
Blot Module Kit CE Mark
Invitrogen
NuPAGE® Novex 4-12% Bis-Tris Gel 
1.0mm, 10 Well
Invitrogen
20x NuPAGE® MOPS SDS Running Buffer Invitrogen
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Pre-stained SeeBlue Plus 2® Molecular 
Weight Marker
Invitrogen
Glycerol Melford
Bromophenol Blue Sigma-Aldrich
p-Mercaptoethanol Sigma-Aldrich
10x Tris-Glycine Transfer buffer Sigma-Aldrich
Methanol Fisher Scientific
Sodium Dodecyl Sulphate (SDS) Sigma-Aldrich
Tris Base Sigma-Aldrich
Hybond-P Polvinylidenedifluoride (PVDF) 
Membrane
GE Healthcare
Tris-Buffered Saline-Tween (TBS/T) Sigma-Aldrich
l-Block Applied Biosystems
Sodium Azide Sigma-Aldrich
Bradford Reagent and BSA Standards Sigma-Aldrich
Prx-I Primary Antibody Lab Frontier, Korea
Prx-ll Primary Antibody Lab Frontier, Korea
Prx-I 11 Primary Antibody Lab Frontier, Korea
Prx-S0 3  Primary Antibody Lab Frontier, Korea
p-Actin Primary Antibody Sigma-Aldrich
Goat-Anti-Rabbit IgG AP Conjugate Bio-Rad
CDP-Star Substrate Applied Biosystems
Whatman Chromatography Paper 3MM Jencons
P200 Gel Loading Tips Alpha Laboratories
Biospectrum-AC Imaging System Ultra Violet Products
2-Mercaptoethanosulfonate (MESNA) Sigma-Aldrich
Phase Contrast light Microscope (DM2500) Leica Ltd.
Table 2.1: Materials used and their suppliers. Ail suppliers were UK based unless stated.
2.2.2  Sto c k  so lutio ns
All stock solutions were prepared and stored at room temperature (RT) unless 
stated otherwise.
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RA was prepared as a 5x1 O’5 working solution from a 1x10'2M stock solution, 
by diluting in DMSO. This working solution was stored in 25pl aliquots at - 
20°C in a light tight container.
FCS was prepared as a 10% working solution by diluting the stock solution in 
RPMI.
Running Buffer was prepared as a 1x working solution from a 20x NuPAGE0 
MOPS SDS Running Buffer stock.
Transfer Buffer was prepared as a 1x working solution from a 10x stock 
0.25M Tris-base, 192M glycine and 10% (v/v) analysis grade methanol.
Sample Buffer (Reducing) was prepared as a 2x working solution containing 
glycerol, double distilled (dd) H2O, SDS, 1M Tris-HCI pH 6.8, 0.2% 
bromophenol blue and p-mercaptoethanol to 10%.
Sample Buffer (Non-Reducing) was prepared as a 4x working solution 
containing glycerol, ddH20, SDS, 1M Tris-HCI pH 6.8 and 0.2% Bromophenol 
Blue.
TBS/T was prepared as a 1x working solution by dissolving 1 packet of 
powdered stock in 1L of deionised water, yielding 0.05M Tris, 0.138M NaCI, 
0.0027M KCL, pH 8 at 25°C, 0.05% Tween 20.
Blocking Buffer was prepared as a 1x working solution containing 0.2% I- 
block and 0.02% (v/v) sodium azide (NaNa) supplemented in TBS/T. The 
blocking buffer was stored for up to 1 month at 4°C.
MESNA Stripping Buffer was prepared as a 1x working solution containing 
62.5mM Tris-HCI pH 6.8, 2% w/v SDS and 50mM MESNA. MESNA stripping 
buffer was kept for no longer than two weeks and was stored at 4°C.
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2.3 M etho ds
2.3.1 C ell  cultur e
2.3.1.1 F irst  Passage
In accordance to the manufacturer’s recommended methods (Lonza Group 
Ltd, Switzerland), a 1ml cryovial of NHBE cells (-500,000 cells) was thawed 
at 37°C and re-hydrated in 60ml of BEGM at 37°C. BEGM was prepared 
using BEBM and growth supplements (Appendix i). The hydrated NHBE cells 
(30ml) were transferred to T75 flasks and incubated at 37°C; cells adhered to 
the flasks during the initial incubation. Twenty four hours post-seeding the 
BEGM (30ml) was replaced with 30ml of fresh BEGM medium; this was 
repeated (two out of three Days) until the cells reached 70% confluency (-2-3 
Days).
2.3.1.2 S eco nd  Pa ssage
Cell cultures were transferred from two T75 flasks and re-seeded into six 
T175 flasks, maximising the cell numbers. Initially, 5ml of HBSS at 37°C was 
added to each T75 flask to wash the cells, 3ml of Trypsin-EDTA solution at 
37°C was then added for 2-3min, until all cells detached. Following this, 30ml 
of 10% FCS with RPMI (30ml) was added to stop the trypsinisation of the 
cells, and cell suspensions were centrifuged at 72 (x g) for 4min, the 
supernatant was removed. The BEGM (180ml) was prepared, and each cell 
pellet re-suspended in 2ml BEGM at 37°C, the BEGM-cell suspension was 
then added to remaining BEGM. The BEGM-cell suspension (30ml) was 
transferred into a T175 flask and incubated at 37°C; cells adhered to the 
flasks during the initial incubation. Twenty four hours post-seeding the BEGM 
was replaced with 30ml fresh BEGM medium; this was repeated (two out of 
three Days) until the cells reached 70% confluency (-2-3 Days).
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2.3.1.3 S eed in g  into  M illipo r e® In se r ts
Cell cultures were transferred from T175 flasks into Millipore® inserts, allowing 
the progenitor cells to differentiate. Initially, 5ml of HBSS at 37°C was added 
to each T175 flask to wash the cells, 3ml of Trypsin-EDTA solution at 37°C 
was then added for 2-3min, until all cells detached. The 10% FCS with RPMI 
(30ml) was added to cease the trypsinisation of the cells and cell suspensions 
were then centrifuged at 72 (x g) for 4min, the supernatant was removed and 
three cell pellets were re-suspended in 2ml BEGM at 37°C. A 
haemocytometer with a 5x5 grid was used to determine the cell concentration 
of the cell suspension. For seeding into inserts, the density required was 0.5 
million cells/ml; the cell suspension was added to the required volume of 
BEGM. The BEGM-cell suspension (150pl) was added apically into each 
insert and 500pl BEGM was added basally; cells adhered to the insert 
membrane during the initial incubation.
2.3.1.4 Confluent Insert Cultures
The apical media was removed 24hr post-seeding, creating an air-liquid 
interface (ALI) culture (Day 1) (Figure 2.2). The basal media was replaced 
with 300pl of ALI media (Appendix ii). Basal ALI media was changed daily, 
adding 300pl of fresh ALI medium into each well. Once mucin secretion began 
to appear on the apical surface (-Day 15), it was removed by aspiration every 
second Day, preventing mucin accumulation (mimicking in vivo conditions).
c:;;;
Figure 2.2: Schematic diagram depicting the inserts within a 24-well plate.
Illustration of the cultures at Day 0 (seeding of cells) and Day 1 (removal of apical media). 
Only the progenitor basal cells were present following seeding (Diagram courtesy of Dr. Z. 
Prytherch, Cardiff University).
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2.3.2 T r a n s -E p ith e l ia l  E le c t r i c a l  R e s is ta n c e  (TEER)
The Endohm chamber (Figure 2.3) was filled with 1ml of PBS and a cell insert 
was placed inside. PBS (150pl) was placed on the apical region of the 
cultures and the top electrode was placed on top of the insert, the reading 
was then taken by releasing the current. The TEER value (recorded on ohms; 
Q) displayed was indicative of the junctional formation within the culture 
(Figure 2.4). A TEER reading using an insert without cells was taken to use as 
a ‘blank’ measurement, and the TEER results from cultures were normalised 
against this. NHBE samples were taken off for analysis every three Days 
throughout the life span of the NHBE model (n=3).
2.3.3 B r a d fo r d  A ssay
The Bradford assay (Bradford, 1976) was undertaken to accurately measure 
protein concentration. A BSA protein standard of 2mg/ml was diluted into the 
following concentrations with PBS: 2pg/ml, 4pg/ml, 6pg/ml, 8pg/ml, 10pg/ml, 
12pg/ml and 14pg/ml, these were used to establish a concentration curve. 
Fifty microlitres of Bradford reagent (colorimetric chemical agent) along with 
150pl of the standard was placed in a plate reader (x3) and read at 570nm 
wavelength. A standard curve was established from which unknown sample 
protein concentrations could be determined.
Figure 2.3: Apparatus used to record TEER readings.
The culture was placed inside the Endohm chamber and filled with PBS; the cap was then 
placed onto the chamber, thus creating a closed circuit. The current was then released from 
the EVOM and the reading taken (Diagram courtesy of Dr. D. Balharry, Cardiff University).
|Cap|
lElectrodel
|Endohm Chambe^ 
lElectrodel
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High Resistance Low Resistance
-  700 0  - 1 0 0  Q
Figure 2.4: Variation in TEER values.
Schematic diagram depicting the differences in TEER readings between a healthy (~700Q) 
confluent epithelial culture and a culture with a disrupted epithelial barrier (i.e. compromise 
tight junction formation) (~100Q) (Diagram courtesy of Dr. D. Balharry, Cardiff University).
2.3.4 W e s t e r n  B l o t /A n t ib o d y  D e t e c t io n
2.3.4.1 1D SDS Pa g e  (P o ly a c r y la m id e  G el E le c tr o p h o r e s is )
The gel electrophoresis apparatus was assembled according to the 
manufacturer’s instructions. The comb was removed from the pre-cast 4-12% 
gel and the wells flushed with 1x MOPS running buffer, the gel was then 
placed into the main tank and the system was filled with 1x running buffer. 
Cells were lysed with lysis buffer and the protein concentration of each lysate 
was determined using the Bradford assay (Section 2.3.3); 2pg of protein from 
each sample was loaded onto the gel. Samples were then prepared with the 
appropriate sample buffer (reducing or non-reducing). Samples were 
sonicated and denatured (100°C for 5min) on a dry heating block (Stuart 
Scientific). These samples, along with a pre-stained molecular weight marker 
(Figure 2.5), were loaded onto the gels using the P200 gel loading tips. Gels 
were subjected to electrophoresis at 200V for 1 hr.
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2.3.4.2 W estern  Blot
Hybond-P polyvinylidenedifluoride (PVDF) membrane was cut to the correct 
size (8cm x 8cm) and soaked for 5min in analysis grade methanol; it was then 
equilibrated in transfer buffer. Polyacrylamide gels were placed onto the 
membranes between two pieces of Whatman 3MM filter paper (8cm x 8cm) 
soaked in transfer buffer in a blotting cassette. Western blotting was carried 
out using the XCell SureLock® System at 30V for 60min at RT. The blots were 
then washed for 5mins in TBS/T.
2.3 .4 .3  A ntibo dy  Incubation  and  Detectio n
Western blots were incubated in a sealed polyethylene bag with 20ml of 
blocking buffer for 1 hr at RT on an orbital shaker (Stuart-Scientific). The 
blocking buffer was then replaced with 10ml of primary antibody diluted to the 
required concentration in blocking buffer (Table 2.2). Blots were then 
incubated with primary antibody overnight at 4°C on an orbital shaker. For 
reduced blots, the membrane was cut (Figure 2.5) to run the Prx and actin 
antibodies simultaneously. However this was not possible for non-reduced 
blots, as Prx dimers were too close in size, and therefore, the blot was 
incubated with each primary antibody in succession. Post-incubation, blots 
were washed for 5min in TBS/T (4x). Subsequently, the blots were incubated 
for 1 hr with 12ml of alkaline phosphatase (AP)-conjugated secondary 
antibody diluted with blocking buffer (Table 2.2). Blots were then washed for 
5min in TBS/T (4x).
Blots were then incubated with 1ml CDP-Star Chemiluminescent Substrate for 
5min in a section of a polyethylene film, excess reagent was removed and 
blots placed in a new polyethylene bag. Blots were then transferred to the 
Biospectrum-AC imaging system for chemiluminescent detection. Following 
exposure, the blots were stripped by incubating in a sealed polyethylene bag 
with approximately 20ml of MESNA stripping buffer for 30min at 50°C. Blots 
were then washed for at 10min in TBS/T (3x) and blocked for 1 hr; this allowed 
the blots to be re-probed for additional primary antibodies (Figure 2.5).
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1°
Antibody
MW
(KDa) Dilution
Final
Concentration
2°
Antibody Dilution
a-Actin 45 1:5000 200ng/ml Anti-Rabbit 1:3000
Prx I 22 1:1000 1pg/ml Anti-Rabbit 1:3000
Prx II 22 1:100 10pg/ml Anti-Rabbit 1:3000
Prx III 28 1:2000 500ng/ml Anti-Rabbit 1:3000
Prx-S03 22/28 1:1000 1 pg/ml Anti-Rabbit 1:3000
Table 2.2: Primary and secondary antibodies for Westerns.
Overview of the primary (1°) and secondary (2°) antibodies with their optimised dilution factor 
used in the antibody detection of a Western blot technique.
MW
(KDa)
197 •
Marker Samples
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28 Prx III and -S03 (~28KDa) 
Prx I, II and -S03 (~22KDa)
Figure 2.5: Schematic overview of Western blot (reducing gel electrophoresis).
The membrane was cut where indicated (red dotted line). The pre-stained marker values 
shown were for MOPS buffer (protein bands have different motilities in different buffer 
systems) (Invitrogen, 2011).
2.3.5 S t a t is t ic a l  A n a ly s is
All descriptive statistics (e.g. mean and standard deviation [SD]) were 
calculated using the Minitab software package (Version 16). The regression 
equation of the Minitab software was used to determine the standard curves 
for protein concentration in the Bradford assay and for H2O2 determination in 
the GOx assay (Dytham, 2003). A one-way ANOVA was performed in
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conjunction with a Levene test (Dytham, 2003) for equal variance, if the data 
was of equal variance the least significant difference (LSD) test (Dytham, 
2003) was performed to indicate significance, if the data was not of equal 
variance significance was determined via the Games-Howell test (Dytham, 
2003). Both the LSD and Games-Howell tests were performed when the 
ANOVA result was significant (P<0.05) (Dytham, 2003). Conventionally a one­
way ANOVA would not be performed if data was not normally distributed, 
however, recent studies (Gillard, 2011) have suggested it is a more powerful 
test to use when the sample number is limited (i.e. n=3 in this study). 
Therefore, the same tests were performed (i.e. one-way ANOVA, Levene, 
LSD and Games-Howell) for data that was not normally distributed.
2.4  R esults
2.4.1 NHBE M orphogenesis: C e l l  C u ltu r e
NHBE cells grown in culture flasks were adherent 24hr post-seeding, 
exhibiting a slightly rounded shape. Cells became increasingly elongated in 
appearance as they approached confluency (Figure 2.6). By 24hr post- 
seeding into inserts (Day 1), a confluent monolayer was observed through 
phase contrast LM (Figure 2.7). At Day 2, the appearance of ‘hills’ and 
‘valleys’ were predominantly seen, and by Day 3, the cells began to take on a 
regular pavement or ‘cobblestone’ style appearance, which remained as such 
until culture demise (Day 42). Real-time observations using the LM revealed 
ciliary action at Day 15, which was manifested as tiny ‘flickers’ and observed 
until culture demise.
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Figure 2.6: Phase contrast LM images of NHBE cells in flasks.
Cells were initially cultured in T75 flasks until they reached -70% confluency; they were then 
seeded into T175 flasks, and again cultured until they reached ~70% confluency. Cells 
appeared oblong in shape, indicating good viability, confluency increased at a steady rate 
from 24hr to 72hr in both flasks. Hours (hr) were post-seeding into the corresponding flasks.
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Figure 2.7: Phase contrast LM images of NHBE cells in Transwell® inserts.
At Day 1 the cells formed a confluent monolayer, by Day 2 ‘hills’ and ‘valleys’ appeared which 
indicated bilayer formation. The ‘cobblestone’ appearance was maintained from Day 3 until 
culture demise at Day 42. Days were post-seeding into inserts.
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2.4.2 NHBE M o r p h o g e n e s is : TEER A n a l y s is
The TEER values were measured every third Day (n=3), over a 42 Day period 
(Figure 2.8). Three NHBE donors were analysed, all were healthy non­
smoking Caucasian men ranging in age from 30 to 50. TEER values 
increased significantly (P<0.05) between Day 9 and 12.
14000 
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Dosing Window
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Figure 2.8: TEER values throughout NHBE cell culture morphogenesis.
The 'conventional dosing window’ was between Days 27 and 33, when the cultures were fully 
differentiated and stable. Three NHBE donors were analysed 5F1169 (■), 8F3123 (♦) and 
105116 (A) .The asterisk (*) denoted a significant (P^0.05) increase in TEERs from the 
previous day. I  Signified ±SD for n=3. TEER values significantly increased between Day 9 
and 12.
TEER readings from the 8F3121 donor increased gradually from 160.cm2 at 
Day 1 to 1740.cm2 at Day 6, with a steep increase to 32290.cm2 at Day 9 
and again to 68310.cm2 at Day 15. The readings plateaued between Days 24 
and 30 with average values remaining between 69000.cm2 and 76000.cm2. 
Values at Day 33 were 57510.cm2, which was outside the plateau range, and 
from Day 33 onwards the readings decreased gradually until culture demise. 
TEER readings from donor 105116 increased steadily from 220.cm2 at Day 1 
to 19450.cm2 at Day 9, this was followed by a steep increase to 52560.cm2 
at Day 12. The readings plateaued between Days 24 and 33 with average 
values remaining between 70000.cm2 and 76000.cm2, and from Day 39
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onwards, the TEER values increased. Donor 5F1169 displayed the same 
pattern as the previous two donors, in that there was a gradual increase from 
29Q.cm2 at Day 1 to 1223Q.cm2 at Day 9, which was followed by a steep 
increase to 5956Q.cm2 at Day 12, and again to 9087Q.cm2 at Day 18. There 
was a plateau phase from Day 21 to 33 where the TEER values remained 
between 7100Q.cm2 and 8000Q.cm2. This preceded a decline in readings 
which went from 6966Q.cm2 at Day 36 to 6077Q.cm2 at Day 42.
2.4.3 NHBE MORPHOGENESIS: WESTERN BLOT ANALYSIS
Following reducing and non-reducing gel electrophoresis, Western blot 
analysis was used to quantify Prx expression levels and oxidation states. 
Following antibody incubations and chemiluminescent detection, the 
densitometry of the bands was quantified using the GeneTool software, 
through applying numerical values to the detected chemiluminescence. To 
allow accurate interpretation of the chemiluminescence signal generated by 
Prx detection, p-actin (house-keeper protein) expression was used to 
normalise the corresponding signal. Nine time-points throughout the lifespan 
of the model were chosen for Western blot analysis. Each Day represented a 
significant stage in the models development. At Days 1 and 3 cells remained 
as undifferentiated basal cells, at Day 9 the intercellular junctions had begun 
to form, by Day 15 there was mucus production and cilia beating, by Day 21 
the cells were fully differentiated. Days 27, 30 and 33 represented the ‘dosing 
window’ and Day 39 marked the beginning of culture demise.
2.4.3.1 NHBE MORPHOGENESIS; WESTERN BLOT ANALYSIS (TOTAL PRX LEVELS)
NHBE cultures from the nine key time-points throughout morphogenesis were 
subjected to reducing gel electrophoresis conditions and analysed via 
Western blotting (Figure 2.9). During initial morphogenesis, i.e. Days 1 and 3, 
Prx I levels were negligible at 0.28 and 0.35, respectively, with levels of total 
Prx III from comparable Days nearly four times greater at 0.84 and 1.1, 
respectively. There were significant (P£0.05) increases in Prx I expression 
between Days 3 and 9, 15 and 21. Prx III levels were consistently high, with
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significant (P<0.05) increases in expression between Days 3 and 9, 9 and 15, 
27 and 30, 33 and 39. There were peaks of Prx III expression reached at 
Days 33 and 39 measuring 2.65 and 3.0, respectively. Levels of Prx-S03 were 
elevated throughout morphogenesis, consistently remaining above 1.0. Levels 
remained steady and under 2 from Days 1 to 30, however, by Day 33 they 
had risen to 3.8 and continued to rise to 3.88 at Day 39. Prx II was not 
sufficiently detected.
Days: 1 3 9 15 21 27 30 33 39
(LActin
Prx-SO
Figure 2.9: Western blot analysis of total Prx levels during NHBE morphogenesis.
Whole cells extracts were generated from NHBE cells during morphogenesis, Days were 
post-seeding into inserts. Lysates were resolved by reducing 1D SDS-PAGE electrophoresis 
followed by Western blotting and chemiluminescent detection. Proteins were analysed using 
1° ABs specific to Prx I, III, -S03 and p-actin. Red denoted bands of interest with minimal Prx I 
expression at Days 1 and 3, and elevated Prx III and Prx-S03 at Days 33 and 39.
5lTPrxl ■ Prx III iPi*S03
3 9 15 21 27 30 33 39
Days
Figure 2.10 Densitometry analysis of total Prx levels during NHBE morphogenesis.
The GeneTool software calculated Prx I (■), Prx III (■) and Prx-S03 (■) band densitometry for 
Western blot (reducing conditions) results of NHBE cell cultures during morphogenesis. 
Results were normalised using the corresponding p-actin expression. The asterisk (*) 
denoted a significant (P<0.05) increase in TEERs from the previous day. I  Signified ±SD for 
n=3.
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2.4.3.2 NHBE MORPHOGENESIS WESTERN BLOT ANALYSIS (PRX III ACTIVITY)
NHBE cultures from the nine key time-points throughout morphogenesis were 
subjected to non-reducing gel electrophoresis conditions and analysed via 
Western blotting (Figure 2.11). The dimer levels (active Prx III) were strong 
throughout morphogenesis, however monomer (inactive Prx III) were also 
consistently elevated, leading to Prx III activity levels of -50% throughout the 
entire time-course. There was a noteworthy reduction in Prx III activity to 47% 
at Day 33, indicated by a rise in monomer levels.
Prx III 
Dimer
Prx III 
Monomer
Figure 2.11: Western blot analysis of Prx III activity during NHBE morphogenesis.
Whole cells extracts were generated from NHBE cells during morphogenesis, Days were 
post-seeding into inserts. Lysates were resolved by non-reducing 1D SDS-PAGE 
electrophoresis followed by Western blotting and chemiluminescent detection. Proteins were 
analysed using 1° ABs specific to Prx III and p-actin. Red denoted areas of interest with low 
levels of total Prx III at Day 1 and elevated monomer levels at Day 33.
Days
Table 2.12: Densitometry analysis of Prx III activity during NHBE morphogenesis.
The GeneTool software calculated Prx III (■) monomer and dimer band densitometry from 
Western blots (non-reducing conditions) of NHBE cell cultures during morphogenesis. Results 
were normalised using the corresponding p-actin expression. I  signified ±SD for n=3.
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2.5 D iscussio n
2.5.1 NHBE M o r p h o g e n e s is : C ell  C u ltu re  a n d  TE E R  A nalysis
The NHBE model was derived from healthy human primary explant tissue, 
consequently, the cells were genotypically and phenotypically more 
representative of normal epithelia; in comparison to other classical respiratory 
models (e.g. A549, BEAS-2B, Calu-3 and 16HBE14o; (BeruBe et al., 2010b). 
The cultures were able to form a 3D, pseudo-stratified state that exhibited a 
functional mucociliary phenotype with tight junctions as observed in vivo in 
humans (B6ruB6 etal., 2010a).
The confluency of the dividing cells was monitored using phase contrast LM to 
determine the rate at which the cells divided post-seeding. The morphological 
appearance of the cells was also a determining factor in their viability, with a 
more oblong shape denoting increased viability (Prytherch, 2010). NHBE cells 
seeded in flasks, retained an undifferentiated basal (progenitor) phenotype, 
cells adopted a differentiated phenotype when transferred to the individual 
Millipore® inserts. Twenty four hours post-seeding into inserts, cultures took 
on a ‘cobblestone’ appearance; by 48hr post-seeding there was a 
characteristic ‘hills’ and ‘valleys’ phenotype, indicating bilayer formation. Early 
stage differentiation began at Day 9 with the formation of junctional 
complexes, denoted by an increase in TEER values (Noske et al., 1994). The 
resistance produced by the cell culture was suggestive of its developmental 
stage and viability, i.e. a high resistance would imply a healthy culture with 
formed junctional complexes, whereas a low resistance would infer either an 
immature culture which is yet to form junctional complexes, or, a damaged 
culture (Matter and Baida, 2003). Mucin production began at approximately 
Day 15 (i.e. viscous and transparent secretion on the apical surface). This has 
also been noted by other investigators (Chemuturi et al., 2005; Balharry et al., 
2008). The presence of mucin, and hence, fully functioning goblet cells has 
been verified by periodic acid Schiff (PAS) analysis (Prytherch, 2010). Day 15 
also marked the appearance of beating cilia, observed as tiny flickers using 
real-time LM, and the hallmark of fully differentiated ciliated cells. By Day 27,
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cultures were fully differentiated and remained stable until Day 36. After this 
point, TEER values dropped marking the beginning of culture demise. A 
reduction in the colour change (dark pink to pale pink) of the media confirmed 
that nutrients were no longer being taken up by the cultures.
2.5.2 NHBE M o r p h o g e n e s is : W estern  B lot  A nalysis
In order to understand the significance of using Prxs as biomarkers of 
intracellular oxidative stress, their status within the NHBE model during 
morphogenesis was warranted. The aim of using reducing and non-reducing 
conditions, in conjunction with Western blotting, was to determine the 
expression levels and oxidation states of each Prx isoform. For oxidation state 
elucidation, levels of hyperoxidised Prx (Prx-SOs) were analysed.
Western blot analysis of the reduced protein samples revealed a significant 
difference in expression levels between Prx I and III throughout the nine key 
day time-course. The low levels of Prx I, which is situated in the cytosol (Chae 
et al., 1999), were detected during the earliest stage of development (Days 1 
to 3) suggested that Prx I was not a feature of basal cell antioxidant defence, 
with only a basal population present in the cultures at this stage. Expression 
of Prx II, which is situated in the cytosol (Chae et al., 1999), were not 
sufficiently detected to warrant further analysis within this project. Prx III, 
which is situated in the mitochondria (Rhee et al., 2001), was expressed at 
comparatively high levels throughout morphogenesis; this was consistent with 
in vivo research (Kinnula et al., 2002a). Expression levels rose consistently 
until Day 9, whereby they remained constant until Day 15. This coincided with 
the formation of the cilia, and hence, an increase in the mitochondria levels 
due to the increasing requirement for ATP to drive cilia beating (Bittar, 2002). 
Following the increase in expression there was a plateau phase that remained 
constant until Day 33, suggesting that by Day 33, biochemically, the cultures 
were not stable. This needed to be addressed with regard to the selection of 
an appropriate ‘dosing window’, which had been previously established by 
Prytherch and co-workers.
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Analysis of reduced and non-reduced protein samples revealed elevated 
levels of hyperoxidised Prxs throughout model morphogenesis and inferred 
that significant basal levels of oxidative stress were occurring. This may be 
due to the nature of the NHBE cell model environment, as it corresponded to 
a repairing airway, having previously undergone maceration and de­
differentiation upon removal from post-mortem donors (BeruBe et a/., 2010b). 
An increased level of oxidative stress is a recognised limitation of in vitro cell 
culture (Halliwell, 2011), and a parameter that should be taken into 
consideration during data analysis. In vitro conditions impose oxidative stress 
upon the cells leading to a phenomenon known as ‘culture shock’ (Halliwell, 
2003). The NHBE cultures were ‘static’ and did not allow the cyclic change of 
nutrients and removal of waste-products; factors that elicit elevated oxidative 
stress levels. Days 33 and 39 exhibited a significant increase in hyperoxidised 
Prx, suggesting that by this stage the cells could no longer suppress the 
elevated stress levels imposed by the static culture conditions. These 
collective results supported the need to modify the dosing window, given that 
NHBE cell cultures exhibited loss in both phenotypic and biochemical stability 
by Day 33.
2 .6  C o n c lu s io n
The detection of two out of the three Prx isoforms within the NHBE cell model 
was a result that further validated this system as a viable in vitro model. 
Secondly, the expression levels observed for each isoform corresponded to 
existing BE in vivo data. The stable expression patterns of Prx I and III within 
the period of toxicological analysis (i.e. dosing window) was a positive 
indicator of their potential role as biomarkers. Predictable expression under 
normal conditions would further highlight fluctuations observed as a direct 
result of increased oxidative stress, either following lung injury or via the 
addition of toxicants.
There was a need to modify the existing ‘dosing window’, to a period where 
the model was fully differentiated and the cultures were stable. Previous work 
by Prytherch and co-workers had established this stable period to be between
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Days 27 and 33; yet, current results suggested that the Prxs oxidation state 
and hence, levels of oxidative stress were not stable at Day 33. A more 
suitable dosing window would be between Days 21 and 30. However, when 
taking into account previous morphological analysis (Prytherch, 2010), it was 
finally concluded that Days 25 to 30 would be a more suitable time-frame to 
employ for the remaining experimental work (i.e. Chapters 3 to 5).
Western blot analysis identified heightened basal levels of Prx hyperoxidation 
within the model. Therefore, it would be necessary to confirm the Western blot 
morphogenesis data and the cellular locations of the Prx isoforms I and III, in 
conjunction with the levels of Prx-S0 3 , within the NHBE cell culture model 
(Chapter 3).
79
IHC ANALYSIS OF PRX STATUS DURING NHBE CELL MODEL MORPHOGENESIS
C h a pter  3:
IMMUNOHISTOCHEMISTRY ANALYSIS OF
Pero xiredo xin  Sta tus  During  NHBE  
C ell  M o del  M o rpho g enesis
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3.1 Intr o ductio n
Immunohistochemistry (IHC) analysis, at both the LM and electron 
microscopy (EM) levels, was required to corroborate the Western blot 
morphogenesis data (Chapter 2), and to provide a more comprehensive 
representation of Prx status at basal levels in the NHBE model. The primary 
objective here was to determine the cellular locations of the Prx isoforms I and 
III and the levels of hyperoxidised Prx (Prx-S0 3 ) within the NHBE cell model. 
Secondary to the immunological analysis, conventional histological 
assessments with haematoxylin and eosin (H+E) were also undertaken. 
These involved examinations of the NHBE cell culture during morphogenesis 
(42 Days) to provide complementary data for the TEER and phase contrast 
LM results (Chapter 2).
All IHC assessments utilised polyclonal Prx antibodies for antigenic detection 
within the NHBE cultures. Results were visualised using chromogenic and 
fluorescent detection at the LM level, and colloidal gold conjugates at the EM 
level. IHC was not a quantitative method since antigenic activity was greatly 
reduced by the process of tissue fixation (Newman and Hobot, 2001). It did 
however, inform on the cellular location of the isoforms, thus augmenting the 
overall understanding of Prx status. Of the nine key developmental time- 
points investigated by Western blotting (Chapter 2), only four days were 
chosen for morphological analysis (i.e. Days 1 , 3 , 9  and 30). These four key 
days represented the widest breadth of morphological and biochemical 
modification within the BE architecture.
3.1.1 Re sea r c h  A ims
The research aims for experimental work in Chapter 3 (Figure 3.1) were as 
follows:
• Employ conventional histology (H+E) to characterise the morphological 
development of the NHBE cell model throughout the 42 day time-course.
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Determine the cellular locations of the Prx isoforms within the fully 
differentiated NHBE model, utilising IHC chromogenic and fluorescent 
detection (LM level) and the conjugated colloidal gold (TEM level) 
systems.
NHBE
Time-Course (—► H+E
Day 30
Eosin
H a e m a to x y iin
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Figure 3.1: Flowchart of experimental work in Chapter 3.
Experimental aims included histological H+E analysis of the NHBE model throughout 
morphogenesis and immunological analysis utilising Prx primary antibodies to visualise Prx 
location at the LM and TEM levels in fully differentiated NHBE cultures.
3 .2  M a t e r ia l s  a n d  S t o c k  S o l u t io n s
3.2.1 Materials  and S uppliers
M a t e r ia l s : S u p p l ie r :
10% Neutral Buffered Formalin (NBF) Sigma-Aldrich
Ethanol Fisher Scientific
Anti-Rabbit IgG Vector Labs
3,3'-Diaminobenzidine (DAB) Chromogen Kit Dako
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Histostain Plus Bulk Kit (Rabbit):
• Blocking Serum Solution 10% Goat 
Non-lmmune System
• Biotinylated Secondary Antibody, 
Goat-Anti-Rabbit
• Streptavidin-Peroxidase HRP
Zymed Laboratories 
(Invitrogen)
Xylene (Mixture of Isomers) Fisher Scientific
Phosphate Buffered Saline-Tween (PBS/T) Sigma-Aldrich
Phosphate Buffered Saline (PBS) Fisher
Bovine Serum Albumin (BSA) Sigma-Aldrich
Gills Hematoxylin Solution Sigma-Aldrich
Microscope Cover Slips Fisher Scientific
Poly-L-Lysine Coated Microscope Slides Fisher Scientific
DPX VWR International Ltd.
Phase Contrast LM (DM2500) Leica Leica Ltd.
Leica RM2135 Microtome Leica Ltd.
HM20 Lowicryl Resin Agar Scientific
Leica Automatic Freeze Substitution (AFS) Leica Ltd.
Paraformaldehyde (PFA) Sigma-Aldrich
Gluteraldehyde (GA) Agar Scientific
Sucrose Sigma-Aldrich
Osmium Tetroxide (OT) Agar Scientific
Uranyl Acetate (UA) Agar Scientific
Nickel Mesh Grids 3.05mm Agar Scientific
Pioloform Film Agar Scientific
Chloroform Fisher Scientific
Parafilm Pechiney, USA
Sodium Periodate (SP) Agar Scientific
Reynold’s Lead Citrate (LC) Agar Scientific
Normal Goat Serum Dako
Ultra Microtome Leica Ltd.
Petri Dishes Fisher Scientific
Diamond Knife, 2.5mm Edge, 45° Blade Angle Agar Scientific
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2° Antibody 10nm Colloidal Gold Conjugate British BioCell
Transmission Electron Microscope (TEM) 208 Phillips
Tween 20 Invitrogen
2° Fluorescent Antibody Goat-Anti-Rabbit Dako
Vectashield with DAP I Vector Lab, USA
Leica TCS SP2 AOBS Laser Scanning Confocal 
Microscope
Leica Ltd
Eosin Y (High Purity) Acros Organics, USA
Table 3.1: Materials used and their suppliers. All suppliers were UK based unless stated.
3.2.2 Sto c k  So lu tio n s
All stock solutions were prepared and stored at RT unless stated otherwise.
PBS/T was prepared as a 1x working solution by dissolving 1 packet of 
powdered stock in 1L of deionised water, yielding 0.01 M PBS (NaCI- 0.138M, 
KCI- 0.027M) pH 7.4 at 25°C. Tween 20 was added to 0.05%.
PBS was prepared as a working solution by dissolving 100 PBS tablets in 10L 
of deionised water, yielding (g/L): NaCI, 8.0; KCI, 0.2; Na2HP04, 1.15; 
KH2P04, 0.2; pH 7.3 at 25°C.
BSA/PBS/T was prepared as a 1% BSA/PBS + 0.05% Tween working 
solution using BSA, PBS and Tween-20. This working solution was stored at 
4°C.
DAB Chromogen was prepared as a working solution containing 1 drop of 
DAB chromogen for every 1ml of DAB substrate buffer. This working solution 
was used following preparation and not stored.
Fixation Solution was prepared using 2% PFA and 0.4% GA. This solution 
was stored at 4°C.
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Cryoprotectant was prepared using 25g sucrose, 30ml glycerol and 70ml 
SOrensen buffer. This buffer was stored at 4°C.
OT was prepared as a 0.2% working solution from a 2% stock solution using 
cryoprotectant.
SOrensen Buffer was prepared using solution A (Na2HP042H20 
5.938g/500ml) and solution B (KH2P04 0.908g/100ml), both were dissolved in 
ddH20. Solution A and B were then combined (81.8ml + 18.2ml, respectively) 
with a final pH of 7.4.
3 .3 M etho ds
3.3.1 H is to lo g ic a l A nalys is  o f  th e  NHBE C e l l  C u ltu re s
3.3.1.1 T issue  Processing
Cell culture inserts were fixed in 10% NBF at 4°C for 24hr prior to paraffin 
embedding and sectioning. Embedding and subsequent sectioning of the 
tissue was carried out by a histotechnologist, Mr Derek Scarborough, at the 
School of Biosciences, Cardiff University.
The formalin fixed tissue was embedded in paraffin which allowed sections 
3pm to 10pm in thickness to be cut. Embedding involved tissue dehydration, 
clearing and paraffin infiltration. The dehydration process was necessary to 
remove the remaining water in the tissue and involved a series of alcohol 
treatments in incremental stages (i.e. 70%, 95% and 100%). Clearing 
removed any alcohol from the tissue. Xylene was used through several 
changes, as it was miscible with paraffin. Finally, the tissue was infiltrated with 
molten paraffin wax at 60°C, whereby several treatments of paraffin were 
used. Samples were then placed in plastic cassettes before being loaded for 
automatic processing, using a fully enclosed vacuum tissue processor.
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3.3.1.2 Paraffin  Em bedding
Air pockets that remained within the tissue were removed by placing the 
‘cleared’ sample into a vacuum. This allowed the tissue to be fully supported 
by the paraffin wax and prevented any shredding of the tissue during 
sectioning. NHBE cell cultures were placed into embedding moulds and a 
Leica EG1140 Embedding Centre was used to embed the tissue in warm 
paraffin wax. The samples were set for 30min using a cold plate and when 
removed from the moulds, were ready for sectioning.
3.3.1.3 S ectio ning
Paraffin embedded NHBE cell cultures were cut into 5pm sections, allowing 
visualisation of the tissue by LM. Sectioning was carried out using a Leica 
RM2135 microtome. Prior to sectioning, embedded samples were placed on 
ice to ensure uniform sections were obtained. Placing the samples on ice 
hardened the wax and softened the tissue, providing the sections with 
consistent thickness. Cut sections were immediately floated on a warm water 
bath at 40-50°C to facilitate the removal of any wrinkles and air bubbles 
formed during sectioning. Sections were then collected on a poly-L-lysine 
coated microscope slide, improving the adhesion between sections and slide. 
The section coated slide was left on a hot plate for 15-30min and then left in 
an oven at 37-45°C for 24hr (minimum) to ensure binding of the sections to 
the slide.
3.3.1.4 De WAXING
The paraffin wax was removed from the tissue, allowing water soluble dyes to 
penetrate the sections. Sections were de-waxed using xylene and decreasing 
alcohol concentrations (i.e. 100%, 95% and 70%). Slides were then 
submerged in tap water to prevent the samples drying out. A wax contour was 
drawn around the sections to keep solutions in place.
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3.3.1.5 Haem atoxylin  and  Eosin  Stain ing
De-waxed tissue sections were stained with Gills Haematoxylin for 8sec, 
followed by washing in running tap water for 10min; giving the ‘blue’ 
haematoxylin colour. The sections were then submerged in eosin Y (high 
purity) for 2min and washed in running tap water for 2min (Bancroft and 
Gamble, 2001).
3.3.1.6 Dehydration  and  M ounting
Stained sections were dehydrated using increasing alcohol concentrations 
(i.e. 70%, 95%, and 100%) and then submerged in xylene. DPX mountant 
(10pl) was placed on a coverslip; slides were taken from the xylene and 
carefully lowered onto the coverslip and DPX. The slides were left overnight at 
RT. The stained sections were then ready to be viewed by LM (Bancroft and 
Gamble, 2001). Sections were viewed using a Leica Phase Contrast LM 
(DM2500) attached to a digital camera (Leica DFC 320).
3.3.2 C h ro m o g en ic  Im m u n o h isto c h em istr y  of the  NHBE C ell C ultures
Sample preparation and de waxing procedures were carried out as described 
in Sections 3 .3 .1.1 to 3 .3 .1.4.
3.3.2.1 A ntibody  Incubation  a nd  D etec tio n
Following de waxing, sections were incubated with serum blocking solution for 
10min; this was blotted off prior to antibody (AB) incubation. Sections were 
incubated with the 1° ABs overnight in a moist chamber at 4°C (Table 3.2) or 
with the serum control (a negative control was performed for every dilution of 
the Prx antibodies used). ABs were diluted in 1% BSA/PBS + 0.05% tween- 
20.
Following 1° AB incubation the sections were submerged in PBS for 5min 
(3x), excess PBS was blotted off and sections incubated with the biotynylated
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secondary (2°) AB for 10min. Sections were then submerged once more in 
PBS for 5min (3x), excess PBS was blotted off and sections incubated with 
streptavidin peroxidase-HRP for 10min, sections were again washed in PBS 
for 5min (3x).
To allow AB visualisation, the slides were incubated with DAB chromogen 
solution for 2min (an optimised time). The chromogen was removed by 
placing the slides under running tap water for 2min; slides were then counter­
stained by immersing in Gills haematoxylin for 8sec. Any excess staining was 
removed by washing the slides in running tap water for 10min. Dehydration 
and Mounting was carried out as described in Section 3.3.1.6
1°
Antibody Dilution
Final
Concentration
Incubation
Period
DAB
Incubation
Period
1:200 5pg/ml 24h (4°C) 2min
Prx I 1:400 2.5pg/ml 24h (4°C) 2min
Prx II 
Prx III
1:1000 1pg/ml 24h (4°C) 2min
Prx-S03 1:2000 500ng/ml 24h (4°C) 2min
1:4000 250ng/ml 24h (4°C) 2min
Table 3.2: Chromogen immunohistochemistry: Optimisation of 1° AB concentrations.
Each of the 1° Prx ABs (Prx I, II, III and -S03) were prepared in a range of concentrations 
from 5pg/ml to 250ng/ml. Every optimisation experiment was performed on paraffin Day 30 - 
wax embedded NHBE cell cultures.
3.3.3 F l u o r e s c e n t  Im m u n o h is t o c h e m is t r y  o f  t h e  NHBE C ell  C u l t u r e s
3.3.3.1 T issue Processing
Cell culture inserts were fixed in 4% PFA at 4°C for 20min. PFA was then 
removed and replaced with PBS and stored at 4°C prior to paraffin embedding 
and sectioning. Embedding and sectioning of the tissue was carried out by Mr 
Derek Scarborough at the School of Biosciences, Cardiff University (Sections
3.3.1.1 to 3.3.1.4).
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3.3 .3 .2  A n tibo d y  In c u b atio n  a n d  D e te c tio n
Sections were submerged in tap water for 2min and then washed in PBS for 
2min (3x); they were then incubated with serum blocking solution for 10min 
which was blotted off prior to AB incubation. The prepared sections were 
incubated with the 1° ABs overnight in a humidifying chamber at 4°C (Table 
3.3) or with the serum control (a negative control was performed for every 
dilution of the Prx ABs used). ABs were diluted in 1% BSA/PBS + 0.05% 
Tween.Following 1° AB incubation the sections were submerged in PBS for 
5min (3x), excess PBS was blotted off and sections incubated with the 
fluorescent goat-anti-rabbit 2° AB (1:400) for 1 hr at RT in the dark. Sections 
were then submerged once more in PBS for 5min (3x) (in the dark). 
Vectashield (w/DAPI) mountant (10pl) was placed on coverslips and slides 
taken from PBS carefully lowered onto them. Clear nail varnish was used to 
surround the coverslip and ensure no detachments. Slides were left overnight 
at 4°C in the dark. The sections were viewed with a Leica laser scanning 
confocal microscope and the images were produced via photomultiplier tubes.
1°
Antibody Dilution
Final
Concentration
Incubation
Period
Prx III
1:500
1:1000
1:2000
2pg/ml
1pg/ml
500ng/ml
24h (4°C) 
24h (4°C) 
24 h (4°C)
Table 3.3: Fluorescent immunohistochemistry: Optimisation of 1° AB concentrations.
Prx III was prepared in a range of concentrations from 2pg/ml to 500ng/ml. Every optimisation 
experiment was performed on Day 30 paraffin-wax embedded NHBE cell cultures. Prx III 
stock concentration was 1 mg/ml.
3.3.4 Immuno  Electron M icroscopy of the NHBE C ell C ultures
3.3.4.1 T is su e  P ro cessing
Cell culture inserts were immersed in fixation solution for 45min at 4°C; 
allowing time for sufficient protein cross-linking. The samples were then
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removed from the fixation solution and washed in SOrensen buffer for 5min. 
Culture inserts were immersed in cryoprotectant for 15min and then post-fixed 
in 0.2% OT for 30min. Post-fixation reduced damage to granulocytes and 
goblet cells during the subsequent dehydration process (Newman and Hobot, 
2001).
3.3.4.2 Dehydration
Cultures were dehydrated in increasing alcohol concentrations (i.e. 30%, 
55%, 70%, 80%, 90% and 100%) and initial dehydrations (30% and 55%) 
were at 4°C, whereas all the subsequent dehydrations were carried out at 
-25°C in the AFS.
3.3.4.3 R esin  Infiltration  and  E mbedding
Cultures were infiltrated in increments with lowicryl HM20 resin. Firstly, 
cultures were incubated in 1:1 (HM20:ETOH) for 60min and then in 2:1 for 
60min, followed by 3:1 for 60min; all at -25°C. Cultures were then embedded 
in pure HM20 at -25°C for 60min (2x) the resin was changed for a third time 
and a UV light used to polymerise the resin for 24hr at -25°C.
3.3.4.4 Preparation  of  the  Su ppo rting  F ilm (P io lo fo rm )
Pioloform was prepared as a 0.8% working concentration using chloroform. A 
clear microscope slide was covered in pioloform and left for 5min. The slide 
was then scored on both sides and placed into a water bath at 90° until both 
sections of the pioloform floated to the surface of the water bath.
3.3.4.5 P reparation  of G rids
Nickel mesh grids were placed dull side down onto a Pioloform film floating in 
a water bath. Once the film was covered in grids, parafilm was superimposed 
(sterile side) to enable removal of the grid/parafilm from the water bath. Grids 
were left to air dry for 1 hr before use and stored inside a sterile Petri dish.
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3.3.4.6 S ec tio n in g
Ultra-thin (60-90nm) sections were cut on a Leica ultra-microtome using a 
diamond knife. Sections were floated on a water trough and collected onto 
Pioloform coated nickel mesh grids. Sections were allowed to air dry inside a 
Petri dish for 1 hr prior to use.
3.3.4.7 A n tibo d y  Inc ubatio n  an d  D etec tio n
Aliquots (100pl) of each solution required for AB detection were placed in 
rows on the sterile side of parafilm; the grids were floated section side down 
on a given droplet in sequence. Firstly, sections were incubated with 
saturated SP for 2hr to remove the OT and unmask the antigens. They were 
then washed in filtered ddH20  for 2min (3x) and submerged in 20% normal 
goat serum overnight at 4°C to prevent unspecific antigen binding. NHBE 
sections were then incubated overnight at RT with various concentrations of 
Prx III 1° AB (Table 3.4) or the rabbit IgG negative control. ABs were diluted in 
1% BSA/PBS + 0.05% Tween. Following 1° AB incubation, sections were 
taken through 1% BSA/PBS for 5min (2x). Sections were then incubated in 
10nm colloidal gold conjugates (1:40) for 2hr; colloidal gold conjugates were 
diluted in Tris-buffered BSA, pH 8.5. NHBE sections were then washed using 
1% BSA/PBS for 5min (2x), before being submerged in ddH20  for 5min (2x).
1°
Antibody Dilution
Final
Concentration
Incubation
Period
1:200 5pg/ml 1 h (RT)
1:400 2.5pg/ml 1h (RT)
Prx III 1:800 1.25pg/ml 1h (RT)
1:1600 750ng/ml 1h (RT)
1:3200 375ng/ml 1 h (RT)
Table 3.4: Immuno electron microscopy: Optimisation of 1° AB concentrations.
Prx III was prepared in a range of concentrations from 5pg/ml to 375ng/ml. Every optimisation 
experiment was performed on Day 30 lowicryl embedded NHBE cell cultures. Prx III stock 
concentration was 1 mg/ml.
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3.3.4.8 C o u n ter -Staining
NHBE cell culture sections underwent heavy metal staining (counter-staining) 
to resolve their ultrastructure. Reynold’s LC and 2% aqueous UA were used 
to counter-stain. UA stained membranous structures and nucleic acids. The 
lead in LC bound to RNA-containing structures and hydroxyl groups of 
carbohydrates (Newman and Hobot, 2001). Droplets of UA and LC were 
placed in rows on sterile parafilm and the grids counter-stained. Sections 
were stained for 10min with UA, followed by staining for 5min with LC. They 
were then washed by transferring over 3 drops of ddH20  for 5min and air 
dried at RT inside sterile Petri dishes prior to visualisation. The sections were 
imaged using a Phillips TEM 208 at an acceleration voltage of 80KeV.
3.4 R esults
3.4.1 NHBE M o r p h o g e n e s is : H isto lo g ic a l  A n alysis
Key time-points in the development of the NHBE cell model, corresponding to 
TEER and Western blot analysis (Chapter 2), were analysed using H+E 
staining (Figure 3.2). Day 1 was the earliest point in the models development, 
whereby cells remained as undifferentiated basal (progenitor) cells. There 
were large gaps between the cells that had successfully adhered to the 
membrane. By Day 3 the cells had proliferated into a bilayer, however, no 
visible junctional complexes were observed. By Day 9 the cultures took on a 
more pseudo-stratified appearance and some intercellular junctions could be 
identified. The columnar cells had begun to differentiate, but no cilia were 
distinct. By Day 30 the cultures were fully differentiated, cilia could be 
visualised and a defined pseudo-stratified BE phenotype was achieved. 
Junctional complexes were fully formed and no intercellular gaps were visible.
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Membrane
(a)
tJOjt
Figure 3.2: Histological H+E analysis of the NHBE cell model during morphogenesis.
Paraffin-fixed 5pm sections, from four key time-points in the morphogenesis of the NHBE cell 
model, were visualised using H+E. Green denoted areas of interest: (a) Day 1, only 
progenitor basal cells (BC) present, no intercellular junctions formed. Nucleus (N); (b) Day 3, 
bilayer formation, no junctional complexes formed; (c) Day 9, pseudo-stratified epithelium 
observed, intermediate cells (IC) present, the beginning of junctional formation; (d) Day 30, 
fully differentiated BE, cilia present and intercellular junctions formed. Scale bars represented 
10pm.
3.4.2 NHBE MORPHOGENESIS: CHROMOGENIC IHC ANALYSIS
Paraffin sections (5pm) of Day 30 NHBE cultures were used to optimise Prx 
1° AB concentrations (Table 3.2). Results from the Western blots (Chapter 2) 
suggested the Prx isoforms were expressed at varying levels within the 
cultures. This was verified by the IHC optimisation results (Figure 3.3). Prx I 
was expressed throughout the columnar cells, but not in the basal cells. Prx III 
and -SO3 were optimised at a 1:2000 dilution with Prx III in particular, 
exhibiting strong immuno positivity towards the apical region within the 
columnar cells. Prx-S03 was also expressed within the columnar cells,
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although it wasn’t restricted to the apical regions. The negative control 
demonstrated that there was no non-specific binding. Prx II was not detected 
at the highest AB concentration (images not shown).
Figure 3.3: Chromogenic IHC analysis of the NHBE cell model.
Paraffin-fixed 5pm sections, from the NHBE Day 30 cultures, were incubated overnight with 
Prx 1° ABs and corresponding negative controls. DAB was used as a chromogen for immuno 
positivity. Red denoted areas of interest: (a) rabbit IgG 1:200; (b) rabbit IgG 1:2000, 
demonstrating no non-specific binding; (c) Prx I (1:200) expression confined to the columnar 
cells; (d) Prx III (1:2000) expression principally in the apical region of the ciliated cells. 
Nucleus (N); (e) Prx-S03 (1:2000) was dispersed throughout the epithelium. Scale bars 
represented 10pm.
3.4.3 NHBE MORPHOGENESIS: FLUORESCENT IHC ANALYSIS
The Prx III isoform was expressed the strongest within the NHBE cultures 
(Chapter 2), and was therefore used in confocal studies to corroborate the 
chromogenic IHC data. Fluorescent IHC results (Figure 3.4) confirmed that 
there was no non-specific binding in the negative controls. Both Prx III (1:1000
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and 1:2000) incubations displayed antigenic detection throughout the apical 
region of the columnar cells, with Prx III at the 1:2000 dilution displaying gaps 
in detection at the apical surface. The 1:500 dilutions caused severe 
overstaining (images not shown).
(d)
Figure 3.4: Fluorescent IHC analysis of the NHBE cell model.
Paraffin-fixed 5pm sections, from the NHBE Day 30 cultures, were incubated overnight with a 
Prx III 1° AB and corresponding negative controls. A fluorescent 2° AB was used to detect 
immuno positivity. Pink denoted areas of interest: (a) Prx III (1:2000) expression 
predominantly at the apical regions of the columnar cells, gaps present possibly where goblet 
cells appear. Nucleus (N); (b) rabbit IgG 1:2000, no non-specific binding; (c) Prx III (1:1000), 
expression at the apical regions of the columnar cells, possibly over-stained as no gaps in 
expression visible; (d) rabbit IgG 1:1000, no non-specific binding. Scale bars represented 
10pm.
3 .4 .4  N H B E  M o r p h o g e n e s is : Im m u n o  E l e c t r o n  M ic r o s c o p y  A n a l y s is
Ultra-thin sections (80-90nm) were used to optimise Prx III concentration for 
antigenic detection. Prx III was located in the mitochondria of the ciliated cells 
(Figure 3.5). The gold conjugates localised to this area, which reinforced
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previous LM results (fluorescent [Section 3.4.3] and chromogenic [Section
3.4.2]). The optimum dilution factor was 1:400, which minimised non-specific 
binding while maintaining sufficient antigenic detection. The negative control 
displayed no non-specific binding.
Figure 3.5: Immuno electron analysis of the NHBE cell model.
Ultra-thin lowicryl sections from the NHBE Day 30 cultures were incubated overnight with a 
Prx III primary antibody and the corresponding negative controls. A colloidal gold conjugate 2° 
AB was used to detect immuno positivity. Yellow arrows indicated areas of Prx III expression: 
(a) rabbit IgG 1:400, no non-specific binding; (b) Prx III (1:400) expression was located 
primarily in the mitochondria (dotted dark blue outline) of the ciliated cells. Scale bars 
represented (a) 100nm and (b) 300nm.
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3.5 D iscussio n
3.5.1 NHBE M o r p h o g e n e s is : H is to lo g ic a l  A nalysis
The four days chosen for morphological analysis (1 ,3 ,9  and 30) represented 
the widest breadth of morphological and biochemical modification with regard 
to the BE architecture (BeruBe et ai, 2010b; Prytherch, 2010). The formation 
of cellular junctions at these days corroborated the previous TEER data 
(Chapter 2). TEER values for Days 1 and 3 were negligible, which was 
representative of the large intercellular gaps observed in the cultures on the 
corresponding days. This also related to previous research confirming that 
cultures consisted solely of basal cell types on these days (Prytherch, 2010). 
The morphology of the cultures by Day 3 had taken on a bilayer formation. 
This was also validated by the phase contrast LM analysis with the 
appearance of ‘hills’ and ‘valleys’ at Day 2 and ‘cobblestone’ architecture by 
Day 3 (Chapter 2). At Day 9, the cultures took on a more pseudo-stratified 
arrangement, with the development of tight junctions signified by an increase 
in TEER values (Lin et a/., 2007). No cilia were observed, confirming the real­
time LM analysis, whereby tiny flickers representing cilia beating were not 
detected until Day 15. Day 30 marked the presence of fully differentiated 
NHBE cell cultures and the subsequent morphological analysis revealed 
complete formation of intercellular junctions; confirmed by elevated TEER 
readings (Chapter 2). The different NHBE cell types (i.e. cilia, goblet, 
intermediate and basal) were clearly distinguished, indicative of a healthy BE 
phenotype; providing confidence in subsequent toxicological analysis (BeruBe 
etal., 2010a).
3.5.2  NHBE MORPHOGENESIS: CHROMOGENIC IHC ANALYSIS
The chromogenic IHC results (Figure 3.3) supported earlier Western blot 
analysis (Chapter 2), with Prx I expression detected at much lower levels than 
Prx III within the NHBE cell cultures. Prx I was optimised at ten times the 
concentration of Prx III and -SO3, which also corresponded to previous 
findings of expression variations between such isoforms within the BE
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(Kinnula et al., 2002a). The relatively weak Prx I expression was detected 
throughout the columnar cells but not in the basal cells; supporting Western 
blot data, whereby no Prx I expression was detected at Days 1 and 3 (i.e. 
when only basal cells were present). Prx III expression was primarily confined 
to the apical regions of the columnar cells, where the cilia could be clearly 
distinguished. It was expected that Prx III expression corresponded to the 
ciliated cell location, due to their high mitochondrial content (Bittar, 2002). 
Unlike Prx I, Prx III was also detected in the basal layer of the epithelium, 
which correlated to Western blot data (Chapter 2), where its expression was 
detected from Day 1. Prx-S0 3  was visible throughout the BE, indicating 
elevated basal levels of oxidative stress; the detected levels of Prx-S0 3  
correlated to earlier results (Chapter 2), and previous research into cell culture 
induced oxidative stress (Halliwell, 2003, 2011). The levels of hyperoxidation 
visualised through IHC were lower than expected, in comparison to Western 
blot analyses. This confirmed the non-quantitative status of IHC, due to the 
destruction of antigens by the tissue processing procedure (Newman and 
Hobot, 2001). Prx II was not sufficiently detected at the highest concentration 
(results not shown), and due to this result, no further analysis with Prx II was 
conducted.
3.5.3 NHBE M o r p h o g e n e s is : F lu o r e s c e n t  IHC A nalysis
Fluorescent IHC was undertaken in order to validate the chromogenic IHC 
findings. Prx III was chosen for further IHC analysis due to its highly specific 
location within the NHBE cultures. Significant Prx III expression at the apical 
region of the columnar cells, in particular the ciliated cells, was demonstrated 
(Figure 3.4). This was due to the extensive number of mitochondria required 
in this area to provide sufficient ATP for adequate cilia beating (Braiman and 
Priel, 2008). The optimal Prx III dilution was determined to be 1:2000, which 
was the same dilution optimised during chromogenic IHC. The consistency 
between both LM level IHC techniques further validated the NHBE model. 
Future work could include dual immunofluorescence to localize the various 
Prx staining to specific cell types e.g using p63 as a BC marker, Muc5A as a 
stain for GCs and acetylated-tubulin markers for cilia staining.
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3.5.4  NHBE M o r p h o g e n e s is : Im m u n o  E lec tro n  M icro sco py  A nalysis
The antigenic detection at the EM level established the presence of Prx III in 
the mitochondria of the NHBE columnar cells (Figure 3.5), which was 
consistent with in vivo analysis (Kinnula et a/., 2002a), as well as IHC results 
at the LM level. The embedding technique employed allowed for a 
compromise between structural preservation and the conservation of the Prx 
antigens (Newman and Hobot, 2001). Conventional embedding at high 
temperatures destroys the antigenic activity but preserved the mitochondrial 
ultrastructure more effectively (data not shown). However, with the aim being 
to detect Prx III presence, low temperature embedding was a far more viable 
option. A higher concentration of 1° AB was needed for Prx III detection at the 
TEM level in comparison with the LM level, due to the nature of the 
embedding technique (Newman and Hobot, 2001); further reinforcing the 
notion that IHC was not a quantitative technique. The immuno EM data 
substantiated those at the LM level and supported the use of the NHBE cell 
model as a viable in vitro alternative.
3.6 C onclusion
Prx detection via IHC analysis of the NHBE cultures, using chromogenic and 
fluorescent techniques at the LM level, along with colloidal gold IHC at the EM 
level, correlated accurately with documented in vivo findings and previous 
NHBE work by Prytherch and co-workers. Prx III was expressed in the 
mitochondria, and hence, there was significant antigenic detection (at LM and 
EM levels) along the apical region of the culture, due to high mitochondrial 
concentration in this area. Chromogenic IHC analysis revealed Prx I 
expression to be dispersed throughout the columnar cells, but not the basal 
cells, which corresponded accurately to Western blot data from the previous 
experimental work (Chapter 2). The hyperoxidised Prx results indicated 
relatively high basal levels, and as such, prominent oxidative stress within the 
cultures, that correlated directly with the Western blot analysis utilising the 
Prx-SC>3 primary antibody. The lower levels of Prx detection via IHC 
techniques, in comparison with other proteomic methods, supported the use
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of IHC as a non-quantitative technique used to corroborate the quantitative 
Western blot data. Due to the difficulty in detecting Prx II, which was known to 
be expressed at much lower levels in the BE (in comparison to Prx I and III) 
and also shown to be problematic to detect in previous work (Chapter 2), it 
was concluded that it would not feature in any future experimental analysis. 
Prx I, which along with Prx II was expressed in the cytosol, would continue to 
be investigated, and hence, by dismissing Prx II from this study, the diversity 
of investigation into the 2-Cys Prxs within the NHBE cell model would not be 
critically affected. The experimental outcomes from Chapters 2 and 3 outlined 
Prx status during NHBE cell culture morphogenesis. Further investigations 
were required into the changes in Prx (I and III) status following toxicological 
exposures with H2O2 (Chapter 4) and cigarette smoke (CS) (Chapter 5). With 
regard to the elevated levels of Prx hyperoxidation within the NHBE cultures, 
measures were considered to alleviate this stress. The option chosen was AO 
addition to the ALI media (Chapter 4), mimicking more closely the in vivo lung 
environment.
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to  Hydrogen  P er o xid e  Exposure
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4.1 In tro ductio n
An increasing need for sensitive biomarkers of oxidative stress have been 
well documented in the literature, and recently several AO, including 
thioredoxin and Prx, have become prominent contenders in this role (Jikimoto 
et a/., 2002; Yoshida et al., 2009). However, with a focus on developments in 
the field of COPD, which is constantly seeking more effective biomarkers 
(Barnes et al., 2006; Jones and Agusti, 2006), the Prxs may be an ideal 
respiratory biomarker candidate, informing on disrupted redox cycling and 
signalling; the earliest form of oxidative cell damage (Repine et al., 1997; 
Rahman et al., 2006).
The experimental work in this Chapter was aimed at assessing the changes in 
Prx expression levels and oxidation state following oxidative insult to the 
NHBE cell model. Continuing on from work in Chapter 2, the fully 
differentiated NHBE cultures were apically exposed to H2O2 , as previous 
related studies have shown H2O2 was able to induce structural and oxidation 
state changes in the Prxs (Phalen et al., 2006; Peskin et al., 2007). H2O2 was 
applied both directly to the cultures and indirectly via the glucose-glucose 
oxidase (GOx) system. GOx catalyses the oxidation of glucose to H2O2 and 
gluconic acid in the presence of oxygen (Wilson and Turner, 1992), releasing 
linear fluxes of H2O2 over time; this is a more physiologically relevant 
exposure in comparison to the direct apical addition of H2O2 (van der Vliet et 
al., 1997). The conventional toxicology (i.e. TEER and ATP) was monitored 
post-exposure to H2O2 , and Prx status was determined using Western blotting 
for reducing and non-reducing gel electrophoresis conditions.
Work in previous Chapters revealed elevated basal levels of oxidative stress, 
which is often a limitation of cell culture conditions (Halliwell, 2003). The under 
appreciated problem of oxidative stress has lead many to question data 
obtained through in vitro studies (Halliwell, 2011). In light of this, precautions 
were needed to limit artefactual data within this study; and AO 
supplementation was chosen as the appropriate course of action. Several 
studies had previously supplemented cell cultures with AOs in order to
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minimise the basal levels of oxidative stress, in particular glutathione (GSH) 
(Teramoto et a/., 1999; Chen et a/., 2009). Work in this Chapter aimed to 
evaluate the benefits of supplementing the NHBE model with AO prior to 
toxicological exposures.
Prx status was used as a dosimeter of intracellular oxidative stress, with 
increased hyperoxidation indicative of oxidative stress levels (Chapter 2). In 
conjunction with Prx status, the levels of the phosphorylated MAPK (mitogen 
activated protein kinase) Erk1/2 (extracellular signal-related kinases) were 
also analysed. Erk1/2 functions within the stress response pathway following 
activation by elevated levels of oxidative stress (Torres and Forman, 2003; 
Mossman et al., 2006), and supplementation of cell cultures with AO has been 
shown to reduce its activation (Kim et a/., 2005). This provided an additional 
parameter that could be used to inform on intracellular levels of oxidative 
stress within the NHBE cell cultures post-exposure to H2O2.
4.1.1 R esearch  A ims
The research aims for experimental work in Chapter 4 (Figure 4.1), were as 
follows:
• Expose the fully differentiated NHBE cell cultures to a concentration range 
of H2 0 2 , and evaluate the cell viability and epithelial barrier integrity by 
monitoring ATP and TEER activities, respectively.
• Investigating further, key H2O2 concentrations highlighted by the 
concentration range study. Prx status in NHBE culture, post-exposure to 
H2O2 , will be analysed via reducing gel electrophoresis, Western blotting 
and chemiluminescence detection.
• Quench the basal levels of oxidative stress within the NHBE cultures 
through the addition of AO to the culture media.
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• Instigate the glucose-glucose oxidase (GOx) system to produce linear 
fluxes of H2O2 over time. Assess the exposed cell cultures (-/+AO) using 
ATP and TEER measurements, in conjunction with reducing and non­
reducing gel electrophoresis, Western blotting and chemiluminescence 
detection.
h2o2
2
GOx
Glucose + Oxygen  ►GluconicAcid + H20 2
24hr H20 j Exposures and 3hr GOx Exposures
+ / - Antioxidant in 
Cell Culture Media 
(24hr Exposure)
ATP Assay
+ /- NAC or Glutathione
LueifMtn
W estern Blot TEER Measurements
Reducing and Non-Reducing Conditions
AP
Secondary
Antibody
Prx Antibody
Prx Antigen
EVOM
Electrode
Endohm
Chamber
NHBE'
Figure 4.1: Flowchart of experimental work in Chapter 4.
Experimental aims included apical exposure of the NHBE cell cultures to H20 2, either directly 
(1) or by means of the glucose-glucose oxidase (GOx) system (2). Investigations were 
undertaken to establish the optimum antioxidant concentration to minimise basal levels of 
oxidative stress, therefore the NHBE model was supplemented with a concentration gradient 
of either NAC or GSH. Culture viability and junction integrity were established via ATP and 
TEER analysis, respectively. Prx status (expression levels and oxidation state) were 
determined through reducing and non-reducing gel electrophoresis conditions followed by 
Western blotting and chemiluminescence detection.
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4.2 M a t e r ia l s  a n d  S t o c k  S o l u t io n s
Materials and stock solutions from previous Chapters have not been included. 
4.2.1 M a te r ia ls  and  S u p p lie rs
M a t e r ia l s : S u p p l ie r :
^ T ^ /ia U g h t^ P lu ^ C e l^ ro life ra tio r^ m d  
Cytotoxicity BioAssay Kit
• Assay Buffer
• Lypophilised AMR Plus
• Cell Lysis Reagent
Lonza Group Ltd, Switzerland
30% Hydrogen Peroxide (H20 2) Sigma-Aldrich
GSH Sigma-Aldrich
N-Acetyl Cysteine (NAC) Sigma-Aldrich
Glucose Oxidase (GOx) MP Biomedicals
Trichloroacetic acid (TCA) Sigma-Aldrich
Fe(NH4)2(S04)2 Sigma-Aldrich
KSCN Sigma-Aldrich
Vortex Scientific Industries
Spectrophotometer Jenway
FLUOstar OPTIMA BMG LABTECH
Table 4.1: Materials used and their suppliers. All suppliers were UK based unless stated.
4.2.2 S to c k  S o lu t io n s
All stock solutions were prepared and stored at RT unless stated otherwise.
H20 2 was prepared as a 1M stock by diluting 30% H20 2 in PBS. The 1M stock 
was further diluted by 1:1000 to provide a working concentration of 1mM, 
stored at 4°C.
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NAC was prepared as a 100mM working concentration by dissolving NAC 
powder in HBSS, the pH was adjusted to 7.4 and the solution filter sterilised 
and stored at 4°C.
GSH was prepared as a 10mM working concentration by dissolving GSH 
powder in ddH20, the pH was adjusted to 7.4 and the solution filter sterilised 
and stored at 4°C.
Phosphate Buffer was prepared as a working concentration of 10mM by 
diluting a 1M stock with ddH20; the pH was adjusted to 7.4.
GOx was prepared as a 10U/ml stock by dissolving GOx powder in 10mM 
phosphate buffer (pH 7.4). The 10U/ml stock was further diluted in 10mM 
phosphate buffer to a working concentration of 1U/ml and stored at -20°C.
TCA was prepared as a 100% stock by dissolving 100g in 100ml ddH20. 
100% TCA was stored at 4°C.
BSA was prepared as a 10mg/ml working concentration by dissolving 100mg 
BSA in 10ml ddH20, this was stored at 4°C.
Fe(NH4)2(S04)2 was prepared as a 250mM working concentration by 
dissolving 9.8035g in 100ml ddH20 , this was made up fresh before use.
KSCN was prepared as a 250mM working concentration by dissolving 
2.4295g in 100ml ddH20, this was made up fresh before use.
4.3 M eth o d s
4.3.1 H20 2 Ex po su r e
NHBE cell cultures (Section 2.2.1) were apically exposed to a concentration 
range of H20 2 (50pl), between Days 25 and 30, post-seeding into Millipore 
inserts. The 1mM H20 2 stock was further diluted to produce the concentration
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range of 50|jM, 100pM, 200pM, 400pM, 800|jM and 1mM; PBS was used as 
a control solution. Inserts were apically exposed to H2O2 and incubated for 
24hr at 37°C and 5% CO2 ; TEER readings were taken before dosing (Section
2.3.2). Subsequent to H2O2 exposure, TEER values were recorded and the 
same insert was used to assess culture viability (Section 4.3.4). The 
concentration that elicited a 20% decrease in culture viability (TD20: toxic dose 
20%), when compared to controls, was used for further analysis. A H2O2 
concentration of ten-fold less than the TD20 H2O2 concentration was also used 
to further investigate the correlation between Prx status change and oxidative 
stress levels. The TD20 concentration was chosen as it was sub-toxic, since 
the research objective was to identify Prx as a biomarker of oxidative stress, 
rather than studying dead or dying cells.
Additional exposure experiments were undertaken over a range of times (i.e. 
1 hr, 3hr and 6hr). Four inserts were apically exposed to H2O2 at 1mM (TD20), 
100pM or OpM (control). Following exposure, excess apical solution was 
removed by aspiration, and the cells lysed with lysis buffer in preparation for 
Western blot analysis to determine Prx status (Section 2.3.4).
4.3 .2  ATP Assa y
The ViaLight® Plus cell Proliferation and Cytotoxicity BioAssay Kit was used to 
assess cellular ATP activity. ATP Monitoring Agent Plus (AMR Plus) was 
prepared by reconstituting the lypophilised AMR Plus with the supplied Assay 
Buffer. The AMR Plus was allowed to equilibrate for 15min at RT. Cell lysis 
solution was brought up to RT before use. The proliferation and cytotoxicity of 
mammalian cells in culture was measured by determination of their ATP 
levels.
Following apical exposures TEER measurements were taken (Section 2.3.2); 
inserts were then placed into an empty well in preparation for the ATP assay. 
Cell lysis reagent (100pl) was applied apically to each insert and incubated for 
10min. The cell lysates (100pl) were then placed into the wells of a 96-well 
plate and AMR Plus reagent (100pl) added to each well and incubated for
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2min (in the d£rk). The luminescence was read using the FLUOstar OPTIMA 
and analysed using the OPTIMA Control System software (BMG LABTECH).
4.3.3 A n tio xid an t  A ddition
Preliminary AO addition was undertaken as a continuous exposure throughout 
the morphogenesis of the NHBE cultures, whereby 1mM of NAC was added 
to the ALI media. Following the continuous exposure a more refined AO 
analysis took place between Days 25 and 30, post-seeding into Millipore 
inserts. NHBE cell cultures (Section 2.2.1) were basally exposed to a 
concentration range of NAC or GSH. NAC (100mM) or GSH (10mM) were 
diluted in the NHBE cell culture medium to create a concentration gradient 
(OmM to 10mM and OmM to 5mM, respectively). TEER readings were taken 
before dosing (Section 2.3.2), cultures were then analysed 24hr post-addition 
via ATP (Section 4.3.4) and TEER readings. Prx status was elucidated via 
Western blotting (Section 2.3.4). Following the pilot optimisations, 800pM 
GSH was chosen as the optimum antioxidant concentration to supplement the 
NHBE cultures 24hr prior to toxicant exposure.
4.3.4 H20 2 G enerated  by GOx
To accurately measure the H20 2 concentrations produced by the GOx 
system, a H20 2 determination method was utilised (van der Vliet et al., 1997). 
A H20 2 stock of 1mM was diluted with DMEM to produce a concentration 
curve as follows: OpM, 6.25pM, 12.5pM, 25pM, 50pM and 100 pM these were 
used to establish a concentration curve. Each H20 2 sample (800pl) was 
added to 100pl of 10mg/ml BSA and 100pl TCA (100%). This was then 
vortexed briefly and centrifuged in a microfuge for 2min at 14000rpm, the 
supernatant removed and added to 200pl Fe(NH4)2(S04)2 and 100pl KSCN. 
The mixture was then vortexed briefly and the absorbance read at 450nm 
within 10min. A standard curve was established from which the H20 2 
concentration in the GOx samples could be determined using the same 
method.
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4.3.5 GOx Expo sur e
NHBE cell cultures (Section 2.2.1) were apically exposed to a concentration 
range of GOx (50pl), between Days 25 and 30, post-seeding into Millipore 
inserts. The 1 U/ml GOx stock was further diluted to produce the concentration 
range of 5mU/ml, 15mU/ml and 25mU/ml; DMEM was used as a control 
solution. Inserts were apically exposed to GOx and incubated for 3hr at 37°C 
and 5% C02, TEER readings were taken before dosing (Section 2.3.2). 
Subsequent to GOx exposure, TEER values were recorded and the same 
insert was used to assess culture viability (Section 4.3.4), followed Western 
blot analysis (Section 2.3.4) to establish Prx status following toxicant (GOx) 
exposure.
4 .4  R esults
4.4.1 H20 2 Expo sur e
4.4.1.1 H20 2 Ex po s u r es : TEER and  ATP A nalysis
TEER values post-exposure (Figure 4.2) revealed that epithelial barrier 
integrities were not significantly (P£0.05) compromised following all H20 2 
exposures. There were significant (P<0.05) increases in TEER readings at the 
400uM and 800uM exposures, peaking at 162%. This was a direct result of 
the toxicant addition, leading to a survival response by the cells which 
involved tightening their intercellular junctions. There was a decrease in 
viability (TD20) at the 1mM concentration. Consequently, the 100uM and 1mM 
H20 2 concentrations were selected for further analysis (Section 4.4.2).
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Figure 4.2: H20 2 dose range responses.
TEER (■) and ATP (♦) analysis of the NHBE cultures 24hr post-exposure to H20 2 Cultures 
were apically exposed to a concentration range of H20 2 (OmM to 1mM). The asterisk (*) 
denoted significance (P^0.05) and I  signified ±SD for n=3. TEER values increased 
significantly post-exposure to 400pM and 800pM H20 2, while ATP levels displayed a biphasic 
response.
4.4.1.2 H20 2 Ex p o s u r e s : W e s te r n  B lo t  A n a ly s is  (T o tal  Prx Levels)
NHBE cultures exposed to 100pM and 1mM H20 2were subjected to reducing 
gel electrophoresis conditions and analysed via Western blotting (Figure 
4.10). Expression of the house-keeping protein (3-actin remained strong 
throughout, which confirmed the ATP and TEER data following the sub-toxic 
H20 2 concentrations. Total Prx I expression remained low throughout all H20 2 
exposures, and decreased significantly (P<0.05) (Figure 4.4) following the 1 hr 
and 3hr 100pM exposures and the 1 hr 1mM exposure. Total Prx III 
expression significantly (P<0.05) decreased following the 3hr 100pM and 
1mM exposures. Elevated levels of Prx-S0 3 , at the 1mM exposures, were 
evident from the raw data blots. This was confirmed via densitometry analysis 
which revealed significant (P<0.05) increases of 62% at the 1 hr exposure and 
54% following the 3hr exposure.
110
R e sp o n s e  of P e r o x ir e d o x in  S t a t u s  to  H y d r o g e n  P e r o xide  Expo sure
1hr 3hr 6hr
(pM) 0 100 1000 0 100 1000 0 100 1000
(3-Actin 
Prx I
Prx III 
Prx-S03
Figure 4.3: Western blot analysis of reduced Prxs post-exposure to H20 2.
NHBE cell cultures were apically exposed to OpM, 100pM or 1mM H20 2 for 1 hr, 3hr or 6hr, 
PBS was used as a control. Whole cells extracts were lysed following exposure. Lysates were 
resolved by reducing 1D SDS-PAGE electrophoresis followed by Western blotting and 
chemiluminescence detection. Proteins were analysed using primary antibodies specific to 
Prx I, III, -S03 and p-actin. Red denoted areas of interest, with increased Prx-S03 levels post­
exposure to 1mM H20 2 for 1 hr and 3hr.
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Figure 4.4: Densitometry analysis of total Prx levels post-exposure to H20 2.
Figure continued below.
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Figure 4.4: Densitometry analysis of total Prx levels post-exposure to H20 2.
The GeneTool software calculated band densitometry from Western blots (reducing 
conditions) of NHBE cell cultures exposed to OpM (■), lOOpM (■) and 1mM (■) H20 2, for 1 hr, 
3hr and 6hr. (a) Prx I, (b) Prx III and (c) Prx-S03. Results were normalised using the 
corresponding p-actin expression. The asterisk (*) denoted significance (P^O.05) and I  
signified ±SD for n=3. There was increased Prx-S03 levels in cultures exposed to 1mM H20 2 
for 1 hr and 3hr, decreased Prx III expression in cultures exposes to 100(jM and 1mM H20 2 for 
3hr, and decreased Prx I expression in cultures exposed to 100pM and 1mM H20 2 for 1 hr and 
to 100pM H20 2 for 3hr.
4.4.2 A n t io x id a n t  A d d it io n
4.4.2.1 NAC Exposures: TEER and ATP Analysis
Following the 24hr incubation with NAC (Figure 4.5), the TEER values 
remained consistent throughout all NAC concentrations. The ATP results 
demonstrated significant (P<0.05) increases of 52% at the 1mM 
concentration, and 40% at the 10mM concentration.
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Figure 4.5: NAC dose range responses.
TEER (■) and ATP (♦) analysis of the NHBE cell cultures 24hr post-addition of NAC to the ALI 
media. Cultures were fed basally with ALI containing a concentration range of NAC (OpM to 
10mM). The asterisk (*) denoted significance (P<0.05) and I  signified ±SD for n=3. TEER 
values remained consistent throughout all exposures, while ATP increased significantly in 
cultures exposed to 1mM and 10mM NAC.
4.4.2.3 Glutathione Exposures: TEER and ATP Analysis
Following the 24hr incubations with GSH (Figure 4.6), the TEER values 
decreased significantly (P<0.05) at the 5mM concentration. The ATP assay 
displayed values that did not veer significantly (P<0.05) from the control levels 
throughout all exposures.
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Figure 4.6: GSH dose range responses.
TEER (■) and ATP (♦) analysis of the NHBE cell cultures 24hr post-addition of GSH to the ALI 
media. Cultures were fed basally with ALI containing a concentration range of GSH (OmM to 
5mM). The asterisk (*) denoted significance (P£0.05) and I  signified ±SD for n=3. TEER 
values decreased significantly in cultures exposed to 5mM GSH, ATP remained consistent.
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4.4.2.4 G lu ta th io n e  Ex p o s u r e s : W e s te r n  B lo t  A n alysis  (T o tal P rx Le v e ls )
GSH was chosen as the more suitable AO candidate following conventional 
toxicology analysis. Accordingly further investigations were undertaken to 
analyse Prx status post-addition of AO and identify the most appropriate GSH 
concentration.
A GSH dose curve (0-5mM) determined which GSH concentration reduced 
the basal levels of Prx-S0 3  within the NHBE cell cultures. The cultures were 
exposed to GSH, subjected to reducing gel electrophoresis conditions and 
analysed via Western blotting (Figure 4.7). The levels of hyperoxidation were 
significantly (P<0.05) increased (Figure 4.8) by 37% at the 400pM 
concentration and by 53% at the 800pM concentration. The only 
concentration to cause a reduction in Prx-S03 levels was the 800pM 
concentration, which elicited a decrease of 6%. The 800pM concentration was 
therefore chosen for future use in alleviating basal levels of intracellular 
oxidative stress within the NHBE cell cultures.
(pM) 0 10 100 200 400 800 1000 5000
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Prx-S03
Figure 4.7: Western blot analysis of total Prx-S03 levels post-addition of GSH.
A concentration range of GSH (OmM to 5mM) was added to the ALI media of the NHBE cell 
cultures. Whole cell extracts were lysed 24hr post-addition of GSH. Lysates were resolved by 
reducing 1D SDS-PAGE electrophoresis followed by Western blotting and 
chemiluminescence detection. Proteins were analysed using primary antibodies specific to 
Prx-S03 and (3-actin. Red denoted areas of interest with elevated levels of Prx-S03 in cultures 
exposed to 400pM and 1mM GSH, and decreased Prx-S03 levels in cultures exposed to 
800pM GSH.
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Figure 4.8: Densitometry analysis of total Prx-S03 levels post-addition of GSH.
The GeneTool software calculated band densitometry for Western blot (reducing conditions) 
results of NHBE cell cultures basally exposed to a concentration range of GSH (■) (OpM to 
5mM). Results were normalised using the corresponding p-actin expression. The asterisk (*) 
denoted significance (PS0.05) and I  signified ±SD for n=3. There were increased Prx-S03 
levels in cultures exposed to 400pM and 1mM GSH.
4.4.3 GOx E x p o s u r e
4.4.3.1 H20 2 Generated by GOx
The three GOx concentrations, 5, 15 and 25mU/ml, released proportionate 
amounts of H20 2(Figure 4.9), increasing overtime in a linear manner.
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Figure 4.9: H20 2 generated by GOx in media overtim e.
The H20 2 concentration released over time by GOx: 5mU/ml (■), 15mU/ml (♦) and 25mU/ml 
(A). GOx was diluted in DMEM. GOx analysis revealed linear increases in H20 2 
concentration over time.
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4.4.3.2 GOx Ex p o s u r e s : TEER a n d  ATP A n alysis
NHBE cultures -/+AO were exposed to increasing concentrations of GOx for 
3hr (Figure 4.10, Figure 4.11). The TEER values were consistent for cultures 
+AO and -AO, remaining at approximately control levels following all GOx 
exposures. In comparison, the ATP analysis revealed a greater response, 
with biphasic responses displayed by cultures +AO and -AO following 
exposures. The cultures -AO demonstrated significantly (P<0.05) reduced 
viability at the 5mU/ml GOx concentration, which was followed by a rise in cell 
viability at the 15mU/ml and 25mU/ml concentrations. The cultures +AO 
responded with significant decreases at the 15mU/ml and 25ml)/ml GOx 
concentrations.
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Figure 4.10: GOx dose range responses (-AO cultures).
TEER (■) and ATP (♦) analysis of the NHBE cultures -AO post-exposure to GOx. Cultures 
were apically exposed to OmU/ml, 5mU/ml, 15mU/ml and 25mU/ml GOx for 3hr. The asterisk 
O  denoted significance (P^0.05) and I  signified ±SD for n=3. TEER values remained 
consistent throughout all exposures, while ATP values decreased significantly in cultures 
exposed to 5mU/ml GOx.
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Figure 4.11: GOx dose range responses (+AO cultures).
TEER (■) and ATP (♦) analysis of the NHBE cultures +AO post-exposure to GOx. Cultures 
were apically exposed to OmU/ml, 5mU/ml, 15mU/ml and 25mU/ml GOx for 3hr. The asterisk 
(*) denoted significance (P^0.05) and I  signified ±SD for n=3. TEER values remained 
consistent throughout all exposures, while ATP values decreased significantly in cultures 
exposed to 15mll/ml and 25mll/ml GOx.
4.4.3.3 GOx Exposures: W estern Blot Analysis (Total Prx Levels)
NHBE cultures, -/+AO, exposed to 25mU/ml GOx were subjected to reducing 
gel electrophoresis conditions and analysed via Western blotting (Figure 
4.12). In cultures -AO, the 0.5hr GOx exposure induced significant (P<0.05) 
increases of 52%, 89% and 40% (Figure 4.13) in Prx III, Prx-S03 and P- 
Erk1/2 levels, respectively. P-Erk1/2 levels increased further to 52% by the 
1 hr exposure and by the 3hr exposure Prx III expression had decreased 
significantly (P<0.05) by 25%. In cultures +AO the 3hr GOx exposure elicited 
a significant (P<0.05) decrease of 30% in Prx I expression and significant 
increases of 25% in both Prx-S03 and P-Erk1/2 levels. In cultures +AO, the 
increase in Prx-S03 was proportionate to the H2O2 concentration, with the 
longer exposures eliciting higher H20 2 concentrations and elevated Prx-S03.
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Figure 4.12: Western blot analysis of total Prx levels post-exposure to GOx.
NHBE cell cultures -/+AO were apically exposed to 25mU/ml GOx for Ohr, 0.5hr, 1 hr and 3hr. 
Whole cells extracts were lysed following exposure. Lysates were resolved by reducing 1D 
SDS-PAGE electrophoresis followed by Western blotting and chemiluminescence detection. 
Proteins were analysed using primary antibodies specific to Prx I, Prx III, Prx-S03, P-Erk1/2 
and (3-actin. Red denoted areas of interest, with elevated Prx III, Prx-S03 and P-Erk1/2 in 
cultures -AO exposed to 25mU/ml GOx for 0.5hr, and elevated Prx III and Prx-S03 in cultures 
+AO exposed to 25mU/ml GOx for 3hr.
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Figure 4.13: Densitometry analysis of total Prx levels post-exposure to GOx.
Figure continued below.
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Figure 4.13: Densitometry analysis of total Prx levels post-exposure to GOx.
The GeneTool software calculated Prx I (■), Prx III (■), Prx-S03 (■) and P-Erk1/2 (■) band 
densitometry from Western blots (reducing conditions) of NHBE cell cultures (a) -AO and (b) 
+AO exposed to 25mU/ml GOx for Ohr, 0.5hr, 1 hr and 3hr. Results were normalised using the 
corresponding (3-actin expression. The asterisk (*) denoted significance (P<0.05) and I  
signified ±SD for n=3. There were elevated Prx III, Prx-S03 and P-Erk1/2 levels in cultures - 
AO exposed to 25mU/ml GOx for 0.5hr, elevated P-Erk1/2 in cultures -AO exposed to 
25mU/ml GOx for 1 hr, and elevated Prx III and Prx-S03 and decreased Prx I in cultures +AO 
exposed to 25mU/ml GOx for 3hr.
4.4.3.4 GOx Ex p o s u r e s : W e s ter n  B lo t  A n a ly s is  (A c tive  P rx III)
NHBE cultures, -/+AO, exposed to 25mU/ml GOx for 3hr, were subjected to 
non-reducing gel electrophoresis conditions and analysed via Western blotting 
(Figure 4.14). Overall there were higher levels of total Prx III cultures in -AO in 
comparison to those +AO (Figure 4.15). In the cultures -AO, there was a 
significant decrease (P<0.05) in Prx III activity to 51% in cultures exposed for 
0.5hr; indicated by a rise in monomer (inactive Prx III) levels. In cultures +AO, 
the monomer levels increased according to the exposure time, and hence, 
H2O2 concentration increased, there was a significant (P<0.05) decrease in 
activity following the 3hr exposure. Thus indicating an inversely proportionate 
relationship between dimer (active Prx III) and monomer levels in the +AO 
cultures exposed to GOx. In general, the cultures +AO had much more Prx III 
activity in comparison to the corresponding -AO cultures, in particular the two 
control samples (+AO: 92%; -AO: 78%).
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Figure 4.14: Western blot analysis of Prx III activity post-exposure to GOx.
NHBE cell cultures -/+AO were apically exposed to 25mU/ml GOx for Ohr, 0.5hr, 1 hr and 3hr. 
Whole cells extracts were lysed following exposure. Lysates were resolved by non-reducing 
1D SDS-PAGE electrophoresis followed by Western blotting and chemiluminescence 
detection. Proteins were analysed using primary antibodies specific to Prx III and (3-actin. 
Dimers corresponded to active Prx III, whereas monomers represent hyperoxidised (inactive) 
Prx III. Red denoted areas of interest, with elevated monomer levels in cultures -AO exposed 
to 25mU/ml GOx for 0.5hr, and monomer levels elevated in proportion to H20 2 concentration 
in cultures +AO.
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Figure 4.15: Densitometry analysis of Prx III activity post-exposure to GOx.
The GeneTool software calculated Prx III monomer and dimer band densitometry from 
Western blots (non-reducing conditions) of NHBE cell cultures -AO (■) and +AO (■) exposed 
to 25mU/ml GOx for Ohr, 0.5hr, 1 hr and 3hr. Results were normalised using the 
corresponding (3-actin expression. The asterisk (*) denoted significance (P£0.05) and I  
signified ±SD for n=3. There was decreased activity in cultures -AO exposed to 25mU/ml GOx 
for 0.5hr, and decreased Prx III activity in cultures +AO exposed to 25mll/ml GOx for 3hr.
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4 .5  D isc u ssio n
4.5.1 H20 2 Ex po su r e
The previous experimental work (Chapters 2 and 3) established a modified 
toxicological exposure window, in accordance with Prx status at the 
biochemical level. This required moving away from the traditional dosing 
window of Days 27-33 (Prytherch, 2010), which was primarily based on 
morphological analysis, in favour of Days 25-30 (Chapters 2 and 3). The 
revised dosing window was utilised for toxicological analysis, where cultures 
were exposed to a concentration range of H2O2 and incubated for 24hr. The 
conventional toxicology revealed that even at the higher H2O2 concentrations, 
the NHBE cells remained intact and cell-cell junctions had not been overly 
compromised. There was a significant (P£0.05) increase in the TEER values 
following the 800pM H2O2 exposure; this increase was attributed to a survival 
attempt, whereby the cultures constricted their intercellular tight junctions to 
prevent toxicant absorption (Schneeberger and Lynch, 1992). The ATP 
analysis revealed a biphasic response known as ‘hormesis’ (Calabrese, 
2004), which is a response characterised by an initial dip in cell viability at the 
lower concentrations, followed by an increase as toxicant concentration 
increased, followed by a subsequent decrease in viability at the highest 
concentrations. The biphasic response has been shown to be an acute 
protection mechanism employed by the cells in response to insult (Balharry et 
a/., 2008).
Subsequent to the initial H2O2 exposures, the 100pM and 1mM 
concentrations were selected for further investigation. The 100pM and 1mM 
H2O2 concentrations were elevated in comparison to other studies utilising 
H2O2 (Phalen et ai, 2006; Cox et at., 2009a), however, in comparison to 
monolayers of pulmonary cells, the NHBE system has been shown to be more 
resilient (Prytherch, 2010). Balharry and co-workers demonstrated that up to 
10 times the concentration of a given classical pulmonary toxin (e.g. tobacco 
smoke components) was required to produce the same effect observed in 
comparable monolayer cultures (Balharry et al., 2008).
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The Western blot results demonstrated significant (P<0.05) increases in the 
levels of Prx-SC>3 at the highest H2O2 concentrations (1mM). This was 
physiologically relevant; as cultures were not significantly (P^0.05) 
compromised with regard TEER and ATP analysis. These findings 
corresponded to the current understanding of how oxidative stress effects 
redox signalling within the cell (Thannickal and Fanburg, 2000; Halliwell, 
2007a). In the first instance, there would be no definable phenotypic 
adaptations, however, on the biochemical level, cycles of injury and repair 
would be occurring, as the cells struggled to maintain homeostasis (Heintz, 
2008). Early stage oxidant damage would therefore be more likely to affect 
the Prx status, whereas the NHBE culture morphology would appear 
phenotypically normal (Rabilloud et al., 2002). The Western blot observations 
demonstrated increased Prx hyperoxidation following H2O2 exposure, 
suggesting that Prx oxidation state may be used as an early predictor of 
elevated oxidative stress within the cells, before phenotypic adaptation 
occurred.
Homeostasis Chronic Oxidative Phenotypic Adaptation
Stress
RepairInjury
Redox
Signalling
Disrupted Redox 
Signalling
Normal Oxidant Increased ROS Augmentation of Redox
Metabolism Production Associated Genes
Figure 4.11: The effect of ROS on homeostasis within the bronchial epithelium.
Optimal redox signalling maintained homeostasis within the lung of a healthy individual. 
Following chronic oxidative stress, there would be increased ROS production, leading to 
cycles of injury and repair. Over-time the redox signalling within the lung would be 
permanently disrupted, leading to phenotypic adaptations through the augmentation of 
antioxidant expression (Adapted from Heintz, 2008).
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4.5.2 A ntio xidant  A ddition
The elevated levels of Prx-S0 3  within the control NHBE cultures (Sections
2.4.3 and 4.4.1) revealed a need to minimise the basal levels of oxidative 
stress. The continuous AO addition, whereby 1mM NAC was added to the ALI 
media for every media change, was unsuccessful as the cultures did not 
differentiate and died at around Day 9. Following the continuous AO 
experiments a concentration range of NAC and GSH was added to the ALI 
culture media, and the cultures analysed by conventional toxicology (ATP and 
TEER) 24hr post-addition. This was undertaken to determine the most 
effective AO supplementation for reducing oxidative stress levels within the 
NHBE cultures. ATP and TEER analysis suggested that 800pM GSH was the 
concentration of AO that had no significant detrimental effect in terms of ATP, 
TEERs and Prx-S0 3 . Further analysis utilised Western blotting by probing for 
Prx-S0 3 ; this substantiated the ATP and TEER data, with 800pM GSH the 
only concentration to reduce the basal levels of Prx-S0 3 . Additional work 
would involve assessing the baseline GSH status of the NHBE cultures.
4.5.3 GOx Expo sure
Preliminary oxidant exposures involved the direct addition of H2O2 to the 
NHBE cell cultures as a means to evoke a detectable change in Prx oxidation 
state. In order to refine the experiments a GOx system was employed that 
emitted a continual flux of H2O2 (van der Vliet et al., 1997; Phalen et al., 2006; 
Cox et al., 2009a), in a manner that was more akin to the in vivo situation. The 
lower levels of H2O2 released by the GOx system permitted more robust 
characterisation of the changes in Prx status, as a result of more subtle 
increases in oxidant burden. The ability to detect and quantify subtle changes 
improved the capacity of the Prxs to be used as an early stage biomarker of 
oxidative stress.
The concentration range of GOx generated comparable TEER responses in 
cultures -/+AO, which remained constant at control levels for all 
concentrations. The ATP results were biphasic in cultures -/+AO, however,
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the +AO cultures required a higher GOx concentration, in comparison to -AO 
cultures, in order to achieve the same initial stimulation (Rozman and Doull, 
2003). This suggested that AO supplementation had buffered the effect of the 
increased oxidant, as observed in vivo.
Cox and co-workers discovered that the addition of cell extract to cell lysis 
buffer caused reduced Prxs to form dimers, therefore both reduced and 
oxidised Prx would appear on Western blots as a dimers following non­
reducing gel electrophoresis conditions (Cox et al., 2010a). This technique 
was therefore exploited to determine the levels of Prx hyperoxidation, with the 
monomer bands representative of Prx hyperoxidation. Western blot analysis 
of reduced and non-reduced NHBE samples revealed elevated levels of Prx 
III expression in GOx exposed cultures -AO, in comparison to corresponding 
+AO cultures; as a mode of compensating for the absence of a basal level AO 
protection (Lehtonen et al., 2005). In cultures -AO exposed to GOx there were 
significantly (P£0.05) increased levels of Prx III and Prx-S03 following the 
0.5hr exposures. These elevated levels were not maintained following the 1 hr 
and 3hr (highest H2O2 concentration) exposures. The rationale for these 
observations was linked to cell cycle arrest, whereby the 0.5hr exposures 
initiated arrest in response to a significant increase in Prx hyperoxidation 
levels (Phalen et al., 2006). By the 1hr and 3hr exposures the overall levels of 
Prx had begun to reduce, and consequently, the levels of hyperoxidation did 
not increase further. In cultures +AO, the levels of Prx-S0 3  increased in 
proportion to H20 2 concentration; with a significant (P£0.05) increase 
following the 3hr exposure. Prx III activity was consistently higher in cultures 
+AO in comparison to those -AO, with 92% activity in control samples. This 
was an indicator of the stability brought to the NHBE model through 
antioxidant supplementation (Leist et al., 1996).
The levels of P-Erk1/2 were also analysed in order to fully relate Prx status 
change to levels of oxidative stress, since increased levels of phosphorylated 
MAP kinase represented activation of the stress response pathways 
(Waskiewicz and Cooper, 1995). The response patterns of Prx III and Prx-S03 
was also seen for P-Erk1/2, whereby in cultures -AO there were significantly
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(P<0.05) increased levels following the 0.5hr exposure, and in cultures +AO 
there were a significant (P^O.05) increases following the 3hr exposure. Again, 
this demonstrated the enhanced stability of the +AO cultures in comparison to 
cultures -AO, with higher H2O2 concentrations needed to activate Erk1/2 (Kim 
et al., 2005). Future work would involve total Erk1/2 levels to be analysed.
The collective Western blot results from GOx exposed cultures reinforced the 
need for AO addition in order to stabilise the cultures at the biochemical level, 
with analysis of cultures supplemented with GSH strengthening the use of Prx 
oxidation state as a marker of intracellular oxidant burden.
4.6  Co nclusio n
Exposing the NHBE cultures to H2O2 (directly and via the GOx system) 
revealed several key features with regard to the model and the potential 
biomarker role of the Prxs. Directly exposing the NHBE cultures to 1mM H2O2 
for 24hr caused only a TD20 (Toxic Dose 20%) response, but induced a 
significant increase in Prx hyperoxidation, demonstrating the models’ 
resilience in comparison to less physiologically relevant monolayer cell 
systems. Cultures exposed to H2O2 via the GOx system also elicited 
significant increases in Prx hyperoxidation at the higher concentrations, with 
+AO cultures following a more expected trend, in terms of Prx status following 
exposure. It could be concluded that incorporating AO into the cell culture 
media, to alleviate the oxidant burden caused by culture conditions (Halliwell,
2003), enhanced the NHBE cell culture viability (i.e. increasing its potential as 
an in vitro alternative).
The GOx system created a more physiologically relevant H2O2 exposure 
system that increased Prx hyperoxidation levels, inferring that Prxs were 
sensitive to minor changes in oxidative stress. Therefore, Prx oxidation state 
may be exploited to elucidate intracellular oxidative stress levels. This, 
coupled with the stable NHBE phenotype at the higher H2O2 concentrations, 
recommended that Prx could act as an ‘early stage biomarker’ for events 
reflecting elevated levels of intracellular oxidative stress.
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C h a pter  5:
Response  of Per o xir ed o xin  Status  
to  C igarette  S m o k e  Expo sure
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5.1 Introductio n
Cigarette smoke (CS) is the most common inhaled human toxicant (IARC,
2004), with smoking the most common cause of COPD Worldwide, 
accounting for over 90% of cases (Boots et al., 2003). Each cigarette contains 
over 4000 compounds, including oxidants, mutagens and carcinogens, along 
with antigenic and cytotoxic components (Hansel and Barnes, 2004). In terms 
of oxidative stress, there is an estimated 1017 reactive oxygen species (ROS) 
per standard inhalation (MacNee and Rahman, 2001; IARC, 2004), imparting 
a substantial oxidant burden on the cells of the pulmonary epithelium.
Work in this Chapter involved exposing the fully differentiated NHBE cultures, 
both -/+AO, to a concentration range of CS. Conventional toxicology was 
utilised for culture analysis 3hr and 24hr post-exposure. Changes in junction 
integrity (TEER) and cell viability (ATP) were monitored over the CS 
concentration range, and Prx status was determined using Western blotting 
for reducing and non-reducing gel electrophoresis conditions. IHC analysis 
was undertaken to investigate further Prx expression levels and oxidation 
following CS exposure.
The aim was to analyse Prx status as a ‘biomarker of oxidative damage’ 
caused by the CS exposures. Analysis at 3hr and 24hr post-exposure was 
undertaken to gauge the repair competency of the NHBE model, potentially 
enhancing the models credentials as a viable in vitro alternative, through 
providing an in vivo like response.
5.1.1 Research  A ims
The research aims for experimental work in Chapter 5 (Figure 5.1), were as 
follows:
• Culture the NHBE cells until the point of full differentiation and expose to a 
concentration range of CS and assess conventional toxicology through 
TEER and ATP analysis.
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• Quench the basal levels of oxidative stress within the NHBE cultures 
through the addition of AO to the culture media.
• Quantify the expression levels and oxidation state of the Prxs by 
employing reducing and non-reducing gel electrophoresis conditions, 
followed by Western blotting and chemiluminescence detection.
• Investigate further Prx oxidation state and region specific expression 
levels, following CS exposure, by utilising the IHC chromogenic detection 
system.
Cigarette Smoke
+ /-Antioxidant in 
Cell Culture Media 
(24hr Exposure)
+/- Gkitath
30min Exposures and 3hr or 24hr Recovery
ATP Assay Western Blot 
Reducing and Non-Reducing Conditions
Chromogenic IHC TEER Measurements
Secondary Antibody
A Prx Antibody
Prx Antigen
Streptavidin 
Biotin 
Secondary Antibody
Prx Antibody 
Prx Antigen
r " " l Electrode
&
— EndohmChamber
4_| Electrode
Figure 5.1: Flowchart of experimental work in Chapter 5.
Experimental aims included apical exposure of the NHBE cell cultures to CS, followed by 
analysis 3hr and 24hr post-exposure. Culture viability (ATP) and junction integrity (TEER) 
were established. Prx status (expression levels and oxidation state) was determined through 
reducing and non-reducing gel electrophoresis conditions followed by Western blotting and 
chemiluminescence detection. Chromogenic IHC was also undertaken.
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5.2 M a t e r ia l s  a n d  S t o c k  S o l u t io n s
Materials and stock solutions from previous Chapters have not been included. 
5.2.1 M a te ria ls  and Suppliers
M a t e r ia l s : S u p p l ie r :
Kentucky Research Cigarettes, 
3R4F
Tobacco-Health Research, University of 
Kentucky, USA
Smoking Robot RM20S Borgwaldt-kc Teknik, Hamburg, Germany
Table 5.1: Materials used and their suppliers. All suppliers were UK based unless stated.
5.3 M e t h o d s
5.3.1 CS Exposure
The CS exposures were undertaken at AstraZeneca R&D (Loughborough, 
UK), using the RM20S smoking robot (Figure 5.2). Experiments were 
performed with the expert guidance of Senior Scientist Ms. Wendy Merrison. 
NHBE cells were exposed between Days 25 and 30. TEER readings were 
taken before exposure (Section 2.3.2) to ensure viability. The smoking 
machine was set up to apically smoke the NHBE cultures (n=3) at one of four 
different constant smoke dilutions; 1:30, 1:50, 1:100 or 1:150. Smoke was 
drawn from Kentucky research cigarettes 3R4F using the International 
Standardisation Organisation (ISO) conditions (i.e. 35ml puff drawn over 
2secs, every minute). The cells were smoked continually for 30min (~4-5 
cigarettes to each smoking chamber). NHBE cultures were placed in their 
smoking chambers (Figure 5.5) containing 38ml ALI media -/+800pM 
glutathione. NHBE cells in the smoking chambers were kept in a cell culture 
laminar flow hood for the smoke exposure. Control cells were left in a cell 
culture laminar flow hood with ALI media for the duration of the experiment so 
that equivalent temperatures were maintained. Post-exposure the cultures 
recovered for 3hr or 24hr in fresh ALI media (-/+AO) at 37°C and 5% CO2 .
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TEER analysis, ATP assays (Section 4.3.4) and Western blotting of the 
reduced and non-reduced samples (Section 2.3.4) were all utilised to analyse 
junction integrity, cell viability and Prx expression levels and oxidation state, 
respectively.
Smoke
Machine
Smoke
Dilution
Chamber
(b)
Smoke Chamber
T
Culture Insert 
Holder
ALI Media 
Reservoir
Figure 5.2: Smoking robot and Smoke chamber.
The smoking robot (a) used to smoke the NHBE cells along with a closer view of the smoke 
dilution chambers used to dilute the CS to the required concentrations. Eight individual NHBE 
culture inserts were held in the smoking chamber (b). The ALI media resided in the large well 
at the base of the smoking chamber and the NHBE culture inserts were placed into the 
appropriate holders. The large chamber lid was placed on top, and the pipes to the smoke 
machine were attached (not shown).
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5.4 R esults
5.4.1 CS ex p o su r e : TEER a n d  ATP A n a lysis
In CS exposed cultures 3hr post-exposure (Figure 5.3) the TEER values 
decreased significantly (P£0.05), in cultures -AO, following exposures to the 
1:50 and 1:30 CS concentrations. In comparison, TEER values in cultures 
+AO remained consistent throughout all exposures. In cultures -AO ATP 
activity increased proportionately to CS concentration, with significant 
(P£0.05) increases at the 1:100, 1:50 and 1:30 CS concentrations, peaking at 
183% following the 1:30 CS exposure. ATP responses in cultures +AO were 
biphasic in nature, decreasing significantly (P<0.05) following exposure to the 
1:150 CS concentration and increasing significantly (P<0.05) following the 
1:50 CS exposures.
In CS exposed cultures 24hrs post-exposure (Figure 5.4) the TEER values 
remained consistent in cultures -AO, with cultures exposed to higher CS 
concentrations demonstrating recovery when compared to the 3hr post­
exposure analyses. The ATP levels in cultures -AO were elevated at all CS 
exposures and significantly (P£0.05) elevated at the 1:30 CS concentration. In 
cultures +AO the TEER values were consistent following exposures to the 
1:150, 1:100 and 1:50 CS concentrations, and significantly (P£0.05) elevated 
following the 1:30 CS exposure. ATP analyses of the cultures +AO revealed a 
response that was biphasic in nature, requiring a higher CS concentration for 
initial stimulation in comparison to cultures +AO at 3hr post-exposure.
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Figure 5.3: CS dose range response on TEER and ATP readings.
TEER (■) and ATP (♦) analysis of the NHBE cultures (a) -AO and (b) +AO 3hr post-exposure 
to CS Cultures were apically exposed to 1:150, 1:100, 1:50 and 1:30 CS dilutions for 30min; 
air exposure was used as a control. The asterisk (*) denoted significance (P^0.05) and I  
signified ±SD for n=3. (a) TEER values decreased significantly at the 1:50 and 1:30 CS 
concentrations, while ATP values increased significantly at the 1:100, 1:50 and 1:30 
concentrations: (b) TEER values remained consistent throughout all exposures, while ATP 
values decreased significantly following exposure to the 1:150 concentrations and increased 
significantly at the 1:50 concentration.
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Figure 5.4: CS dose range response on TEER and ATP readings.
TEER (■) and ATP (♦) analysis of the NHBE cultures (a) -AO and (b) +AO 24hr post­
exposure to CS Cultures were apically exposed to 1:150, 1:100, 1:50 and 1:30 CS for 30min, 
air exposure was used as a control. The asterisk (*) denoted significance (P^0.05) and I  
signified ±SD for n=3. (a) TEER values were consistent throughout all exposures, while ATP 
values increased significantly at the 1:30 concentration; (b) TEER increased significantly at 
the 1:30 concentration, while ATP values decreased significantly at the 1:100 concentrations 
and increased significantly at the 1:50 concentration.
5.4.2 CS exposures: W estern Blot A nalysis (Total Prx Levels)
At 3hr post-exposure to CS the NHBE cultures -/+AO were subjected to 
reducing gel electrophoresis conditions and analysed via Western blotting 
(Figure 5.5). In cultures -AO the 1:50 CS concentration elicited a significant 
(P<0.05) increase of 41% (Figure 5.6) in Prx III expression, whereas
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expression in cultures +AO remained consistent. Levels of Prx hyperoxidation 
(Prx-S03) in cultures -AO were detected throughout all exposures, particularly 
in air exposed cultures. In contrast, Prx-S03 levels were low in air exposed 
cultures +AO, and significantly (P<0.05) increased by 30% and 37% in 
cultures exposed to the 1:50 and 1:30 CS concentrations, respectively. The 
levels of P-Erk1/2 in -AO cultures significantly (P<0.05) increased following all 
CS exposures, peaking with a 67% increase following the 1:50 and 1:100 
exposures. Conversely levels of P-Erk1/2 were undetectable in control and 
exposed +AO cultures. The doublet band seen in the Prx-S03 analysis 
revealed hyperoxidised Prx I/ll (22KDa) and Prx III (21KDa).
(CS)
P-Actin
Prx III 
Prx-S03
P-Erk1/2
Figure 5.5: Western blot analysis of total Prx levels 3hr post-exposure to CS.
NHBE cell cultures -/+AO were apically exposed to 1:100, 1:50 and 1:30 CS for 30min, air 
exposure was used as a control. Cultures were analysed 3hr post-exposure. Whole cells 
extracts were lysed following exposure. Lysates were resolved by reducing 1D SDS-PAGE 
electrophoresis followed by Western blotting and chemiluminescence detection. Proteins 
were analysed using primary antibodies specific to Prx III, Prx-S03, P-Erk1/2 and p-actin. Red 
denoted areas of interest, with elevated Prx-S03 in control cultures -AO, elevated P-Erk1/2 in 
cultures -AO exposed to 1:30 CS, and elevated Prx-S03 in cultures +AO exposed 1:50 and 
1:30 CS.
- Antioxidant + Antioxidant
Control 1:30 1:50 1:100 Control 1:30 1:50 1:100
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Figure 5.6: Densitometry analysis of total Prx levels 3hr post-exposure to CS.
The GeneTool software calculated Prx III (■), Prx-S03 (■) and P-Erk1/2 (■) band 
densitometry from Western blots (reducing conditions) of NHBE cell cultures (a) -AO and (b) 
+AO 3hr post-exposure to CS (air control, 1:30, 1:50 and 1:100 CS for 30min) Results were 
normalised using the corresponding p-actin expression. The asterisk (*) denoted significance 
(P^O.05) and I  signified ±SD for n=3. There was elevated Prx III in cultures -AO exposed to 
1:50 CS, elevated P-Erk1/2 in cultures -AO exposed 1:100, 1:50 and 1:30 CS, and elevated 
Prx-S03 cultures +AO exposed 1:50 and 1:30 CS.
At 24hr post-exposure to CS the NHBE cultures -/+AO were subjected to 
reducing gel electrophoresis conditions and analysed via Western blotting 
(Figure 5.7). In cultures -AO, Prx III showed no significant (P<0.05) changes 
in expression following exposure to all CS concentrations (Figure 5.8), which 
represented a decrease in expression when compared to the corresponding 
cultures at 3hr post-exposure (Figure 5.6). There were elevated levels of Prx- 
S03 in cultures -AO following all exposures, however, subsequent 
densitometry analysis revealed no significant (P<0.05) changes. In contrast, 
the Western blots for cultures +AO revealed that levels of Prx-S03 decreased 
in proportion to CS concentration, which was substantiated by densitometry
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analysis; this confirmed a recovery response in +AO cultures 24hr post­
exposure when compared to the corresponding 3hr post-exposure cultures. 
Levels of P-Erk1/2 in cultures -AO were significantly (P<0.05) increased by 
38% following the 1:30 CS exposure, with more modest increases of 24% and 
19% following the 1:50 and 1:100 CS exposures respectively, however, in 
comparison to the corresponding cultures at 3hr post-exposure, the P-Erk1/2 
levels were decreased. The doublet band seen in the Prx-S03 analysis 
revealed hyperoxidised Prx I/ll (22KDa) and Prx III (21KDa).
(CS) 
p-Actin
Prx-lll 
Prx-S03
P-Erk1/2
Figure 5.7 Western blot analysis of total Prx levels 24hr post-exposure to CS.
NHBE cell cultures -/+AO were apically exposed to 1:100, 1:50 and 1:30 CS for 30min, air 
exposure was used as a control. Cultures were analysed 24hr post-exposure. Whole cells 
extracts were lysed following exposure. Lysates were resolved by reducing 1D SDS-PAGE 
electrophoresis followed by Western blotting and chemiluminescence detection. Proteins 
were analysed using primary antibodies specific to Prx III, Prx-S03, P-Erk1/2 and (3-actin. Red 
denoted areas of interest, with elevated Prx-S03 in control cultures -AO, elevated P-Erk1/2 in 
cultures -AO exposed to 1:30 CS and reduced Prx-S03 in cultures +AO in comparison to 
cultures +AO at 3hr post-exposure.
- Antioxidant + Antioxidant
Control 1:30 1:50 1:100 Control 1:30 1:50 1:100
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Figure 5.8: Densitometry analysis of total Prx levels 24hr post-exposure to CS.
The GeneTool software calculated Prx III (■), Prx-S03 (■) and P-Erk1/2 (■) band 
densitometry from Western blots (reducing conditions) of NHBE cell cultures (a) -AO and (b) 
+AO 24hr post-exposure to CS (air control, 1:30, 1:50 and 1:100 CS for 30min). Results were 
normalised using the corresponding (3-actin expression. The asterisk (*) denoted significance 
(P^0.05) and I  signified ±SD for n=3. There was elevated P-Erk1/2 in cultures -AO exposed 
1:30 CS.
5.4.3 C S e x p o s u r e s : W e s t e r n  B l o t  A n a l y s is  (A c t iv e  P r x  III)
At 3hr post-exposure to CS the NHBE cultures -/+AO were subjected to non­
reducing gel electrophoresis conditions and analysed via Western blotting 
(Figure 5.9). In cultures -AO levels of monomeric Prx III (inactive Prx III) were 
elevated in cultures exposed to air controls and the 1:30 CS concentration. 
Subsequent densitometry evaluation revealed that only 55% of Prx III was 
active following the air exposure (Figure 5.10), which reduced to 53% 
following the 1:30 CS exposures. Conversely, in cultures +AO, the levels of 
dimeric Prx III (active Prx III) remained elevated throughout all exposures; this
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was confirmed by the densitometry analysis showing Prx III activity -80% 
throughout all CS exposures.
- Antioxidant + Antioxidant
(CS) Control 1:30 1:50 1:100 Control 1:30 1:50 1:100
f3-Actin
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Figure 5.9: Western blot analysis of Prx III activity 3hr post-exposure to CS.
NHBE cell cultures -/+AO were apically exposed to 1:100, 1:50 and 1:30 CS for 30min, air 
exposure was used as a control. Cultures were analysed 3hr post-exposure. Whole cells 
extracts were lysed and resolved by non-reducing 1D SDS-PAGE electrophoresis followed by 
Western blotting and chemiluminescence detection. Proteins were analysed using primary 
antibodies specific to Prx III and p-actin. Dimers corresponded to active Prx III, whereas 
monomers represent hyperoxidised (inactive) Prx III. Red denoted areas of interest with 
elevated monomer levels in cultures -AO following the air control and 1:30 CS exposures, and 
consistently elevated dimer levels in cultures +AO following all exposures.
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Figure 5.10: Densitometry analysis of Prx III activity 3hr post-exposure to CS.
The GeneTool software calculated band densitometry from Western blots (non-reducing 
conditions) of NHBE cell cultures -AO (■) and +AO (■) 3hr post-exposure to CS (air control, 
1:30, 1:50 and 1:100 CS for 30min). Results were normalised using the corresponding p-actin 
expression. There was no significant (P<0.05) increases/decreases in Prx III activity, I  
signified ±SD for n=3.
■ -AO b  + AO
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At 24hr post-exposure to CS the NHBE cultures -/+AO were subjected to non­
reducing gel electrophoresis conditions and analysed via Western blotting 
(Figure 5.11). The results revealed a contrast between cultures -AO and those 
+AO, with the total level of Prx III higher in cultures -AO. Levels of dimeric Prx 
III (active Prx III) in cultures -AO decreased at CS concentrations that elicited 
increased levels of monomeric Prx III (inactive Prx III); this was consistent 
with the levels of total Prx III, which remained stable throughout all exposures 
(Figure 5.12). In cultures -AO the air control exposure elicited a reduction in 
Prx III activity to 53%; this was further reduced to 46% following the 1:50 CS 
exposure. In cultures +AO the monomer levels increased following the 1:50 
and 1:30 CS exposures, reducing Prx III activity to 69% and 55%, 
respectively.
(CS) 
p-Actin
Prx III 
Dimer
Prx III 
Monomer
Figure 5.11: Western blot analysis of Prx III activity 24hr post-exposure to CS.
NHBE cell cultures -/+AO were apically exposed to 1:100, 1:50 and 1:30 CS for 30min, air 
exposure was used as a control. Cultures were analysed 24hr post-exposure. Whole cells 
extracts were lysed and resolved by non-reducing 1D SDS-PAGE electrophoresis followed by 
Western blotting and chemiluminescence detection. Proteins were analysed using primary 
antibodies specific to Prx III and P-actin. Dimers correspond to active Prx III, whereas 
monomers represent hyperoxidised (inactive) Prx III. Red denoted areas of interest with 
elevated monomer levels in cultures -AO following the air control and 1:50 CS exposures, and 
elevated monomer levels in cultures +AO following 1:50 and 1:30 CS exposures.
- Antioxidant + Antioxidant
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Figure 5.12: Densitometry analysis of Prx III activity 24hr post-exposure to CS.
The GeneTool software calculated -AO (■) and +AO (■) band densitometry from Western 
blots (non-reducing conditions) of NHBE cell cultures -/+AO 24hr post-exposure to CS (air 
control, 1:30, 1:50 and 1:100 CS for 30min). Results were normalised using the 
corresponding p-actin expression. There was no significant (P^0.05) increases/decreases in 
Prx III activity, I  signified ±SD for n=3.
5.4.4 CS E x p o s u r e  IHC A n a l y s is
Results from IHC analysis of the CS exposed NHBE cultures 24hr post­
exposure (Figure 5.13) reinforced the corresponding Western blot data. 
Control exposures established negligible morphological damage, whereas all 
of the 1:30 CS exposed cultures contained varying degrees of damage, 
including, disruption of intercellular junctions, enlarged vacuoles, squamation 
and general epithelial degradation. The Prx III stained sections demonstrated 
no significant variation in expression between the control and the 1:30 CS 
exposed cultures. This correlated to Western blot data where levels of total 
Prx III did not increase or decrease significantly (P<0.05), in cultures -/+AO, 
following CS exposures. In Prx-S03 stained sections there was a marked 
difference between cultures +AO and -AO, with elevated levels of Prx-S0 3  
observed in control cultures -AO, which increased following 1:30 CS 
exposures. In contrast, control cultures +AO contained minimal levels of Prx- 
S03, with a detectable increase in levels following exposures at the 1:30 CS 
concentration.
■ -AO ■ +AO
Control 1:30 1:50 1:100
C igarette  Sm oke Dilution
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Figure 5.13: Chromogenic IHC analysis of the CS exposed NHBE cell cultures.
Paraffin-fixed 5(jm sections from 30min CS exposed NHBE cultures were incubated overnight 
with Prx 1° ABs. Green denoted areas of damage as a result of CS exposures; red denoted 
areas of expression: (a) air exposed (control) cultures +AO 24hr post-exposure, moderate Prx 
III (1:2000) expression; (b) 1:30 CS +AO 24hr post-exposure, moderate Prx III (1:2000) 
expression; (c) air exposed cultures -AO 24hr post-exposure, elevated Prx-S03 (1:2000) 
expression; (d) 1:30 CS -AO 24hr post-exposure, elevated Prx-S03 levels; (e) Air exposed 
cultures +AO 24hr post-exposure, low Prx-S03 levels; (f) 1:30 CS +AO 24hr post-exposure, 
elevated Prx-S03 levels. DAB was used as a chromagen for immuno-positivity. Scale bars 
represented 10pm. Corresponding negative controls were clean (not shown).
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5.5 D iscussio n
Each CS inhalation has been shown to impart a significant oxidant burden 
onto the pulmonary epithelial cells (Foronjy and D'Armiento, 2006), in 
particular the bronchial epithelium, which is one of the early target sites for 
toxicant exposure (Mercer et a/., 2006). The NHBE model was exposed to CS 
and analysed 3hr and 24hr post-exposure. The inclusion of AO to the culture 
media was undertaken to resolve the oxidant/AO imbalance, and create an in 
vitro system to mimic the in vivo situation. CS exposures were employed to 
validate the utility of using the Prxs as an early biomarker of intracellular 
oxidative stress in vitro, as a proxy for in vivo like responses.
5.5.1 CS Exposure: TEER and A T P  A n a lys is
In cultures -AO, TEER values dropped significantly (P<0.05), in comparison to 
control levels, at the higher CS concentrations (1:50 and 1:30) 3hr post­
exposure to CS, followed by recovery 24hr post-exposure; thus supported the 
robust nature of the NHBE model (Balharry et ai., 2008). The initial disruption 
of epithelial cell junctions (i.e. 3hr post-exposure) may have been part of a 
protective and regeneration response, with cells detaching in order to migrate 
to areas of increased damage and restore the epithelial barrier (Park et al., 
2006b). The corresponding ATP values were significantly (P£0.05) elevated 
following both 3hr and 24hr post-exposure. The elevation in ATP levels could 
be explained by a hypothesis linking ATP concentration to stress response 
mechanisms, whereby cells maximise their available adenylate pool in 
response to the increased oxidant burden (Ataullakhanov and Vitvitsky, 2002). 
This would account for the ATP increase observed as a result of CS exposure 
and furthermore the proportionate response recorded to increasing CS 
concentration.
In cultures +AO, there were no significant (P£0.05) changes in TEER values 
for all CS exposures, both 3hr and 24hr post-exposure. This may have 
indicated enhanced culture resistance as a consequence of AO 
supplementation (Leist et al., 1996). The ATP response was biphasic
142
R esponse  of P er o xiredo xin  S ta tu s  to  C igarette  S moke
(Calabrese, 2004) in nature, characterised by a low dose stimulation that was 
followed by a high dose inhibition (Rozman and Doull, 2003; Balharry et al., 
2008). When comparing the ATP results 3hr and 24hr post-exposure, there 
was a definite repair response evident, with the higher concentration needed 
to elicit the same initial stimulation with regard to the biphasic effect. A 
biphasic response was also elicited in +AO cultures exposed to GOx (Chapter 
4). This reproducibility further strengthened the use of the AO supplemented 
NHBE model in toxicological screening, in addition to Prx as a biomarker of 
oxidant injury severity and repair competency.
5.5.2 CS Ex p o s u r e : W estern  B lo t  A n alysis
The Western blot analysis was used to determine the sensitivity of Prx as a 
potential biomarker of oxidative stress. CS contained several thousand 
compounds (Hansel and Barnes, 2004), including H2O2 (Pryor and Stone, 
1993). Therefore, CS exposure would be expected to initiate a more complex 
and synergistic response, in comparison to the H2O2 exposure (Cantin, 2010). 
Cell cultures -/+AO when exposed to CS and analysed under reducing 
conditions elicited elevated Prx hyperoxidation 3hr and 24hr post-exposure. 
This inferred that a substantial oxidant burden was imparted onto the cultures 
by the CS, and that Prx oxidation state was a reliable measure of this. As with 
the ATP results, it was apparent that cultures -AO were not viable when 
analysing intracellular stress via the Prx system, with results 24hr post­
exposure not indicating recovery, with regard to Prx hyperoxidation or P- 
Erk1/2 levels. This corroborated with data from several previous studies 
whereby cells supplemented before toxicant exposure were able to withstand 
greater insults (Leist et al., 1996; Greer et al., 2005). In contrast, the cultures 
+AO displayed Prx hyperoxidation proportionate to CS concentration, and 
hence, oxidative stress levels. The Western blot (Figure 5.5) revealed 
significantly (P£0.05) increased levels of Prx-S0 3 , in the +AO cultures, 3hr 
post-exposure that had decreased by 24hr post-exposure. The ability of the 
cells to demonstrate recovery post-exposure, at biochemical and 
morphological levels, enhanced not only the cultures in vivo comparability, but
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also the Prxs responsiveness and sensitivity as a biomarker of intracellular 
oxidative stress.
The results from non-reduced CS exposed cultures -/+AO contradicted those 
obtained from the reduced blots, with levels of hyperoxidised Prx III 
(monomers) elevated at 24hr post-exposure in comparison to 3hr post­
exposure -/+AO cultures. The reason for the discrepancy between the 
reduced and non-reduced data may have been due to the reduced results 
recording the total levels of Prx hyperoxidation (including Prx I, II, III and IV), 
whereas the non-reduced only reported the active (dimer) or hyperoxidised 
(monomer) Prx III (Cox et a/., 2010a). However, one aspect remained 
consistent, with hyperoxidised levels in -AO cultures continually surpassing 
those in the corresponding +AO cultures (Phalen et al., 2006).
5.5.3 CS Ex p o s u r e : IHC A n a lysis
The histological analysis was undertaken to establish morphological changes 
to the BE as a result of CS. The preliminary effect of CS was a reduction in 
cilia beat frequency (Simet et al., 2010), preceding a total loss of cilia 
attachments (Sisson etal., 1994). Previous work by Prytherch and co-workers 
identified loss of cilia and microvillus as a consequence of CS exposure, in 
conjunction with squamation and de-differentiation (Prytherch, 2010), 
accordingly, there was a distinct reduction in cilia number following the 1:30 
CS exposures within cultures -/+ AO. In addition to the cilia damage the 1:30 
CS exposed cultures -/+AO also sustained, disruption to intercellular 
junctions, enlarged vacuoles and squamation, which corroborated work by 
Sexton and co-workers, whereby the NHBE cultures were exposed to 
individual tobacco smoke components (Sexton et al., 2008). The IHC analysis 
substantiated the Western blot data by displaying elevated levels of Prx 
hyperoxidation in control cultures -AO, in contrast to the minimal levels in +AO 
cultures, denoting reduced levels of oxidative stress due to AO 
supplementation (Leist et al., 1996). The results obtained from the IHC 
analysis further strengthened the ability of Prx oxidation state to act as a 
reliable marker of intracellular oxidative stress, with levels of Prx-S0 3  visibly
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increased following CS exposure. The IHC analysis confirmed Western blot 
results of lower levels of Prx-S0 3  within the NHBE cultures +AO in 
comparison to cultures -AO.
5.6 Co nclusio n
The CS exposure findings were consistent with the GOx data (Chapter 4) and 
upheld the ability of the Prxs to act as biomarkers of increased oxidant 
burden. The collective results verified the significant (P£0.05) benefits brought 
through AO supplementation, showing that CS imparted a greater oxidant 
burden on cultures -AO, in comparison to cultures +AO. The Prx-S0 3 , P- 
Erk1/2 and ATP levels did not recover by 24hr post-exposure, which 
suggested that the -AO cultures were unable to maintain the stable phenotype 
maintained in +AO cultures following CS exposures. Consequently, in cultures 
-AO, increased levels of Prx-S0 3  would exhibit biochemical instability, for 
which Prx oxidation state would act as a consistent biomarker. In +AO 
cultures, the biphasic ATP response further confirmed the use of the NHBE 
model in conjunction with the Prx system, with repair responses at the 
biochemical and morphological levels being observed. With regard to Prx as a 
biomarker of intracellular oxidative stress, its oxidation state has been shown 
to be sensitive enough to detect recovery responses; which will be further 
examined in Chapter 6.
The CS exposure findings were consistent with the GOx data (Chapter 4) and 
upheld the ability of the Prxs to act as biomarkers of increased oxidant 
burden. The collective results verified the significant (P£0.05) benefits brought 
through AO supplementation, showing that CS imparted a greater oxidant 
burden on cultures -AO, in comparison to cultures +AO. The Prx-S0 3 , P- 
Erk1/2 and ATP levels did not recover by 24hr post-exposure, which 
suggested that the -AO cultures were unable to maintain the stable phenotype 
maintained in +AO cultures following CS exposures. Consequently, in cultures 
-AO, increased levels of Prx-S0 3  would exhibit biochemical instability, for 
which Prx oxidation state would act as a consistent biomarker. In +AO
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cultures, the biphasic ATP response further confirmed the use of the NHBE 
model in conjunction with the Prx system, with repair responses at the 
biochemical and morphological levels being observed. With regard to Prx as a 
biomarker of intracellular oxidative stress, its oxidation state has been shown 
to be sensitive enough to detect recovery responses; which will be further 
examined in Chapter 6.
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P eroxiredoxin  S ta tu s
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6.1 In tro d u c tio n
In vivo correlation is integral to the validation and development of in vitro 
analysis (Emami, 2006), and as such, it was essential that Prx status within 
the NHBE model was comparable to that of the in vivo situation. To assess 
this IHC was performed, using 1° Prx ABs, on human lung tissue that 
contained a variety of epithelial phenotypes (i.e. re-epithelisation, basal cell 
hyperplasia, goblet cell hyperplasia and inflammation). These epithelial 
phenotypes (excluding inflammation) also represented the various stages of 
NHBE recapitulation from patient donors upon cell culturing (Prytherch, 2010). 
All samples were retrieved from very severe, i.e. GOLD4 (GOLD, 2006) 
COPD patients, that had undergone total lung transplants. Unfortunately, 
there was no healthy lung tissue available for direct comparison, therefore all 
Prx status comparisons were carried out between the tissues obtained from 
the three GOLD4 patients. The COPD lung tissue was prepared in the same 
manner, for histopathological and IHC assessments, as the NHBE cultures.
In conjunction with Prxs, the expression of cytokeratin 5/6 (CK 5/6) was also 
analysed. The cytokeratins are a family of intermediate filaments (Ordonez, 
1998) that form three-dimensional filament arrays extending from the nucleus 
to the cell membrane. They are integral for the maintenance of cell shape and 
viability (Presland and Jurevic, 2002) and have been extensively used to 
differentiate between epithelial cell types (Kasper et al., 1993). CK 5/6 is also 
a basal cell marker (Presland and Dale, 2000) used to evaluate the injury and 
repair capacity of the epithelium (Pierce etal., 1994).
6.1.1 Research  A im s
The research aims for experimental work in Chapter 6 (Figure 6.1) were as 
follows:
• Obtain human bronchial tissue samples from COPD (GOLD4) patients 
that had undergone total lung transplants.
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• Undertake pathological assessment of the human bronchial tissue 
samples through H+E staining.
• Utilise the IHC chromogenic detection system to analyse CK 5/6 
expression and Prx status, including expression level and oxidation 
state, within the human bronchial tissue samples.
COPD Patient Total Lung 
Transplant
Chromogenic IHC
Colour
Detection
" HRP
— Streptavidin
Biotin
Secondary
Antibody
Prx Antibody  
Prx Antigen
Eosin
Haematoxylin
Figure 6.1: Flowchart of experimental work in Chapter 6.
Experimental aims included histological analysis utilising H+E staining, and immunological 
(IHC) analysis which utilised the Prx 1° ABs along with the chromogenic DAB detection 
system. These methods were used to analyse the tissue pathology and Prx status within BE 
samples from COPD (GOLD4) patients.
149
-----------------------------------------------In  v iv o  C o r r e la t io n  o f  P ero x ired o x in  S ta tu s  ---------------------------------------------
6 .2  M a t e r ia l s  a n d  S t o c k  S o l u t io n s
Materials and stock solutions from previous Chapters have not been included. 
6.2.1 Materials and S uppliers
M a t e r ia l s : S u p p l ie r :
EnVision FLEX Buffer Wash Dako
EnVision FLEX Target Retrieval Solution 
High pH
Dako
EnVision FLEX Peroxidase-Blocking 
Reagent
Dako
EnVision FLEX Haematoxylin Dako
Cytokeratin (CK) 5/6 Primary Antibody Dako
EnVision FLEX/HRP Dako
EnVision FLEX DAB Dako
RHS-2 Rapid Microwave Histoprocessor Milestone Sri. Italy
LEICA TP 1050 Leica Ltd.
Leica Histoembedder Leica Ltd.
Leica Jung RM2155 Leica Ltd.
Table 6.1: Materials used and their suppliers. All suppliers were UK based unless stated.
6 .3  M e t h o d s
6.3.1 Histological A nalysis of the Human T issue Samples
Tissue processing, i.e. paraffin embedding, sectioning and haematoxylin and 
eosin (H+E) staining, was carried out in the AstraZeneca Histology 
Department, Loughborough, UK. Experiments were performed with the expert 
guidance of Dr. Kate Brown.
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6.3.1.1 Sample Acquisition
Lung lobes from COPD (GOLD4) patients whom underwent total lung 
transplants (Table 6.2) were provided by AstraZeneca, and originally obtained 
from the University Hospital of Leicester, with full ethical consent.
Patient (N°) Age Gender Smoking Status Lobe Data
3 46 Male Ex-Smoker Left Lower Lobe
4 55 Female Ex-Smoker Left Lower Lobe
9 52 Female Ex-Smoker Right Lower Lobe
Table 6.2: Demographics of Three COPD Patients undergoing total lung transplants.
Three COPD (GOLD4) patients underwent total lung transplants, all were ex-smokers. Patient 
3 was deficient in a-1 antitrypsin, and therefore more emphysematous histopathology was 
expected. One lobe was taken from each patient for IHC analysis.
6.3.1.2 Sample Preparation
The tissue samples were fixed in 10% NBF for 48hr at RT, and then dissected 
into 3mm slices for overnight embedding using a Leica Tissue Processor 
(LEICA TP 1050 fully enclosed vacuum tissue processor). Embedded tissues 
were then dehydrated using a series of increasing alcohol concentrations (i.e. 
30%, 50%, 70%, 90% and 100%) prior to being placed into paraffin wax using 
the Leica Histoembedder. Final wax-tissue blocks were stored at RT until use.
6.3.1.3 Sectioning, De-Waxing and Haematoxylin and Eosin Staining
Sections were cut to 4pm thickness using a Leica Jung RM2155. The sections 
were floated on water at 37°C, and subsequently transferred to charged slides 
that were dried overnight at 45°C. De-waxing was performed as outlined in 
Section 3.3.1.4. H+E staining was performed as outlined in Section 3.3.1.5
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6.3.2 C hro m og enic  Im m u n o h is to c h e m istr y  of the  H uman  T issue  Sam ples
Sample preparation and de-waxing procedures were carried out as described 
in Sections 6.3.1.1 to 6.3.1.3.
6.3.2.1 Antigen Retrieval
Pre-treatment allowed the target retrieval of antigens prior to IHC staining 
procedures. Following de-waxing, the slides were submerged in EnVision 
FLEX target retrieval solution high pH and heated to 98°C for 1min in the 
rapid microwave histoprocessor. Slides were then allowed to cool for 5min 
before being immersed in the EnVision FLEX wash buffer at RT.
6.3.2.2 Antibody Incubation and Detection
Following pre-treatment, slides were washed using the EnVision FLEX wash 
buffer for 2min (3x). To block endogenous peroxidase activity, the slides were 
immersed in EnVision FLEX peroxidase-blocking reagent (further blocking 
steps were unnecessary) for 5min. Slides were then incubated with Prx 1° AB 
(Table 6.2) or serum control (a negative control was performed for every 
dilution of primary antibodies used). ABs were diluted in 1% BSA/PBS +
0.05% Tween.
Following 1° AB incubation, the slides were submerged in EnVision FLEX 
wash buffer for 2min (3x); slides were then incubated with EnVision 
FLEX/HRP for 20min. Slides were again submerged EnVision FLEX wash 
buffer for 2min (3x). To allow AB visualisation, the slides were incubated with 
FLEX DAB chromogen solution (Table 6.3). The chromogen was removed by 
placing the slides under running tap water for 2min, followed by counter- 
staining by briefly immersing in EnVision FLEX haematoxylin. Any excess 
staining was removed by washing the slides in running tap water for 10min. 
Dehydration and mounting was carried out as described in Chapter 3, Section 
3.3.1.6.
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1°
Antibody Dilution
Final
Concentration
Incubation
Period
DAB
Incubation
Period
Prx I 1:500 2pg/ml 20min (RT) 5min
Prx III 1:5000 200ng/ml 20min (RT) 5min
Prx-S03 1:2000 500ng/ml 20min (RT) 10min
CK 5/6 1:30 33.3pg/ml 20min (RT) 5min
Table 6.3: Optimisation of 1° AB concentrations and incubation periods.
The 1° AB concentrations and incubation times used for Prx I, III, -S03and CK 5/6 detection 
within the BE of COPD patient samples. All 1° AB stock concentrations were 1 mg/ml.
6 .4  R e s u l t s
The featured sections were representative of all three COPD patients.
6.4.1 G r o s s  P a t h o l o g y
Bronchial tissue samples were taken from three COPD (GOLD4) patients that 
had undergone total lung transplants. One lobe from each patient (Table 6.2) 
was used for histopathology and IHC analysis. The lobe from Patient 9 
(Figure 6.2) was blackened in appearance and contained significant lesions 
and tar deposits on the external surface that pervaded throughout the lobe; 
this was consistent with observations from all three patient lobes. The lung 
pathology was caused by persistent and heavy smoking, restricting the 
patients’ airflow, and eventually leading to loss of lung function, and hence, 
the need for a total lung transplant.
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Figure 6.2: Right lower lobe from Patient 9.
AstraZeneca obtained one lobe from each COPD (GOLD4) patient undergoing a total lung 
transplant (Patients 3, 4 and 9). The right lower lobe of Patient 9 (a and b) revealed tar 
accumulation, as a result of heavy and persistent smoking, that was visible throughout the 
entire lobe (c and d). The appearances of the lobes from all three patients were consistent 
with that of Patient 9.
6.4.2 R e -E p ith e lis a tio n  ( E a r ly  S ta g e  R e p a ir )
Serial sections of the remodelling airway demonstrated a severely injured, 
and consequently, denuded epithelium with areas of goblet cell hyperplasia 
(GCH) (Figure 6.3). The denudation triggered a repair attempt whereby the 
remaining basal (progenitor) cells proliferated along the exposed airway in 
order to repopulate the area (i.e. re-epithelisation), resulting in a leading edge 
effect which could be seen via the CK 5/6 staining. Prx III expression was 
detected within the immature basal cells during early stage re-epithelisation 
and within the areas of GCH along with elevated Prx-S03. In regard to COPD 
pathologies, there was excess mucus throughout the lumen due to GCH.
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Leading Edge
Re-Epithelisation
Goblet Cell' 
Hyperplasia
Figure 6.3: Early stage repair (Re-epithelisation).
Serial sections of a BE from the lower right lobe of Patient 9 contained re-epithelisation and 
GCH (prominent mucus granules), demonstrated by H+E staining (a). Basal cells, denoted 
by CK 5/6 expression (b), were proliferating in order to repopulate the denuded airway. Red 
denoted areas of interest, with Prx III expression (c) within the basal cells during re- 
epithelisation and in the apical regions of the columnar cells during hyperplasia. There was 
also Prx-S03(d) detected within the regions of hyperplasia. Scale bars represented 20pm.
Following histological and immunohistological analysis of serial sections, an 
airway containing several different stages of remodelling was observed 
(Figure 6.4). Within the single airway there were regions of re-epithelisation 
and hyperplasia. The earliest stage of repair, re-epithelisation, was indicated 
by squamous epitheloid and basal (progenitor) cells, whereby the basal cells 
proliferated to protect the exposed airway; within this region there was no Prx 
I expression. The hyperplastic region contained a disorganised epithelium, 
characterised by excessive columnar cell numbers and basal cells admixed 
within columnar cell regions, associated with elevated Prx I expression. The 
areas of the epithelium that appeared morphologically ‘normal’ (i.e. organised 
pseudo-stratified epithelium) contained lower Prx I expression in comparison
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to the hyperplasic region. It should be noted this albeit normal-looking 
epithelium may not be representative of that seen in a healthy human lung.
1. Re-Epithelisation
3. ‘Normal- I2. Hyperplasia
(b)
1. Re-Epithelisation 2. Hyperplasia 3. ‘Normal’
Figure 6.4: Repairing airway.
Serial sections of a BE from the lower left lobe of Patient 3 contained a repairing airway with 
several stages of remodelling, visualised via H+E staining (a). The three stages of 
remodelling included: (1) early stage repair and re-epithelisation, with no Prx I expression (b); 
(2) areas of hyperplasia, with elevated levels of Prx I expression (b); (3) areas of epithelia that 
appeared morphologically ‘normal’ (i.e. organised pseudo-stratified epithelium) contained 
moderate Prx I expression (b). Scale bars represented (a) 20pm and (b) 10pm.
6.4.3 H y p e r p l a s ia
The relatively small airway contained a thickened basement membrane, 
indicating a degree of remodelling following injury (Figure 6.5). The CK 5/6 
expression was consistently present in the basal cells adjacent to the 
basement membrane, with some staining in the columnar cell region. Prx III 
was expressed mainly in the apical regions of the columnar cells, in particular 
in the regions of increased hyperplasia. The mucus within the numerous
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goblet cells was highly visible, however no Prx III or -SO3 was present in 
these regions. Prx-S03 expression followed a similar distribution pattern to 
Prx III.
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Figure 6.5: Goblet cell hyperplasia.
Serial sections of a BE from the lower left lobe of Patient 3 contained areas of GCH observed 
via H+E staining (a). Consistent CK 5/6 expression (b) indicated a healthy basal cell 
population Red denoted areas of interest, with elevated Prx III (c) in regions of hyperplasia 
and Prx-S03 (d) following a similar distribution pattern to Prx III. Scale bars represented 
20pm.
Histological assessment of the serial sections revealed basal cell hyperplasia 
(BCH) throughout the BE of the airway (Figure 6.6). Hyperproliferation of the 
progenitor (basal) cells was consistent with airway repair, as the re- 
epithelisation of the damaged BE exceeded the requirement, leading to 
hyperplasia. There was no Prx I expression within the basal cells including 
those in the areas of BCH The columnar cells appeared to be expressing Prx 
I, with the stronger staining present in the more disorganised hyperplasic 
regions, adjacent to the region of BCH.
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Figure 6.6: Basal cell hyperplasia.
Serial sections of a BE from the lower left lobe of Patient 4 contained significant BCH, 
demonstrated by the H+E staining (a). Red denoted areas of interest with no Prx I expression 
(b) within the basal cells, and moderate levels throughout the columnar cells. Scale bars 
represented (a) 20pm and (b) 10pm.
Histological and IHC assessment revealed regions of BCH and GCH, 
suggestive of airway remodelling (Figure 6.7). The CK 5/6 expression was 
elevated in areas of BCH. There was also CK 5/6 expression extending 
throughout some areas populated by columnar cells, indicating either regions 
of incomplete differentiation or regions with admixed basal and columnar cell 
populations. Prx III expression was elevated in regions of GCH, particularly 
toward the apical region of the columnar cells. Prx-S03 was highly elevated 
as a result of GCH, following a similar distribution pattern to Prx III. With 
regard to the COPD pathology, there was excessive mucus and inflammatory 
cells present in the lumen of the airway, which could result in increased the 
levels of oxidative stress.
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Basal Cell Hyperplasia
Goblet Cell 
Hyperplasia
Figure 6.7: Goblet and basal cell hyperplasia.
Serial sections of a BE from the lower right lobe of Patient 9 underwent H+E staining (a), 
which revealed GCH indicative of late stage remodelling and elevated oxidative stress. Red 
denoted areas of interest with elevated CK 5/6 expression (b) in areas of BCH, with moderate 
Prx III and Prx-S03 in this region. There was elevated Prx III (c) and Prx-S03 (d) levels within 
the regions of GCH. Scale bars represented 20pm.
6.4.4 Inflammation
Histological analysis, of BE serial sections, identified an acute inflammatory 
response within the airway, which was confirmed by the abundance of 
macrophages and mononuclear cells within the surrounding lamina propria 
(Figure 6.8). The macrophages stained highly positive for Prx III, and 
moderately for Prx-S0 3 . This occurred for all sections analysed from each of 
the three COPD (GOLD4) patients. In comparison, the lymphocytes did not 
stain for Prx III or Prx-S03. Prx III levels were also elevated throughout the BE 
during inflammation, with the apical region of the columnar cells 
demonstrating particularly high expression. The staining for Prx-S03 followed
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a similar pattern to that of Prx III, with high levels throughout the columnar 
cells; suggesting elevated levels of intracellular oxidative stress.
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Figure 6.8: Inflammatory response.
Serial sections of a BE from the lower left lobe of Patient 4 contained severe inflammation, 
with an influx of mononuclear cells and macrophages, under these conditions there were 
increased levels of ROS. CK 5/6 expression (a), red denoted areas of interest with elevated 
Prx III (b) and Prx-S03 (c) within the airway as a result of the inflammatory response. Scale 
bars represented 20pm.
The inflammatory cell influx, elicited due to airway damage, was observed in 
the surrounding lamina propria of the entire airway (Figure 6.9). 
Consequently, the columnar cells of the BE responded through increasing Prx 
I expression within these regions. The regions of particularly high Prx I 
expression appeared hyperplasic in nature, in comparison to the regions with 
more moderate Prx I expression. Prx I was not expressed within the basal 
cells throughout all epithelial phenotypes.
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Figure 6.9: Inflammatory response.
Serial sections of a BE from the lower right lobe of Patient 9 contained a significant 
inflammatory cell influx, seen via the H+E stain (a). Red denoted areas of interest, with 
elevated Prx I expression (b) as a consequence of the inflammatory response. Scale bars 
represented (a) 20pm and (b) 10pm.
6.4.5 Endothelium / S mooth  M uscle
The endothelium in samples from all three COPD (GOLD4) patients stained 
consistently positive for Prx III. However, the endothelial cells of the 
endothelium in close proximity to a damaged or repairing/remodelling airway 
had elevated levels of Prx III expression (Figure 6.10), which correlated with 
an inflammatory response triggered by the damaged airway. The staining 
extends beyond the endothelium to the smooth muscle surrounding the 
vessel, which could also be indicative of elevated oxidative stress within the 
tissue.
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Figure 6.10: Endothelium/ Smooth muscle.
Serial sections of a BE from the lower left lobe of Patient 3 contained an endothelium 
adjacent to a repairing airway. The red blood cells and the surrounding endothelium were 
observed by H+E staining (a). Red denoted areas of interest, with elevated Prx III expression 
(b) within the endothelial cells of endothelium in close proximity to damaged/repairing 
airways. These levels, of Prx III, were elevated in comparison to the more moderate levels 
observed within endothelial cells not associated with an injured airway. Prx III expression also 
extended throughout the smooth muscle surrounding the endothelium. Scale bars 
represented 20pm.
6.5 D is c u s s io n
Correlation with in vivo data was essential for validating the results obtained 
from the NHBE cell model. Human tissue often demonstrated several stages 
of injury and repair within the same airway (Puchelle et al., 2006), which 
provided crucial information on the role of Prxs during BE remodelling; in 
concordance with the NHBE cell model morphogenesis. No healthy lung 
tissue was available for comparison therefore all Prx analysis was undertaken 
using comparative tissue from the three GOLD4 patients.
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6.5.1 BE Remodelling
There were three key stages in BE remodelling (Figure 6.11): (1) the first was 
the initial re-epithelisation, with only the progenitor (basal) cells present 
(Bucchieri et al., 2009), some of which were squamated, in an attempt to 
protect as much of the exposed airway as possible (Erjefalt et al., 1997): (2) 
the second was the hyperplasic region that contained basal and/or columnar 
cell hyperplasia. Hyperplasia was due to either direct epithelial injury or as a 
consequence of over proliferation during re-epithelisation (Coraux et al., 
2008). This led to mucus hypersecretion, a phenotypic adaptation common to 
airway damage (Ye et al., 2009): (3) the third distinct epithelium detected 
appeared morphologically ‘normal’, i.e. an organised pseudo-stratified 
epithelium that contained a mixed mucociliary phenotype (Randell, 2006). 
However, it must be re-iterated that the appearance of a morphologically 
‘normal’ epithelium was not necessarily representative of healthy tissue.
Bronchial Epithelium
Morphologically ‘Normal'
•  Fully Differentiated Epithelial Cells 
•  No Hyperplasia 
• Pseudo-Stratified Epithelium
Early Stage Repair
•  Re-Epithelisation 
Basal Cells (Progenitor)
•  Squamated Cells 
•  No Columnar Cells
  Hyperplasia
•  Basal Cell Hyperplasia
•  Goblet Cell Hyperplasia
- Excess Mucus
•  Inflammatory Response
• Disorganised Epithelium
- Admixed Basal and Columnar Cells
- Squamous Cells
Figure 6.11: Three main stages of BE remodelling.
There were three main stages of remodelling evident in the human BE tissues analysed. The 
first was early stage repair (blue), whereby the epithelium had either been totally or partially 
denuded; in response to this the basal (progenitor) cells proliferated to re-populate the 
epithelium. The second stage contained a hyperplasic epithelial subtype (red), due to either 
direct epithelial injury or as a consequence of over proliferation during re-epithelisation. The 
third distinct epithelium detected was an epithelium that appeared morphologically ‘normal’ 
(i.e. organised pseudo-stratified epithelium) (green) containing fully differentiated bronchial 
epithelial cell types.
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6.5.2 P rx  and C K  5/6 L e ve ls  in th e  BE o f  T h re e  C O PD  P atien ts
The samples from the three COPD patients demonstrated consistent Prx 
expression levels and oxidation states within the distinct epithelial phenotypes 
(Table 6.4). The expression levels of CK 5/6 were very high in areas of BCH, 
compared to moderate expression in areas of GCH. Prx I expression was not 
detectable within the basal cells, even within regions of BCH; however, there 
was increased expression in areas of GCH and inflammation. Prx III 
expression was elevated in regions of inflammation and hyperplasia, in 
addition to this Prx III was detected within the endothelial cells of endothelium 
in close proximity to damaged airways, which also extended throughout the 
surrounding smooth muscle of the vessels. The levels of Prx-S03 increased 
considerably in airways affected by oxidative stress i.e. inflammation and 
GCH.
Epithelial Phenotype CK 5/6 Prx I Prx III Prx-S03
Re-Epithelisation ++ — + +
Basal Cell Hyperplasia +++ — + +
Goblet Cell Hyperplasia + ++ ++ ++
Inflammation + ++ +++ +++
Endothelium/ Smooth Muscle — — ++ +
Table 6.4: Levels of CK 5/6, Prx I, III and -S 0 3 in different epithelial phenotypes.
Expression levels of CK 5/6, Prx I and Prx III along with levels of Prx-S03 were analysed 
within the human bronchial epithelial tissue samples from COPD (GOLD4) patients. The 
bronchial epithelial sections examined contained a range of epithelial subtypes. The 
endothelium/ smooth muscle of vessels in close proximity to damaged airways was also 
analysed, (-absent, tminimal, +moderate, ++high and +++very high).
Basal cells have been identified as the progenitor cells of the BE (Bucchieri et 
al., 2009) and lead the repair response through a process of dedifferentiation, 
migration and proliferation (Coraux et al., 2008). CK 5/6 expression was used 
as a basal cell marker in the BE of human tissue samples, with considerable 
increases in areas of BCH and more modest increases during re-
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epithelisation. Cytokeratin 5 was expressed baso-laterally in stratified tissue,
i.e. the zone thought to replenish the more apical layer (Gomperts et al.,
2007). Cytokeratin 6 may be expressed supra-basally and associated with 
differentiation (Presland and Dale, 2000). CK 5/6 expression within the 
columnar cell population was suggestive of either difficulties with 
differentiation (incomplete differentiation) or basal cells admixed in this area.
The major region of Prx I expression was in disorganised and hyperplasic 
epithelia. Prx I has been identified as PAG1 (proliferation-associated gene 1) 
(Prosperi et al., 1993), suggesting that the variances seen in Prx I expression 
may be due to the proliferative state of the cell, with elevated Prx I expression 
seen throughout areas of columnar cell hyperplasia and during cellular 
proliferation. In several morphologically identical columnar cells there were 
variances in Prx I expression, which could be indicative of cellular variations in 
intracellular oxidative stress; a biochemical variation that was undetectable by 
morphological analysis. There was no Prx I expression within the basal cells, 
even in tissue with BCH, suggesting an alternative antioxidant mechanism at 
work during re-epithelisation. The lack of Prx I expression within the basal 
cells was mirrored in the NHBE cultures, through the use of Western blotting 
and IHC techniques.
Prx III was highly expressed within the BE of all of the COPD samples 
analysed, which correlated to previous in vivo research (Kinnula et al., 
2002a), in addition to the expression patterns observed in the NHBE cell 
model throughout morphogenesis (i.e. Chapter 2 and 3). IHC analysis of the 
human tissue sections corroborated with IHC of the NHBE cell model, with 
strong Prx III expression at the apical region of the columnar cells (ciliated 
cells), conveying the considerable mitochondrial content in this region (Rhee 
et al., 2001). With regard to epithelial damage and airway remodelling, the 
expression level of Prx III rose substantially in areas of GCH; a pathological 
adaptation often observed in COPD (Saetta et al., 2000). The most common 
cause of GCH is elevated ROS levels, elicited by both endogenous 
inflammatory cells (Barnes, 2009) and CS (Baginski et al., 2006). However, 
emerging evidence has suggested a role for the epidermal growth factor
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(EGF) system in the initiation of GCH; with stimulation of the EGF receptor 
inducing the expression of MUC5AC within epithelial cells (Takeyama et al., 
1999; Takeyama et al., 2000; Kim and Nadel, 2004). The inflamed epithelium 
also contained elevated levels of Prx III expression, which was a 
consequence of the inflammatory cells imparting further oxidant burden onto 
the injured epithelium, and hence, perpetuating the cycle of oxidative damage 
(Hansel and Barnes, 2004). There was also elevated Prx III expression within 
the endothelial cells of endothelium that was in close proximity to damaged 
airways. The immune cells within these vessels have been shown to respond 
to pro-inflammatory cytokines released by the epithelial cells, and migrate to 
the site of injury (Rennard, 1999; Becker et al., 2005). This inflammatory cell 
exodus may have elicited an increase in endothelial cell Prx III expression. 
Prx III expression was also detected within the smooth muscle surrounding 
the endothelium, which may be an indicator of increased oxidative stress 
within the tissue. Additionally it may also represent the process of smooth 
muscle hypertrophy, which is one of the main clinical symptoms associated 
with COPD (Repine et al., 1997).
Several studies have shown that increased oxidant burden elicited an 
increase in the levels of Prx hyperoxidation (Phalen et al., 2006; Cox et al., 
2009b; Cox et al., 2010b), and therefore, reversible inactivation (Woo et al., 
2003a; Woo et al., 2003b). The level of Prx hyperoxidation was moderate in 
epithelium that appeared morphologically ‘normal’ (i.e. organised pseudo- 
stratified epithelium), which was encouraging as this corroborated with data 
from the NHBE cell cultures (+AO), whereby there was low to moderate basal 
levels of Prx-S0 3 . There were high levels of Prx-S0 3  as a result of elevated 
levels of oxidative stress (Rabilloud et al., 2002; Lehtonen et al., 2005), i.e. 
within regions of GCH and inflammation (Barnes, 2009). There were 
particularly high Prx-S03 levels within the apical regions of the columnar cells 
that coincided with increases in Prx III expression. This may suggest that the 
elevated Prx-S03 levels were primarily that of Prx lll-S03, as opposed to Prx 
I/II-SO3 . IHC of the human tissue samples confirmed previous data (i.e. 
Chapters 4 and 5), whereby increased oxidant burden elicited increased 
levels of Prx hyperoxidation. Further work should be carried out to ascertain
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whether Prx expression and/or hyperoxidation co-localises with areas of 
oxidative stress, this could be achieved through utilising a stain for 
malondialdehyde, which is a product of polyunsaturated fatty acid 
peroxidation, widely used as a biomarker of oxidative stress in COPD 
research (Tug etal., 2004; Rahman, 2008).
6.6 C onclusio n
The IHC results derived from lung tissue of COPD patients (GOLD4), inferred 
that Prx I and III, in conjunction with Prx-S0 3 , had the possibility of acting as 
an indicator of epithelial injury within the human bronchial epithelium. There 
were marked distinctions between Prx I and III expression levels throughout 
the various stages of airway remodelling (i.e. re-epithelisation, hyperplasia 
and inflammation), in conjunction with elevated levels of Prx-S0 3  in regions of 
increased oxidative stress (e.g. hyperplasia and inflammation). The levels of 
Prx III within the endothelium and surrounding smooth muscle were also a 
good indication of injury severity, with higher expression levels proportionate 
to damage within adjacent airways. Despite the lack of an in vivo 
corroboration of Prx status in healthy patient tissue (an imperative for future 
research), the collective results bode well for pursuing Prx as a detection 
method for lung research.
Prx I and Prx III, in conjunction with Prx-S0 3 , could be used as an indicator of 
epithelial injury within the human bronchial epithelium. There were marked 
distinctions between Prx I and III expression levels detected in the three key 
stages of airway remodelling, i.e. healthy epithelia, re-epithelisation and 
hyperplasia. The levels of Prx III within the endothelium were also a good 
indication of injury severity, with higher expression levels proportionate to 
damage within adjacent airways. The levels of Prx-S0 3  remained low 
throughout the healthier epithelia, and increased within areas of hyperplasia 
and inflammation. This indicated that the Prxs in this area were stable, and 
that the oxidation status corroborated to findings within the in vitro NHBE cell 
model.
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7.1 R esearch  O v e r v ie w
The overall objective of this research was to determine whether the Prxs, in 
conjunction with the NHBE model, could be used as a reliable and sensitive in 
vitro system to resolve physiochemical events mediated by intracellular 
oxidative stress. To establish the biomarker potential of the Prxs, the NHBE 
model was analysed throughout morphogenesis and subsequently exposed to 
GOx and CS (i.e. oxidative stress mediators). Any detectable changes in Prx 
status, induced as a result of toxicological challenge, would be indicative of 
the capacity of the Prxs to respond to and inform on the surrounding 
environment (i.e. intelligent biomarkers of exposure and harm).
Disrupted redox signalling and cycling, or oxidative stress, is the primary 
cause of lung disease. Thus, highlighting the need for intelligent biomarkers, 
of exposure and harm, both during homeostasis and following injury (Therond 
et a/., 2000; Dalle-Donne et al., 2005). In addition, there is a demand for high 
through-put in vitro systems that mimic the human in vivo lung environment. 
Previous studies have utilised cell lines to investigate Prx response to oxidant 
burden; however, the tumour-derived and immortalised cells lack many of the 
basic characteristics of the human BE (i.e. pseudo-stratified mucociliary 
phenotype; (BeruBe et al., 2010b). Therefore, primary NHBE cultures would 
be a more prudent in vitro system, and would have provided more dependable 
insights into human Prx status in vivo (BeruB6 et al., 2010a). In addition, 
investigations have reported that in vitro cell culture conditions elicit elevated 
basal levels of oxidative stress within the in vitro cultures, rendering any such 
data as being unreliable (Halliwell, 2011). In light of this, AO supplementation 
was explored as a viable solution to ameliorate basal stress levels to enhance 
the NHBE models’ ability to produce in situ like responses. Perturbations in 
redox cycling and signalling lead to cycles of injury and repair which precede 
morphological and phenotypic adaptations (Chapter 4, Figure 4.11). 
Accordingly, an important research aim was to determine the ability of the 
Prxs to respond to oxidative stress pre-phenotypic adaptation, informing on 
the earliest events of pulmonary injury.
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7.1.1 R ecapitulatio n  of Hy p o th e s e s
The first hypothesis was concerned with the premise that “Prx status could 
be used in conjunction with the NHBE model as a biomarker of 
intracellular oxidative stress”. This hypothesis was resolved to be correct in 
that distinct Prx I and III expression levels were detected, as observed in vivo 
(Kinnula et al., 2002a), and furthermore, Prx oxidation state was an indicator 
of intracellular oxidative stress levels. For the Prxs to be judged as a reliable 
and sensitive biomarker, it was important that the expression levels and 
oxidation states remained stable under normal conditions; as a consequence, 
fluctuations in Prxs status could be fully attributed to oxidative burden. 
Elevated levels of hyperoxidation, and hence, oxidative stress (Lehtonen et 
al., 2005), were detected by Western blotting and complementary IHC during 
the conventional dosing window (Prytherch, 2010), revealing biochemical 
instability. Consequently, there was a need to modify the dosing window, 
ensuring biochemical as well as morphological stability throughout 
toxicological analysis. Elevated basal levels of oxidative stress were detected 
throughout NHBE morphogenesis (Halliwell, 2003), conveying the need for 
AO supplementation. Preliminary AO work involved supplementing the 
cultures throughout morphogenesis; however, this inhibited culture 
proliferation and differentiation (data not shown). In light of this, a more 
conventional mode of supplementation, 24hr pre-exposure, was employed. 
The principal advantage of analysing the Prxs within the NHBE model was 
that the cells were genotypically and phenotypically more representative of 
normal epithelia in comparison to other more commonly used models e.g. 
A549 (Padar et al., 2005) and BEAS-2B (Penn et al., 2005). The in vivo 
comparable results obtained from the Prx analysis further strengthened the 
models credentials as a reliable in vitro alternative, avoiding the cross-species 
and ethical issues often encountered with other laboratory animal systems.
The second hypothesis was based upon the supposition that “exposure of 
the NHBE cultures to H2O2 and CS will alter Prx status, providing a 
measurable parameter directly linked to the level of intracellular 
oxidative stress, injury severity and repair competency”. This was indeed
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the circumstance, whereby H2O2 and CS exposures elicited a significant 
increase in levels of Prxs hyperoxidation within the NHBE cultures (-/+AO). 
However, AO supplementation significantly alleviated the basal levels of 
oxidative stress and improved the repair competency of the cultures following 
insult, and subsequently, enhanced the in vivo like characteristics of the 
model. Post-toxicant exposures, junction integrity of cultures +AO were not 
compromised, confirming the resilience and in vivo like response of the BE 
multilayered cultures, in comparison to equivalent monolayers (Balharry et a/.,
2008). The cell viability assay (ATP) revealed a dose-dependant hormetic 
response (Calabrese, 2004), typified by a decrease in viability at lower 
concentrations, often referred to as the ‘initial stimulation’, followed by a 
viability increase at higher concentrations. Reproducibility of this response 
was achieved post-exposure to both GOx and CS, which further strengthened 
the use of the NHBE model in toxicological screening. Bronchial epithelia 
within the in vivo environment demonstrate remodelling and repair following 
insult (Bucchieri et al., 2009), and the ability of the NHBE model to achieve 
this was therefore essential. Accordingly, the cultures were analysed 3 and 
24hr post-exposure to CS, with +AO cultures demonstrating recovery at the 
physiological level via improved cell viability and at the biochemical level via a 
reduction in levels of Prx hyperoxidation. Levels of hyperoxidation in +AO 
cultures were proportionate to toxicant concentration and decreased 
accordingly following a recovery period, denoting the ability of the Prx to act 
as a sensitive and consistent marker of intracellular oxidative stress. 
Furthermore, the significant increases in Prx hyperoxidation following 
exposure suggested a possible role for the Prxs as an ‘early stage’ biomarker, 
with disruptions in redox state occurring far in advance of phenotypic or 
morphological adaptations (Rahman e ta i, 2006).
The third hypothesis postulated that “in vivo correlation would substantiate 
the NHBE in vitro findings and confirm that Prx status was a sensitive 
biomarker of oxidative damage and epithelial remodelling”. This was 
confirmed through IHC and complementary histopathology of COPD (GOLD4) 
bronchial samples. The samples were grouped by epithelial phenotype; 
healthy, early stage re-epithelisation, hyperplasia and inflammatory, with
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distinct Prx expression patterns and oxidation states between subtypes. Prx I 
expression, which has also been identified as proliferation-associated gene 1 
(PAG1), was elevated in areas of columnar cell hyperplasia, indicating a 
response to cellular proliferative state (Prosperi et al., 1993) in addition to 
oxidative stress. The absence of Prx I expression within the basal cells 
corroborated with analysis of the NHBE model during morphogenesis 
(Chapter 2); these findings suggested that an alternate antioxidant defence 
was active within the basal cells. There was prevalent Prx III expression in 
regions of inflammation and hyperplasia; both subtypes were known to induce 
oxidative stress, with inflammatory cells in particular releasing ROS into the 
surrounding lamina propria (Hansel and Barnes, 2004). Prx hyperoxidation 
followed a similar distribution to Prx III, with elevated levels observed in 
inflammatory and hyperplasic airways. The elevated levels of hyperoxidation 
corroborated with exposures of the NHBE model to both GOx and CS, 
indicating a quantitative role for Prx oxidation state in the elucidation of 
intracellular oxidant burden in vitro. Each airway investigated contained 
several pathological modifications and various degrees of remodelling 
(Coraux etal., 2008); all of which were represented by distinct Prx expression 
levels and oxidation states. Healthy epithelia were defined by moderate and 
regimented expression patterns, in contrast to the strong and diffuse patterns 
within hyperplasic regions.
7.2 C o nclusio ns
The research objectives and hypotheses encompassed four fundamental 
areas of experimental focus for the deduction of Prx expression levels and 
oxidation state. These areas included NHBE cell model morphogenesis, in 
vitro toxicological exposures (H2O2 and CS) and in vivo correlations. The 
more salient features of these deductions may be summarised as follows.
Key deductions from NHBE model morphogenesis analysis:
• Prx I and III were detected throughout morphogenesis and in the fully 
differentiated NHBE model via Western blotting and IHC analysis
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• IHC analysis revealed that Prx III was expressed predominantly in the 
apical region of the ciliated cells (LM), and more specifically in the 
mitochondria (EM)
• Western blotting in conjunction with IHC analysis revealed that Prx I was 
not expressed in the basal (progenitor) cells
• Prx II was not detected within the NHBE model via Western blotting or 
IHC analysis
• Basal levels of Prx hyperoxidation (Prx-SC>3) were elevated throughout 
morphogenesis (Days 1-39)
• Due to significantly elevated Prx-S03 levels at Day 33, the toxicological 
dosing window was modified from Days 27-33 to Days 25-30 (post- 
seeding into Millipore inserts). Prx I, III and SO3 levels were stable 
throughout the modified dosing window
Key deductions from H2O2 exposures:
• Direct H2O2 exposure elicited an increase in Prx-S0 3  levels in proportion 
to H2O2 concentration at all exposure times
• TEER, ATP and Western blot analysis revealed that the optimum AO 
supplementation was 800pM glutathione; to be added basally to the 
cultures 24hr pre exposure
• AO supplementation minimised the basal levels of Prx-S0 3  within the 
NHBE model and enhanced the models in vivo like responses
• A biphasic response was observed when measuring cellular ATP levels, 
with an initial reduction in cell viability at low GOx concentrations, followed 
by an increase at a higher GOx concentration. The initial decrease in cell
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viability occurred at a higher GOx concentration in cultures +AO in 
comparison to those -AO
• Levels of Prx-S0 3  increased in proportion to GOx concentration in 
cultures +AO, while in cultures -AO there was a peak following the 30min 
exposure and a subsequent decline in levels following the 1 hr and 3hr 
exposures
• Levels of P-Erk1/2 significantly increased following all GOx exposures in 
cultures -AO, while in the corresponding +AO cultures there were no 
increases
• Levels of Prx III activity were higher in cultures +AO, in comparison to 
-AO, following all GOx exposures
Key deductions from CS exposures:
• Cultures +AO demonstrated recovery at the morphological and 
biochemical levels by 24hr post-exposure. Cell viability and Prx-S03 
levels had improved in comparison with the corresponding cultures 3hr 
post-exposure, which further indicated the sensitivity of Prx oxidation state 
as a marker of oxidative stress
• Cultures -AO did not recover in the same manner as cultures +AO 
following CS exposure. Cell viability, Prx-S0 3  and P-Erk1/2 levels did not 
significantly improve by 24hr post-exposure in comparison to the 
corresponding cultures 3hr post-exposure. In contrast, the TEER values 
following the 1:30 and 1:50 CS exposures fell significantly at 3hr post­
exposure and recovered significantly by 24hr post exposure
• Levels of active Prx III in cultures +AO were higher following 3hr post­
exposure in comparison to 24hr post-exposure, indicating a delayed 
response
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• Evidence of morphological damage, following the 1:30 CS exposure, was 
resolved by IHC analysis. Higher levels of Prx-S0 3 were observed in -AO 
control and CS exposed cultures in comparison to the corresponding +AO 
cultures
• IHC analysis revealed that there were no region specific increases in Prx 
III following CS exposures
Key deductions from IHC analysis of human tissue (in vivo correlation):
• Prx I and III expressions were ordered in regions of healthy epithelia, 
indicating a ‘standard’ expression pattern that could be utilised to 
comparatively grade damage in other BE
• Prx I expression was not expressed within the basal (progenitor) cells, 
and was therefore not a feature of ‘early stage’ repair
• Prx I and III expressions were elevated in regions of columnar cell 
hyperplasia, informing on the proliferative state in conjunction with levels 
of oxidative stress
• Prx-S0 3  levels were increased in airways demonstrating elevated levels 
of oxidative stress, i.e. inflammatory and hyperplasic airways
• Prx oxidation state could be used as a biomarker of COPD susceptibility, 
with only 15-20% of long-term smokers developing the disease
7.3 Future W o r k
7.3.1 In  vitro  NHBE M o d e l
This study has advanced the development of the NHBE model via the addition
of AO; however, there remains vast potential for further enhancements (Le
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Visage et al., 2004; Rothen-Rutishauser et al., 2005). For example, the lungs 
represent a target for airborne detritus (e.g. particles and gases), that, upon 
gaining access, deposit in the conducting airways. The detritus may then go 
on to interact with macrophages, which, either result in its clearance or its 
entrance into the interstitium, making contact with fibroblasts, endothelial cells 
and cells of the immune system. Therefore, lung epithelial cells, macrophages 
and other immune cells represent key targets for observing toxicant effects 
with specific regard to inflammation, immuno-pathology, microbial defence 
and clearance (BeruBe, 2011). The creation of co-culture models with 
different combinations of these cell types, according to the potential target 
cell(s) of a given inhaled hazard, will offer more in vivo like systems (Wottrich 
et al., 2004; Rothen-Rutishauser et al., 2005; Diabate et al., 2008; Lehmann 
et al., 2011).
Another avenue for exploration would be to improve the biotransformation 
(BT) capabilities of the model. There is a low level of BT within the lung 
(Hukkanen et al., 2000); therefore, there is a need to improve the limited 
xenobiotic-metabolising cytochrome P450 (CYPP450) enzyme activity within 
the NHBE cells (Prytherch, 2010). In order to achieve this, NHBE cells could 
be co-cultured with primary hepatocytes (Figure 7.1). Pilot studies within our 
lab have successfully co-cultured a NHBE-hepatocyte model (Metabo-Lung™, 
Patent pending), which provided Phase 1, 2 and P450 metabolic functions 
(W.A.G., 2010) data not published). The metabolising BE model now allows 
for the characterisation of toxic events following BT of parent compounds, 
yielding more in vivo like responsiveness.
Following on from the NHBE-Hepatocyte model, there could be further 
augmentation through the development of a full-thickness (FT) model. This 
would be achieved by the inclusion of primary human fibroblasts during sub- 
culturing of the NHBE cells (Figure 7.1). The fibroblasts would then establish 
hemidesomosomes (Andriani et al., 2003) along the plasma membrane of the 
NHBE basal cells, while fine anchoring fibrils would connect to the underlying 
collagen matrix. This FT model would provide appropriate in vivo like
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morphology and basement membrane development; attributes that will enable 
more realistic in vitro studies of airway epithelium.
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Figure 7.1 Metabolising full-thickness in vitro BE model.
In order to improve the existing NHBE cell culture model a xenobiotic metabolising full- 
thickness co-culture model could be developed. Initially the NHBE cells (ALI) and primary 
hepatocytes (submerged) would be cultured separately (1). The second phase would be to 
feed the NHBE cells with ALI culture media that contained primary hepatocytes (2). The 
hepatocytes would provide further BT capabilities to the model through the addition of 
metabolic activity including CYPP450. The final stage would involve sub-culturing the 
fibroblasts and the NHBE cells (3); this would provide a metabolising full-thickness model that 
more closely resembled the in vivo human BE environment.
In addition to tissue-engineering morphological enhancements, the NHBE 
model could be further manipulated to incorporate disease phenotypes, i.e. 
GCH or inflammation. GCH can be induced by exposing the cells to IL-4 and 
IL-13 (e.g. EpiAirway-FT™; (BeruBe et al., 2010a). This would provide a more 
complex view of the unique signalling pathways active as a consequence of
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phenotypic adaptation, and reveal the survival response and protective 
mechanisms employed by the bronchial epithelium following injury. In addition 
to disease state elucidation, the enhancement of the NHBE model would 
provide increased confidence in Prx status analysis following toxicological 
challenge. The in vitro redox model could also be utilised for increased 
understanding of oxidative stress in other tissue pathologies, such as the liver, 
that are subjected to injury through oxidative stress (Hoek and Pastorino, 
2002; Tanikawa and Torimura, 2006).
7.3.2 T o xico lo g ica l  Expo sure
Continuation of the GOx and CS exposures could be undertaken to establish 
the sensitivity of the Prxs as biomarkers of intracellular oxidative stress. 
Toxicant challenge could be refined in order to determine the concentration 
whereby Prx status remains completely unaffected, i.e. the no observed effect 
level (NOEL) (IUPAC, 1997).
Additional toxicological exposures could also incorporate AZ (AstraZeneca) 
compounds; Prx status could inform on the liability of inhaled or systemic AZ 
compounds to cause ROS induced injury to the bronchial epithelium. The 
NHBE-Prx system could also have a role in the evaluation of candidate 
respiratory drugs and novel therapeutic formulations developed to treat lung 
injury and disease. Comparative in vivo investigations for corresponding AZ 
compounds would substantiate the NHBE-Prx in vitro data, enhancing the 
models credentials as a viable pre-screening toxicological tool, prior to animal 
testing.
7.3.3 Exper im en ta l  D evelo pm en t
In addition to the reducing and non-reducing gel electrophoresis conditions, 
non-denaturing or ‘native’ gel electrophoresis could be employed, which 
informs on the native state of a given protein (Westermeier, 2005). The Prx 
undergo structural transitions in response to elevated levels of oxidative
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stress (Phalen et al., 2006), which would provide a further parameter linking 
levels of intracellular oxidative stress with Prx status.
In order to further develop the Prxs as biomarkers of oxidative stress, more 
detailed analysis of their regulatory mechanisms must be undertaken. 
Quantitative PCR (q-PCR) could be utilised through harvesting the mRNA of 
cultures post-exposure, this would inform on whether the changes in Prx 
status were at the translational and/or transcriptional level. The overriding 
advantage of using q-PCR is the relative sensitivity, detecting quantities as 
low as a few copy numbers (VanGuilder et al., 2008); this would enhance the 
Western blot data, as sensitivity limitations were evident in detecting changes 
in expression post-toxicant exposure. Q-PCR could also be used to 
substantiate the stress response Western blot data, through providing a more 
detailed analysis of the pathways targeted by elevated oxidative stress, i.e. 
the p38 and JNK pathways (Torres and Forman, 2003). Knowledge of the 
signalling pathways that are critical to an injury and repair event would 
enlighten the biopharmaceutical industry on the novel therapeutic formulations 
required in the development of candidate respiratory drugs.
As an extension to the in vivo correlation analysis, Prx status within samples 
from healthy smokers could be investigated. Prx status within the bronchial 
epithelial of smokers with no COPD symptoms could be an indicator of the 
individuals’ potential to develop COPD, and used as a further deterrent to 
smoking.
7.4 Future  B en efits
The NHBE-Prx system developed during this study encompasses a wide 
range of benefits for future in vitro biological and clinical research. These 
developments include:
• A system for screening candidate respiratory drugs before 
entering animal testing. The high cost involved in candidate drug 
selection has fuelled pharmaceutical companies to seek increasingly
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accurate and cost-effective methods to screen pre-clinical drugs 
(Seethala, 2001). Fifty percent of new chemical entities fail (e.g. lack of 
efficacy/safety from use of poorly predictive cell lines and animal based 
assays) during Phase 3, and 25% fail during registration; all of which 
can take up to 10 years at an average cost of 800 million US dollars 
(BeruBe, 2011). An in vitro testing platform using primary, human 
derived cells to tissue-engineer in vivo like models, such as the NHBE- 
Prxs system would improve drug development to create more effective 
respiratory drugs with fewer side-effects and faster translational times.
• Development of 3D in vivo like microenvironments. It is well- 
established that cell culture monolayers, i.e. 2D cell systems, lack the 
complexity of whole-tissues and animal models themselves fail to 
capture important facets of human disease, thus limiting their potential 
to predict cellular responses of humans (Forbes, 2000). The use of 
human tissue equivalents (HTEs) can bridge the gap between cell 
culture monolayers and in vivo animal systems (BeruBe et al., 2009). 
The NHBE-Prxs model can mimic to a certain degree the in vivo 
situation but also significantly reduces its complexity by the removal of 
confounding physiological factors to ‘tease-out’ finite and meaningful 
mechanistic information.
•  Delivery of drugs for non-pulmonary syndromes. There could also 
be a role for the NHBE-Prxs system in the field of inhaled 
biopharmaceuticals and the delivery of drugs for non-pulmonary 
syndromes (Patton et al., 2004). Drugs delivered by the respiratory 
system have improved pharmacokinetic profiles and offer an alternative 
delivery mode when conventional oral and intravenous routes are not 
suitable (Scheuch et al., 2006; Shoyele and Cawthorne, 2006).
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7.5 F inal  C o n c lu s io n
The Prxs were determined to be sensitive and reliable biomarkers of 
intracellular oxidative stress, injury severity and epithelial remodelling, thus 
indicating a role for the Prxs as an ‘early stage’ biomarker, with disruptions in 
redox state occurring far in advance of phenotypic or morphological 
adaptations. The in vitro NHBE cell model was developed further via the 
addition of AO, thereby reducing the basal levels of oxidative stress, and 
therefore, improving data viability and reproducibility. Furthermore, the NHBE 
model eliminated the issue of interspecies reactivity, indicating a potential role 
for the NHBE-Prx system as an in vivo pre-screening tool. It can therefore be 
concluded that the use of high content biology has developed the 
understanding of the association between morphological changes and 
biochemical pathways.
181
R e f e r e n c e s
R e f e r e n c e s
182
R e f e r e n c e s
Agusti, A. (2006). Thomas a. Neff lecture. Chronic obstructive pulmonary 
disease: a systemic disease. Proc Am Thorac Soc 3: 478-481.
Akuthota, P., Wang, H.B., Spencer, L.A., and Weller, P.F. (2008). 
Immunoregulatory roles of eosinophils: a new look at a familiar cell. Clin Exp 
Allergy 38: 1254-1263.
Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., and Walter, P.
(2002). Molecular biology of the cell. Garland Science.
Anderson, G.P. (2006). COPD, asthma and C-reactive protein. Eur Respir J 
27: 874-876.
Andriani, F., Margulis, A., Lin, N., Griffey, S., and Garlick, J.A. (2003). 
Analysis of microenvironmental factors contributing to basement membrane 
assembly and normalized epidermal phenotype. J Invest Dermatol 120: 923- 
931.
Antonicelli, F., Parmentier, M., Drost, E.M., Hirani, N., Rahman, I., 
Donaldson, K., and MacNee, W. (2002). Nacystelyn inhibits oxidant- 
mediated interleukin-8 expression and NF-kappaB nuclear binding in alveolar 
epithelial cells. Free Radic Biol Med 32: 492-502.
Ataullakhanov, F.I., and Vitvitsky, V.M. (2002). What determines the 
intracellular ATP concentration. Biosci Rep 22: 501-511.
Ayers, M.M., and Jeffery, P.K. (1988). Proliferation and Differentiation in 
Mammalian Airway Epithelium. European Respiratory Journal 1: 58-80.
Baginski, T.K., Dabbagh, K,, Satjawatcharaphong, C., and Swinney, D.C.
(2006). Cigarette smoke synergistically enhances respiratory mucin induction 
by proinflammatory stimuli. American journal of respiratory cell and molecular 
biology 35: 165-174.
183
R e f e r e n c e s
Baldwin, F. (1994). Basal cells in human bronchial epithelium. Anat Rec 238: 
360-367.
Balharry, D., Sexton, K., and BeruBe, K.A. (2008). An in vitro approach to 
assess the toxicity of inhaled tobacco smoke components: Nicotine, cadmium, 
formaldehyde and urethane. Toxicology 244: 66-76.
Barnes, P.J. (2009). The cytokine network in chronic obstructive pulmonary 
disease. American journal of respiratory cell and molecular biology 41: 631- 
638.
Barnes, P.J., Chowdhury, B., Kharitonov, S.A., Magnussen, H., Page, 
C.P., Postma, D., and Saetta, M. (2006). Pulmonary biomarkers in chronic 
obstructive pulmonary disease. American Journal of Respiratory and Critical 
Care Medicine 174: 6-14.
Barnes, P.J., Shapiro, S.D., and Pauwels, R.A. (2003). Chronic obstructive 
pulmonary disease: molecular and cellular mechanisms. Eur Respir J 22: 
672-688.
Barranco-Medina, S., Lazaro, J.J., and Dietz, K.J. (2009). The oligomeric 
conformation of peroxiredoxins links redox state to function. Febs Letters 583: 
1809-1816.
Bast, A., Haenen, G.R., and Doelman, C.J. (1991). Oxidants and 
antioxidants: state of the art. Am J Med 91: 2S-13S.
BDWG. (2001). Biomarkers and surrogate endpoints: preferred definitions 
and conceptual framework. Clin Pharmacol Ther 69: 89-95.
Becker, S., Mundandhara, S., Devlin, R.B., and Madden, M. (2005). 
Regulation of cytokine production in human alveolar macrophages and airway 
epithelial cells in response to ambient air pollution particles: further 
mechanistic studies. Toxicol Appl Pharm 207: 269-275.
184
R e f e r e n c e s
Berne, R.M., Levy, M.N., Koeppen, B.M., and Stanton, B.A. (2004). 
Physiology. Mosby.
BeruBe, K.A. (2011). Alternatives for lung research: stuck between a rat and 
a hard place. Altern Lab Anim 39: 121-130.
BeruBe, K.A., Aufderheide, M., Breheny, D., Clothier, R., Combes, R., 
Duffin, R., Forbes, B., Gaca, M., Gray, A., Hall, I., Kelly, M., Lethem, M., 
Liebsch, M., Merolla, L., Morin, J.P., Seagrave, J., Swartz, M.A., Tetley, 
T.D., and Umachandran, M. (2009). In vitro models of inhalation toxicity and 
disease. The report of a FRAME workshop. Altern Lab Anim 37: 89-141.
BeruBe, K.A., Pitt, A., Hayden, P., Prytherch, Z., and Job, C. (2010a). 
Filter-well technology for advanced three-dimensional cell culture: 
perspectives for respiratory research. Altern Lab Anim 38 Suppl 1: 49-65.
BeruBe, K.A., Prytherch, Z., Job, C., and Hughes, T. (2010b). Human 
primary bronchial lung cell constructs: The new respiratory models. 
Toxicology 278: 311-318.
Bianchi, M.E. (2007). DAMPs, PAMPs and alarmins: all we need to know 
about danger. J Leukoc Biol 81: 1-5.
Biteau, B., Labarre, J., and Toledano, M.B. (2003). ATP-dependent 
reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature 
425: 980-984.
Bittar, E.E. (2002). Pulmonary biology in health and disease. Springer.
Blenkinsopp, W.K. (1967). Proliferation of respiratory tract epithelium in the 
rat. Exp Cell Res 46: 144-154.
185
R e f e r e n c e s
Boers, J.E., Ambergen, A.W., and Thunnissen, F.B. (1998). Number and 
proliferation of basal and parabasal cells in normal human airway epithelium. 
Am J Respir Crit Care Med 157: 2000-2006.
Boers, J.E., Ambergen, A.W., and Thunnissen, F.B. (1999). Number and 
proliferation of clara cells in normal human airway epithelium. American 
Journal of Respiratory and Critical Care Medicine 159: 1585-1591.
Boots, A.W., Haenen, G.R., and Bast, A. (2003). Oxidant metabolism in 
chronic obstructive pulmonary disease. Eur Respir J Suppl 46: 14s-27s.
Boyton, R.J., and Openshaw, P.J. (2002). Pulmonary defences to acute
respiratory infection. Br Med Bull 61: 1-12.
Braiman, A., and Priel, Z. (2008). Efficient mucociliary transport relies on
efficient regulation of ciliary beating. Respir Physiol Neurobiol 163: 202-207.
Breeze, R.G., and Wheeldon, E.B. (1977). The cells of the pulmonary 
airways. Am Rev Respir Dis 116: 705-777.
Brody, A.R. (1984). Inhaled particles in human disease and animal models: 
use of electron beam instrumentation. Environ Health Perspect56: 149-162.
Bucchieri, F., Fucarino, A., Rizzuto, L., Pitruzzella, A., Noto, A., Cappello, 
F., and Zummo, G. (2009). Stem cell populations and regenerative potential 
in chronic inflammatory diseases. The Open Tissue Eng Regen Med J 2: 34- 
39.
Calabrese, E.J. (2004). Hormesis: a revolution in toxicology, risk assessment 
and medicine. EMBO Rep 5 Spec No: S37-40.
Cantin, A.M. (2010). Cellular response to cigarette smoke and oxidants: 
adapting to survive. Proceedings of the American Thoracic Society 7: 368- 
375.
186
R e f e r e n c e s
Castell, J.V., Donato, M.T., and Gomez-Lechon, M.J. (2005). Metabolism 
and bioactivation of toxicants in the lung. The in vitro cellular approach. Exp 
Toxicol Pathol 57 Suppl 1: 189-204.
Cerveri, I., and Brusasco, V. (2010). Revisited role for mucus hypersecretion 
in the pathogenesis of COPD. Eur Respir Rev 19: 109-112.
Cha, M.K., Yun, C.H., and Kim, I.H. (2000). Interaction of human thiol- 
specific antioxidant protein 1 with erythrocyte plasma membrane. 
Biochemistry 39: 6944-6950.
Chae, H.Z., Chung, S.J., and Rhee, S.G. (1994a). Thioredoxin-dependent 
peroxide reductase from yeast. J Biol Chem 269: 27670-27678.
Chae, H.Z., Kim, H.J., Kang, S.W., and Rhee, S.G. (1999). Characterization 
of three isoforms of mammalian peroxiredoxin that reduce peroxides in the 
presence of thioredoxin. Diabetes Res Clin Pract45: 101-112.
Chae, H.Z., Robison, K., Poole, L.B., Church, G., Storz, G., and Rhee, 
S.G. (1994b). Cloning and sequencing of thiol-specific antioxidant from 
mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant 
define a large family of antioxidant enzymes. Proc Natl Acad Sci U S A 91: 
7017-7021.
Chae, H.Z., Uhm, T.B., and Rhee, S.G. (1994c). Dimerization of thiol-specific 
antioxidant and the essential role of cysteine 47. Proc Natl Acad Sci U S A 91: 
7022-7026.
Chang, J.W., Jeon, H.B., Lee, J.H., Yoo, J.S., Chun, J.S., Kim, J.H., and 
Yoo, Y.J. (2001). Augmented expression of peroxiredoxin I in lung cancer. 
Biochem Biophys Res Commun 289: 507-512.
187
R e f e r e n c e s
Chang, T.S., Cho, C.S., Park, S., Yu, S., Kang, S.W., and Rhee, S.G.
(2004). Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates 
apoptotic signaling by mitochondria. J Biol Chem 279: 41975-41984.
Chang, T.S., Jeong, W., Choi, S.Y., Yu, S., Kang, S.W., and Rhee, S.G.
(2002). Regulation of peroxiredoxin I activity by Cdc2-mediated 
phosphorylation. J Biol Chem 277: 25370-25376.
Chemuturi, N.V., Hayden, P., Klausner, M., and Donovan, M.D. (2005). 
Comparison of human tracheal/bronchial epithelial cell culture and bovine 
nasal respiratory explants for nasal drug transport studies. J Pharm Sci 94: 
1976-1985.
Chen, C., Arjomandi, M., Balmes, J., Tager, I., and Holland, N. (2007). 
Effects of chronic and acute ozone exposure on lipid peroxidation and 
antioxidant capacity in healthy young adults. Environ Health Perspect 115: 
1732-1737.
Chen, H., Wang, D., Bai, C., and Wang, X. (2010). Proteomics-based 
biomarkers in chronic obstructive pulmonary disease. J Proteome Res 9: 
2798-2808.
Chen, J.W., Dodia, C., Feinstein, S.I., Jain, M.K., and Fisher, A.B. (2000). 
1-Cys peroxiredoxin, a bifunctional enzyme with glutathione peroxidase and 
phospholipase A2 activities. J Biol Chem 275: 28421-28427.
Chen, Q., Zhang, S.M., Liu, H.Y., and Li, Y.Q. (2009). Protective effect of 
glutathione against oxidative injury in intestinal epithelial cells of piglet in vitro. 
J Anim Biol 59: 263-272.
Chilvers, M.A., and O'Callaghan, C. (2000). Local mucociliary defence 
mechanisms. Paediatr Respir Rev 1: 27-34.
188
R e f e r e n c e s
Choi, H.J., Kang, S.W., Yang, C.H., Rhee, S.G., and Ryu, S.E. (1998). 
Crystal structure of a novel human peroxidase enzyme at 2.0 A resolution. 
Nat Struct Biol 5: 400-406.
Churg, A., Wang, R.D., and Wright, J.L. (2006). Cigarette smoke causes 
small airway remodeling by direct growth factor induction and release. 
Proceedings of the American Thoracic Society 3: 493.
Ciencewicki, J., Trivedi, S., and Kleeberger, S.R. (2008). Oxidants and the 
pathogenesis of lung diseases. J Allergy Clin Immunol 122: 456-468; quiz 
469-470.
Com, E., Bourgeon, F., Evrard, B., Ganz, T., Colleu, D., Jegou, B., and 
Pineau, C. (2003). Expression of antimicrobial defensins in the male 
reproductive tract of rats, mice, and humans. Biol Reprod 68: 95-104.
Comhair, S.A., and Erzurum, S.C. (2002). Antioxidant responses to oxidant- 
mediated lung diseases. Am J Physiol Lung Cell Mol Physiol 283: L246-255.
Coraux, C., Roux, J., Jolly, T., and Birembaut, P. (2008). Epithelial cell- 
extracellular matrix interactions and stem cells in airway epithelial 
regeneration. Proceedings of the American Thoracic Society 5: 689-694.
Costello, M.L., Mathieu-Costello, O., and West, J.B. (1992). Stress failure 
of alveolar epithelial cells studied by scanning electron microscopy. The 
American review of respiratory disease 145: 1446-1455.
Cox, A.G., Pearson, A.G., Pullar, J.M., Jonsson, T.J., Lowther, W.T., 
Winterbourn, C.C., and Hampton, M.B. (2009a). Mitochondrial 
peroxiredoxin 3 is more resilient to hyperoxidation than cytoplasmic 
peroxiredoxins. Biochem J 421: 51-58.
189
R e f e r e n c e s
Cox, A.G., Peskin, A.V., Paton, L.N., Winterbourn, C.C., and Hampton, 
M.B. (2009b). Redox potential and peroxide reactivity of human peroxiredoxin 
3. Biochemistry 48: 6495-6501.
Cox, A.G., Winterbourn, C.C., and Hampton, M.B. (2010a). Measuring the 
redox state of cellular peroxiredoxins by immunoblotting. Methods Enzymol 
474: 51-66.
Cox, A.G., Winterbourn, C.C., and Hampton, M.B. (2010b). Mitochondrial 
peroxiredoxin involvement in antioxidant defence and redox signalling. 
Biochem J 425: 313-325.
Cozens, A.L., Yezzi, M.J., Kunzelmann, K., Ohrui, T., Chin, L., Eng, K., 
Finkbeiner, W.E., Widdicombe, J.H., and Gruenert, D.C. (1994). CFTR 
expression and chloride secretion in polarized immortal human bronchial 
epithelial cells. American journal of respiratory cell and molecular biology 10: 
38-47.
D'Autreaux, B., and Toledano, M.B. (2007). ROS as signalling molecules: 
mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell 
Biol 8: 813-824.
Dalle-Donne, I., Scaloni, A., Giustarini, D., Cavarra, E., Tell, G., 
Lungarella, G., Colombo, R., Rossi, R., and Milzani, A. (2005). Proteins as 
biomarkers of oxidative/nitrosative stress in diseases: the contribution of 
redox proteomics. Mass Spectrom Rev 24: 55-99.
Davies, J.R., Herrmann, A., Russell, W., Svitacheva, N., Wickstrom, C., 
and Carlstedt, I. (2002). Respiratory tract mucins: structure and expression 
patterns. Novartis Found Symp 248: 76-88; discussion 88-93, 277-282.
Davis, C.W., and Dickey, B.F. (2008). Regulated airway goblet cell mucin 
secretion. Annu Rev Physiol 70: 487-512.
190
R e f e r e n c e s
Declercq, J.P., Evrard, C., Clippe, A., Stricht, D.V., Bernard, A., and 
Knoops, B. (2001). Crystal structure of human peroxiredoxin 5, a novel type 
of mammalian peroxiredoxin at 1.5 A resolution. J Mol Biol 311: 751-759.
Decramer, M., De Benedetto, F., Del Ponte, A., and Marinari, S. (2005). 
Systemic effects of COPD. Respiratory Medicine 99 Suppl B: S3-10.
Decramer, M., Sibille, Y., Bush, A., Carlsen, K.H., Rabe, K.F., Clancy, L., 
Turnbull, A., Nemery, B., Simonds, A., and Troosters, T. (2011). The 
European Union conference on chronic respiratory disease: purpose and 
conclusions. The European respiratory journal : official journal of the 
European Society for Clinical Respiratory Physiology 37: 738-742.
Dekhuijzen, P.N., Aben, K.K., Dekker, I., Aarts, L.P., Wielders, P.L., van 
Herwaarden, C.L., and Bast, A. (1996). Increased exhalation of hydrogen 
peroxide in patients with stable and unstable chronic obstructive pulmonary 
disease. American Journal of Respiratory and Critical Care Medicine 154: 
813-816.
Diabate, S., Mulhopt, S., Paur, H.R., and Krug, H.F. (2008). The response 
of a co-culture lung model to fine and ultrafine particles of incinerator fly ash 
at the air-liquid interface. Altern Lab Anim 36: 285-298.
Doelman, C.J., and Bast, A. (1990). Oxygen radicals in lung pathology. Free 
Radic Biol Med 9: 381-400.
Drexler, H.G., Dirks, W.G., Matsuo, Y., and MacLeod, R.A. (2003). False 
leukemia-lymphoma cell lines: an update on over 500 cell lines. Leukemia 17: 
416-426.
Drost, E.M., Skwarski, K.M., Sauleda, J., Soler, N., Roca, J., Agusti, A., 
and MacNee, W. (2005). Oxidative stress and airway inflammation in severe 
exacerbations of COPD. Thorax 60: 293-300.
191
R e f e r e n c e s
Dubuisson, M., Vander Stricht, D., Clippe, A., Etienne, F., Nauser, T., 
Kissner, R., Koppenol, W.H., Rees, J.F., and Knoops, B. (2004). Human 
peroxiredoxin 5 is a peroxynitrite reductase. FEBS Lett 571: 161-165.
Dytham, C. (2003). Choosing and using statistics: a biologists guide. 
Blackwell Publishing.
Ebert, R.V., and Hanks, P.B. (1981). Mucus secretion by the epithelium of 
the bronchioles of cigarette smokers. Br J Dis Chest 75: 277-282.
Elbert, K.J., Schafer, U.F., Schafers, H.J., Kim, K.J., Lee, V.H., and Lehr, 
C.M. (1999). Monolayers of human alveolar epithelial cells in primary culture 
for pulmonary absorption and transport studies. Pharm Res 16: 601-608.
Ellis, H.R., and Poole, L.B. (1997). Roles for the two cysteine residues of 
AhpC in catalysis of peroxide reduction by alkyl hydroperoxide reductase from 
Salmonella typhimurium. Biochemistry 36: 13349-13356.
Emami, J. (2006). In vitro - in vivo correlation: from theory to applications. J 
Pharm Pharm Sci 9: 169-189.
Engelhardt, J.F., Schlossberg, H., Yankaskas, J.R., and Dudus, L. (1995). 
Progenitor cells of the adult human airway involved in submucosal gland 
development. Development 121: 2031-2046.
Erjefalt, J.S., Sundler, F., and Persson, C.G. (1997). Epithelial barrier 
formation by airway basal cells. Thorax 52: 213-217.
Evans, M.D., Dizdaroglu, M., and Cooke, M.S. (2004). Oxidative DNA 
damage and disease: induction, repair and significance. Mutat Res567: 1-61.
EU Directive 76/68/EEc. (2003). Directive 2003/15/EC of the European 
parliament and of the council of 27 February 2003. Official Journal of the 
European Union. L66: 26-35.
192
R e f e r e n c e s
Finkel, T. (1998). Oxygen radicals and signaling. Curr Opin Cell Biol 10: 248- 
253.
Finkelstein, R., Fraser, R.S., Ghezzo, H., and Cosio, M.G. (1995). Alveolar 
inflammation and its relation to emphysema in smokers. American Journal of 
Respiratory and Critical Care Medicine 152: 1666-1672.
Fletcher, C., Peto, R., Tinker, C., and Speizer, F.E. (1976). The natural 
history of chronic bronchitis and emphysema. Oxford: Oxford University 
Press.
Fletcher, C.M., and Pride, N.B. (1984). Definitions of emphysema, chronic 
bronchitos, asthma, and air-flow obstruction - 25 years on from the CIBA 
symposium. Thorax 39: 81-85.
Fliegauf, M., Benzing, T., and Omran, H. (2007). When cilia go bad: cilia 
defects and ciliopathies. Nat Rev Mol Cell Biol 8: 880-893.
Folkerts, G., and Nijkamp, F.P. (1998). Airway epithelium: more than just a 
barrier! Trends in pharmacological sciences 19: 334-341.
Forbes, 1.1. (2000). Human airway epithelial cell lines for in vitro drug 
transport and metabolism studies. Pharm Sci Technolo Today 3: 18-27.
Forman, H.J., Fukuto, J.M., and Torres, M. (2004). Redox signaling: thiol 
chemistry defines which reactive oxygen and nitrogen species can act as 
second messengers. Am J Physiol Cell Physiol 287: C246-256.
Foronjy, R.F., and D'Armiento, J.M. (2006). The effect of cigarette smoke- 
derived oxidants on the inflammatory response of the lung. Clin Appl Immunol 
Rev 6: 53-72.
193
R e f e r e n c e s
Foster, K.A., Avery, M.L., Yazdanian, M., and Audus, K.L. (2000). 
Characterization of the Calu-3 cell line as a tool to screen pulmonary drug 
delivery. Int J Pharm 208: 1-11.
Freshney, R.I. (2005). Culture of animal cells: a manual of basic techniques. 
Wiley.
Fridovich, I., and Freeman, B. (1986). Antioxidant defenses in the lung. 
Annu Rev Physiol 48: 693-702.
Garban, Z., Avacivici, A., Garban, G., Ghibu, G.D., Velciov, A.B., and Pop,
C.l. (2005). Biomarkers: Theoretical aspects and applicative peculiarities. 
Note I. General characterisation of biomarkers. J Agroalimentary Process 
Technol 11: 139-146.
Gardner, D.E. (2006). Toxicology of the lung.
Genestra, M. (2007). Oxyl radicals, redox-sensitive signalling cascades and 
antioxidants. Cell Signal 19: 1807-1819.
Germann, W., and Stanfield, C. (2004). Principles of human physiology. 
Benjamin Cummings, New York.
Gillard, J. (2011). Performing the one-way ANOVA test when samples are 
not equally distributed. School of mathematics, Cardiff University Personal 
communication.
GOLD. (2006). Global initiative for chronic obstructive lung disease. Global 
strategy for diagnosis, management and prevention of COPD. National 
institute of health / World health organisation, www.goldcopd.org.
Gomperts, B.N., Belperio, J.A., Fishbein, M.C., Keane, M.P., Burdick, 
M.D., and Strieter, R.M. (2007). Keratinocyte growth factor improves repair in
194
R e f e r e n c e s
the injured tracheal epithelium. American journal of respiratory cell and 
molecular biology 37: 48-56.
Grainger, C.I., Green well, L.L., Lockley, D.J., Martin, G.P., and Forbes, B.
(2006). Culture of Calu-3 cells at the air interface provides a representative 
model of the airway epithelial barrier. Pharm Res 23: 1482-1490.
Greer, K.A., Pine, M., and Busbee, D.L. (2005). Development of an in vitro 
model of excess intracellular reactive oxygen species. Age 27: 97-105.
Griffith, L.G., and Swartz, M.A. (2006). Capturing complex 3D tissue 
physiology in vitro. Nat Rev Mol Cell Biol 7: 211-224.
Hackett, N.R., Heguy, A., Harvey, B.G., O'Connor, T.P., Luettich, K., 
Flieder, D.B., Kaplan, R., and Crystal, R.G. (2003). Variability of antioxidant- 
related gene expression in the airway epithelium of cigarette smokers. Am J 
Respir Cell Mol Biol 29: 331-343.
Hall, A., Parsonage, D., Poole, L.B., and Karplus, P.A. (2010). Structural 
evidence that peroxiredoxin catalytic power is based on transition-state 
stabilization. J Mol Biol 402: 194-209.
Halliwell, B. (1991). Reactive oxygen species in living systems: source, 
biochemistry, and role in human disease. Am J Med 91: 14S-22S.
Halliwell, B. (2003). Oxidative stress in cell culture: an under-appreciated 
problem? Febs Letters 540: 3-6.
Halliwell, B. (2006). Reactive species and antioxidants. Redox biology is a 
fundamental theme of aerobic life. Plant Physiol 141: 312-322.
Halliwell, B. (2007a). Biochemistry of oxidative stress. Biochem Soc Trans 
35: 1147-1150.
195
R e f e r e n c e s
Halliwell, B. (2007b). Oxidative stress and cancer: have we moved forward? 
Biochem J 401: 1-11.
Halliwell, B. (2011). Free radicals and antioxidants - quo vadis? Trends in 
pharmacological sciences 32: 125-130.
Halliwell, B., and Gutteridge, M.C. (1999). Free radicals in biology and 
medicine. Oxford University Press.
Hansel, T.T., and Barnes, P.J. (2004). An atlas of chronic obstructive 
pulmonary disease COPD. The Parthenon Publishing Group.
Haridas, V., Ni, J., Meager, A., Su, J., Yu, G.L., Zhai, Y., Kyaw, H., Akama, 
K.T., Hu, J., Van Eldik, L.J., and Aggarwal, B.B. (1998). TRANK, a novel 
cytokine that activates NF-kappa B and c-Jun N-terminal kinase. J Immunol 
161: 1-6.
Harris, J.R. (1968). Release of a macromolecular protein component from 
human erythrocyte ghosts. Biochim Biophys Acta 150: 534-537.
Harris, J.R. (1969). Some negative contrast staining features of a protein 
from erythrocyte ghosts. J Mol Biol 46: 329-335.
Harris, J.R., Schroder, E., Isupov, M.N., Scheffler, D., Kristensen, P., 
Littlechild, J.A., Vagin, A.A., and Meissner, U. (2001). Comparison of the 
decameric structure of peroxiredoxin-ll by transmission electron microscopy 
and X-ray crystallography. Biochim Biophys Acta 1547: 221-234.
Hasleton, P.S. (1996). Spencer's pathology of the lung. McGraw-Hill.
Heintz, N. (2008). A model for the role of ROS in the pathogenesis of disease 
Personal communication.
196
R e f e r e n c e s
Hill, E.M., Eling, T., and Nettesheim, P. (1998). Differentiation dependency 
of eicosanoid enzyme expression in human tracheobronchial cells. Toxicol 
Lett 96-97: 239-244.
Hirotsu, S., Abe, Y., Okada, K., Nagahara, N., Horl, H., Nishino, T., and 
Hakoshima, T. (1999). Crystal structure of a multifunctional 2-Cys 
peroxiredoxin heme-binding protein 23 kDa/proliferation-associated gene 
product. Proc Natl Acad Sci U S A 96: 12333-12338.
Hlastala, M.P., and Berger, A.J. (2001). Physiology of respiration. Oxford 
University Press.
Hoek, J.B., and Pastorino, J.G. (2002). Ethanol, oxidative stress, and 
cytokine-induced liver cell injury. Alcohol 27: 63-68.
Hofmann, B., Hecht, H.J., and Flohe, L. (2002). Peroxiredoxins. Biol Chem 
383: 347-364.
Hong, K.U., Reynolds, S.D., Watkins, S., Fuchs, E., and Stripp, B.R.
(2004). Basal cells are a multipotent progenitor capable of renewing the 
bronchial epithelium. Am J Pathol 164: 577-588.
Hukkanen, J., Lassila, A., Paivarinta, K., Valanne, S., Sarpo, S., Hakkola, 
J., Pelkonen, O., and Raunio, H. (2000). Induction and regulation of 
xenobiotic-metabolizing cytochrome P450s in the human A549 lung 
adenocarcinoma cell line. American journal of respiratory cell and molecular 
biology 22: 360-366.
I ARC. (2004). Tobacco smoke and involuntary smoking. IARC monographs 
on the evaluation of carcinogenic risks to humans 83.
Ilumets, H., Rytila, P.H., Sovijarvi, A.R., Tervahartiala, T., Myllarniemi, M., 
Sorsa, T.A., and Kinnula, V.L. (2008). Transient elevation of neutrophil
197
R e f e r e n c e s
proteinases in induced sputum during COPD exacerbation. Scand J Clin Lab 
Invest 68: 618-623.
Immenschuh, S., and Baumgart-Vogt, E. (2005). Peroxiredoxins, oxidative 
stress, and cell proliferation. Antioxidants & redox signaling 7: 768-777.
Invitrogen. (2011). SeeBlue pre-stained standard.
Ishii, T., Yamada, M., Sato, H., Matsue, M., Taketani, S., Nakayama, K., 
Sugita, Y., and Bannai, S. (1993). Cloning and characterization of a 23-kDa 
stress-induced mouse peritoneal macrophage protein. J Biol Chem 268: 
18633-18636.
IUPAC. (1997). No observed effect level (NOEL). International union of pure 
applied chemistry.
Iwahara, S., Satoh, H., Song, D.X., Webb, J., Burlingame, A.L., Nagae, Y., 
and Muller-Eberhard, U. (1995). Purification, characterization, and cloning of 
a heme-binding protein (23 kDa) in rat liver cytosol. Biochemistry 34: 13398- 
13406.
Janeway, C.A., Jr., and Medzhitov, R. (2002). Innate immune recognition. 
Annu Rev Immunol 20: 197-216.
Janoff, A., Carp, H., Laurent, P., and Raju, L. (1983). The Role of Oxidative 
Processes in Emphysema. American Review of Respiratory Disease 127: 
S31-S38.
Janssen-Heininger, Y.M.W., Mossman, B.T., Heintz, N.H., Forman, H.J., 
Kalyanaraman, B., Finkel, T., Stamler, J.S., Rhee, S.G., and van der Vliet,
A. (2008). Redox-based regulation of signal transduction: Principles, pitfalls, 
and promises. Free Radical Biology and Medicine 45: 1-17.
198
R e f e r e n c e s
Janssen, Y.M., Van Houten, B., Borm, P.J., and Mossman, B.T. (1993). 
Cell and tissue responses to oxidative damage. Lab Invest 69: 261-274.
Jeffery, P.K. (2000). Comparison of the structural and inflammatory features 
of COPD and asthma. Giles F. Filley Lecture. Chest 117: 251S-260S.
Jikimoto, T., Nishikubo, Y., Koshiba, M., Kanagawa, S., Morinobu, S., 
Morinobu, A., Saura, R., Mizuno, K., Kondo, S., Toyokuni, S., Nakamura, 
H., Yodoi, J., and Kumagai, S. (2002). Thioredoxin as a biomarker for 
oxidative stress in patients with rheumatoid arthritis. Mol Immunol 38: 765- 
772.
Jin, D.Y., Chae, H.Z., Rhee, S.G., and Jeang, K.T. (1997). Regulatory role 
for a novel human thioredoxin peroxidase in NF-kappaB activation. J Biol 
Chem 272: 30952-30961.
Jones, D.P. (2006). Redefining oxidative stress. Antioxid Redox Signal 8: 
1865-1879.
Jones, P.W., and Agusti, A.G. (2006). Outcomes and markers in the 
assessment of chronic obstructive pulmonary disease. Eur Respir J 27: 822- 
832.
Kang, S.W., Baines, I.C., and Rhee, S.G. (1998a). Characterization of a 
mammalian peroxiredoxin that contains one conserved cysteine. J Biol Chem 
273:6303-6311.
Kang, S.W., Chae, H.Z., Seo, M.S., Kim, K., Baines, I.C., and Rhee, S.G.
(1998b). Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide 
generated in response to growth factors and tumor necrosis factor-alpha. J 
Biol Chem 273: 6297-6302.
Kasper, M., Rudolf, T., Verhofetad, A.A., Schuh, D., and Muller, M. (1993). 
Heterogeneity in the immunolocalization of cytokeratin-specific monoclonal
199
R e f e r e n c e s
antibodies in the rat lung: evaluation of three different alveolar epithelial cell 
types. Histochemistry 100: 65-71.
Kawai, S., Takeshita, S., Okazaki, M., Kikuno, R., Kudo, A., and Amann,
E. (1994). Cloning and characterization of OSF-3, a new member of the 
MER5 family, expressed in mouse osteoblastic cells. J Biochem 115: 641- 
643.
Keatings, V.M., Collins, P.D., Scott, D.M., and Barnes, P.J. (1996). 
Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum 
from patients with chronic obstructive pulmonary disease or asthma. Am J 
Respir Crit Care Med 153: 530-534.
Kelly, F.J. (1999). Gluthathione: in defence of the lung. Food Chem Toxicol 
37: 963-966.
Kelly, F.J., and Mudway, I.S. (2003). Protein oxidation at the air-lung 
interface. Amino Acids 25: 375-396.
Kim, H.S., Manevich, Y., Feinstein, S.I., Pak, J.H., Ho, Y.S., and Fisher, 
A.B. (2003). Induction of 1-cys peroxiredoxin expression by oxidative stress in 
lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 285: L363-369.
Kim, K., Kim, I.H., Lee, K.Y., Rhee, S.G., and Stadtman, E.R. (1988). The 
isolation and purification of a specific "protector" protein which inhibits enzyme 
inactivation by a thiol/Fe(lll)/02 mixed-function oxidation system. J Biol Chem 
263: 4704-4711.
Kim, K., Rhee, S.G., and Stadtman, E.R. (1985). Nonenzymatic cleavage of 
proteins by reactive oxygen species generated by dithiothreitol and iron. J Biol 
Chem 260: 15394-15397.
Kim, S., and Nadel, J.A. (2004). Role of neutrophils in mucus hypersecretion 
in COPD and implications for therapy. Treat Respir Med 3: 147-159.
2 0 0
R e f e r e n c e s
Kim, S.K., Woodcraft, K.J., Oh, S.J., Abdelmegeed, M.A., and Novak, R.F.
(2005). Role of mechanical and redox stress in activation of mitogen-activated 
protein kinases in primary cultured rat hepatocytes. Biochem Pharmacol 70: 
1785-1795.
Kim, S.Y., Jang, H.H., Lee, J.R., Sung, N.R., Lee, H.B., Lee, D.H., Park,
D.J., Kang, C.H., Chung, W.S., Lim, C.O., Yun, D.J., Kim, W.Y., Lee, K.O., 
and Lee, S.Y. (2009). Oligomerization and chaperone activity of a plant 2-Cys 
peroxiredoxin in response to oxidative stress. Plant Sci 177: 227-232.
Kim, S.Y., Kim, T.J., and Lee, K.Y. (2008). A novel function of peroxiredoxin 
1 (Prx-1) in apoptosis signal-regulating kinase 1 (ASKI)-mediated signaling 
pathway. FEBS Lett 582: 1913-1918.
Kim, W.D., Eidelman, D.H., Izquierdo, J.L., Ghezzo, H., Saetta, M.P., and 
Cosio, M.G. (1991). Centrilobular and panlobular emphysema in smokers. 
Two distinct morphologic and functional entities. Am Rev Respir Dis 144: 
1385-1390.
Kinnula, V.L. (2005). Focus on antioxidant enzymes and antioxidant 
strategies in smoking related airway diseases. Thorax 60: 693-700.
Kinnula, V.L., llumets, H., Myllarniemi, M., Sovijarvi, A., and Rytila, P.
(2007). 8-lsoprostane as a marker of oxidative stress in nonsymptomatic 
cigarette smokers and COPD. The European respiratory journal : official 
journal of the European Society for Clinical Respiratory Physiology 29: 51-55.
Kinnula, V.L., Lehtonen, S., Kaarteenaho-Wiik, R., Lakari, E., Paakko, P., 
Kang, S.W., Rhee, S.G., and Soini, Y. (2002a). Cell specific expression of 
peroxiredoxins in human lung and pulmonary sarcoidosis. Thorax 57: 157- 
164.
2 0 1
R e f e r e n c e s
Kinnula, V.L., Lehtonen, S., Sormunen, R., Kaarteenaho-Wiik, R., Kang, 
S.W., Rhee, S.G., and Soini, Y. (2002b). Overexpression of peroxiredoxins I, 
li, III, V, and VI in malignant mesothelioma. J Pathol 196: 316-323.
Kirkham, P., and Rahman, I. (2006). Oxidative stress in asthma and COPD: 
antioxidants as a therapeutic strategy. Pharmacol Ther 111: 476-494.
Kitano, K., Niimura, Y., Nishiyama, Y., and Miki, K. (1999). Stimulation of 
peroxidase activity by decamerization related to ionic strength: AhpC protein 
from Amphibacillus xylanus. J Biochem 126: 313-319.
Knight, D.A., and Holgate, S.T. (2003). The airway epithelium: structural and 
functional properties in health and disease. Respirology 8: 432-446.
Knoops, B., Clippe, A., Bogard, C., Arsalane, K., Wattiez, R., Hermans, 
C., Duconseille, E., Falmagne, P., and Bernard, A. (1999). Cloning and 
characterization of AOEB166, a novel mammalian antioxidant enzyme of the 
peroxiredoxin family. J Biol Chem 274: 30451-30458.
Koo, K.H., Lee, S., Jeong, S.Y., Kim, E.T., Kim, H.J., Kim, K., Song, K., 
and Chae, H.Z. (2002). Regulation of thioredoxin peroxidase activity by C- 
terminal truncation. Arch Biochem Biophys 397: 312-318.
Korpas, J., and Honda, Y. (1996). Aspects of airway defence mechanisms. 
J. Pathophys 3: 81-86.
Langen, R.C., Korn, S.H., and Wouters, E.F. (2003). ROS in the local and 
systemic pathogenesis of COPD. Free Radic Biol Med 35: 226-235.
Le Visage, C., Dunham, B., Flint, P., and Leong, K.W. (2004). Coculture of 
mesenchymal stem cells and respiratory epithelial cells to engineer a human 
composite respiratory mucosa. Tissue Eng 10: 1426-1435.
202
R e f e r e n c e s
Lederer, J.A., Rodrick, M.L., and Mannick, J.A. (1999). The effects of injury 
on the adaptive immune response. Shock 11: 153-159.
Lehmann, A.D., Daum, N., Bur, M., Lehr, C.M., Gehr, P., and Rothen- 
Rutishauser, B.M. (2011). An in vitro triple cell co-culture model with primary 
cells mimicking the human alveolar epithelial barrier. Eur J Pharm Biopharm 
77: 398-406.
Lehtonen, S.T., Markkanen, P.M., Peltoniemi, M., Kang, S.W., and 
Kinnula, V.L. (2005). Variable overoxidation of peroxiredoxins in human lung 
cells in severe oxidative stress. Am J Physiol Lung Cell Mol Physiol 288: 
L997-1001.
Lehtonen, S.T., Ohlmeier, S., Kaarteenaho-Wiik, R., Harju, T., Paakko, P., 
Soini, Y., and Kinnula, V.L. (2008). Does the oxidative stress in chronic 
obstructive pulmonary disease cause thioredoxin/peroxiredoxin oxidation? 
Antioxid Redox Signal 10: 813-819.
Lehtonen, S.T., Svensk, A.M., Soini, Y., Paakko, P., Hirvikoski, P., Kang, 
S.W., Saily, M., and Kinnula, V.L. (2004). Peroxiredoxins, a novel protein 
family in lung cancer. International Journal of Cancer 111: 514-521.
Leist, M., Raab, B., Maurer, S., Rosick, U., and Brigelius-Flohe, R. (1996). 
Conventional cell culture media do not adequately supply cells with 
antioxidants and thus facilitate peroxide-induced genotoxicity. Free radical 
biology & medicine 21: 297-306.
Levitsky, M.G. (2003). Pulmonary physiology. McGraw-Hill.
Leyens, G., Donnay, I., and Knoops, B. (2003). Cloning of bovine 
peroxiredoxins-gene expression in bovine tissues and amino acid sequence 
comparison with rat, mouse and primate peroxiredoxins. Comp Biochem 
Physiol B Biochem Mol Biol 136: 943-955.
203
R e f e r e n c e s
Lim, Y.S., Cha, M.K., Kim, H.K., Uhm, T.B., Park, J.W., Kim, K., and Kim,
I.H. (1993). Removals of hydrogen peroxide and hydroxyl radical by thiol- 
specific antioxidant protein as a possible role in vivo. Biochem Biophys Res 
Commun 192: 273-280.
Lin, H., Li, H., Cho, H.J., Bian, S., Roh, H.J., Lee, M.K., Kim, J.S., Chung, 
S.J., Shim, C.K., and Kim, D.D. (2007). Air-liquid interface (ALI) culture of 
human bronchial epithelial cell monolayers as an in vitro model for airway 
drug transport studies. J Pharm Sci 96: 341-350.
Lin, J.H. (1998). Applications and limitations of interspecies scaling and in 
vitro extrapolation in pharmacokinetics. Drug Metab Dispos 26:1202-1212.
Lopez, A.D., Mathers, C.D., Ezzati, M., Jaimison, D.T., and Murray, C.J.L.
(2006). Global burden of disease and risk factors. Oxford University Press.
MacNee, W. (2000). Oxidants/antioxidants and COPD. Chest 117: 303S- 
317S.
MacNee, W. (2001). Oxidative stress and lung inflammation in airways 
disease. European Journal of Pharmacology 429: 195-207.
MacNee, W., and Rahman, I. (2001). Is oxidative stress central to the 
pathogenesis of chronic obstructive pulmonary disease? Trends in Molecular 
Medicine 7: 55-62.
Makris, D., Paraskakis, E., Korakas, P., Karagiannakis, E., Sourvinos, G., 
Siafakas, N.M., and Tzanakis, N. (2008). Exhaled breath condensate 8- 
isoprostane, clinical parameters, radiological indices and airway inflammation 
in COPD. Respiration 72: 138-144.
Manevich, Y., Feinstein, S.I., and Fisher, A.B. (2004). Activation of the 
antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated 
by heterodimerization with pi GST. Proc Natl Acad Sci U S A 101: 3780-3785.
204
R e f e r e n c e s
Manevich, Y., and Fisher, A.B. (2005). Peroxiredoxin 6, a 1-Cys 
peroxiredoxin, functions in antioxidant defense and lung phospholipid 
metabolism. Free Radic Biol Med 38: 1422-1432.
Mannino, D.M., and Braman, S. (2007). The epidemiology and economics of 
chronic obstructive pulmonary disease. Proc Am Thorac Soc 4: 502-506.
Mannino, D.M., and Buist, A.S. (2007). Global burden of COPD: risk factors, 
prevalence, and future trends. Lancet 370: 765-773.
Martin, T.R., and Frevert, C.W. (2005). Innate immunity in the lungs. Proc 
Am Thorac Soc 2: 403-411.
Matsumoto, A., Okado, A., Fujii, T., Fujii, J., Egashira, M., Niikawa, N., 
and Taniguchi, N. (1999). Cloning of the peroxiredoxin gene family in rats 
and characterization of the fourth member. FEBS Lett 443: 246-250.
Matter, K., and Baida, M.S. (2003). Functional analysis of tight junctions. 
Methods 30: 228-234.
McCay, P.B. (1985). Vitamin E: interactions with free radicals and ascorbate. 
Annu Rev Nutr 5: 323-340.
McCord, J.M., and Fridovich, I. (1969). Superoxide dismutase. An enzymic 
function for erythrocuprein (hemocuprein). J Biol Chem 244: 6049-6055.
McDowell, E.M., Barrett, L.A., Glavin, F., Harris, C.C., and Trump, B.F.
(1978). The respiratory epithelium. I. Human bronchus. J Natl Cancer Inst 61: 
539-549.
Medzhitov, R. (2007). Recognition of microorganisms and activation of the 
immune response. Nature 449: 819-826.
205
R e f e r e n c e s
Medzhitov, R., and Janeway, C.A., Jr. (1997). Innate immunity: impact on 
the adaptive immune response. Current opinion in immunology 9: 4-9.
Mercer, B.A., Lemaitre, V., Powell, C.A., and D'Armiento, J. (2006). The 
Epithelial Cell in Lung Health and Emphysema Pathogenesis. Curr Respir 
Med Rev 2: 101-142.
Meyrick, B., and Reid, L. (1970). Ultrastructure of cells in the human 
bronchial submucosal glands. J Anat 107: 281-299.
Miller, F.J., Graham, J.A., and Gardner, D.E. (1983). The changing role of 
animal toxicology in support of regulatory decisions. Environ Health Perspect 
52: 169-176.
Mitsumoto, A., Takanezawa, Y., Okawa, K., Iwamatsu, A., and Nakagawa,
Y. (2001). Variants of peroxiredoxins expression in response to hydroperoxide 
stress. Free Radic Biol Med 30: 625-635.
Montuschi, P., Barnes, P.J., and Ciabattoni, G. (2010). Measurements of 8- 
isoprostane in exhaled breath. Meth Mol Biol 594: 73-84.
Moore, B.B., Moore, T.A., and Toews, G.B. (2001). Role of T- and B-
lymphocytes in pulmonary host defences. Eur Respir J 18: 846-856.
Morgan, D.O. (1995). Principles of CDK regulation. Nature 374: 131-134.
Morrison, D., Rahman, I., Lannan, S., and MacNee, W. (1999). Epithelial 
permeability, inflammation, and oxidant stress in the air spaces of smokers. 
Am J Respir Crit Care Med 159: 473-479.
Mossman, B.T., Lounsbury, K.M., and Reddy, S.P. (2006). Oxidants and 
signaling by mitogen-activated protein kinases in lung epithelium. Am J Respir 
Cell Mol Biol 34: 666-669.
206
R e f e r e n c e s
MRC. (1965). Definition and classification of chronic bronchitis for clinical and 
epidemiological purposes. A report to the Medical Research Council by their 
Committee on the Aetiology of Chronic Bronchitis. Lancet 1: 775-779.
Nagase, T., Miyajima, N., Tanaka, A., Sazuka, T., Seki, N., Sato, S., 
Tabata, S., Ishikawa, K., Kawarabayasi, Y., Kotani, H., and Nobuo, N.
(1995). Prediction of the coding sequences of unidentified human genes. III. 
The coding sequences of 40 new genes (KIAA0081-KIAA0120) deduced by 
analysis of cDNA clones from human cell line KG-1. DNA Res 2: 37-43.
Nakayama, T., Church, D.F., and Pryor, W.A. (1989). Quantitative analysis 
of the hydrogen peroxide formed in aqueous cigarette tar extracts. Free Radic 
Biol Med 7: 9-15.
Newman, G.R., and Hobot, J.A. (2001). Resin microscopy and on-section 
immuno-cytochemistry. Springer.
Nicod, L.P. (1999). Pulmonary defence mechanisms. Respiration 66: 2-11.
Noske, W., Stamm, C.C., and Hirsch, M. (1994). Tight junctions of the 
human ciliary epithelium: regional morphology and implications on
transepithelial resistance. Exp Eye Res 59: 141-149.
Nowak, D., Antczak, A., Krol, M., Pietras, T., Shariati, B., Bialasiewicz, P., 
Jeczkowski, K., and Kula, P. (1996). Increased content of hydrogen 
peroxide in the expired breath of cigarette smokers. European Respiratory 
Journal 9: 652-657.
Nowak, D., Kasielski, M., Antczak, A., Pietras, T., and Bialasiewicz, P.
(1999). Increased content of thiobarbituric acid-reactive substances and 
hydrogen peroxide in the expired breath condensate of patients with stable 
chronic obstructive pulmonary disease: no significant effect of cigarette 
smoking. Respiratory Medicine 93: 389-396.
207
R e f e r e n c e s
Nussbaumer-Ochsner, Y., and Rabe, K.F. (2011). Systemic manifestations 
of COPD. Chest 139: 165-173.
Okada, S.F., Nicholas, R.A., Kreda, S.M., Lazarowski, E.R., and Boucher, 
R.C. (2006). Physiological regulation of ATP release at the apical surface of 
human airway epithelia. The Journal of biological chemistry 281: 22992- 
23002.
Ordonez, N.G. (1998). Value of cytokeratin 5/6 immunostaining in 
distinguishing epithelial mesothelioma of the pleura from lung 
adenocarcinoma. Am J Surg Pathol 22: 1215-1221.
Oudijk, E.J., Lammers, J.W., and Koenderman, L. (2003). Systemic 
inflammation in chronic obstructive pulmonary disease. Eur Respir J Suppl 
46: 5s-13s.
Owen, C.A. (2005). Proteinases and oxidants as targets in the treatment of 
chronic obstructive pulmonary disease. Proceedings of the American Thoracic 
Society 2: 373-385; discussion 394-375.
Padar, S., Bose, D.D., Livesey, J.C., and Thomas, D.W. (2005). 2- 
Aminoethoxydiphenyl borate perturbs hormone-sensitive calcium stores and 
blocks store-operated calcium influx pathways independent of cytoskeletal 
disruption in human A549 lung cancer cells. Biochem Pharmacol 69: 1177- 
1186.
Pampaloni, F., Reynaud, E.G., and Stelzer, E.H. (2007). The third 
dimension bridges the gap between cell culture and live tissue. Nat Rev Mol 
Cell Biol 8: 839-845.
Papadakos, P.J., and Lachman, B. (2008). Mechanical ventilation: clinical 
applications and pathophysiology.
208
R e f e r e n c e s
Park, J.H., Kim, Y.S., Lee, H.L., Shim, J.Y., Lee, K.S., Oh, Y.J., Shin, S.S., 
Choi, Y.H., Park, K.J., Park, R.W., and Hwang, S.C. (2006a). Expression of 
peroxiredoxin and thioredoxin in human lung cancer and paired normal lung. 
Respirology 11: 269-275.
Park, J.W., Piszczek, G., Rhee, S.G., and Chock, P.B. (2011). 
Glutathionylation of peroxiredoxin I induces decamer to dimers dissociation 
with concomitant loss of chaperone activity. Biochemistry 50: 3204-3210.
Park, K.S., Wells, J.M., Zorn, A.M., Wert, S.E., Laubach, V.E., Fernandez, 
L.G., and Whitsett, J.A. (2006b). Transdifferentiation of ciliated cells during 
repair of the respiratory epithelium. American journal of respiratory cell and 
molecular biology 34: 151-157.
Patton, J.S., Fishburn, C.S., and Weers, J.G. (2004). The lungs as a portal 
of entry for systemic drug delivery. Proceedings of the American Thoracic 
Society 1: 338-344.
Penn, A., Murphy, G., Barker, S., Henk, W., and Penn, L. (2005). 
Combustion-derived ultrafine particles transport organic toxicants to target 
respiratory cells. Environ Health Perspect 113: 956-963.
Peskin, A.V., Cox, A.G., Nagy, P., Morgan, P.E., Hampton, M.B., Davies, 
M.J., and Winterbourn, C.C. (2010). Removal of amino acid, peptide and 
protein hydroperoxides by reaction with peroxiredoxins 2 and 3. Biochem J 
432: 313-321.
Peskin, A.V., Low, F.M., Paton, L.N., Maghzal, G.J., Hampton, M.B., and 
Winterbourn, C.C. (2007). The high reactivity of peroxiredoxin 2 with H202 is 
not reflected in its reaction with other oxidants and thiol reagents. J Biol Chem 
282: 11885-11892.
Phalen, T.J., Weirather, K., Deming, P.B., Anathy, V., Howe, A.K., van der 
Vliet, A., Jonsson, T.J., Poole, L.B., and Heintz, N.H. (2006). Oxidation
209
R e f e r e n c e s
state governs structural transitions in peroxiredoxin II that correlate with cell 
cycle arrest and recovery. J Cell Biol 175: 779-789.
Pierce, G.F., Yanagihara, D., Klopchin, K., Danilenko, D.M., Hsu, E., 
Kenney, W.C., and Morris, C.F. (1994). Stimulation of all epithelial elements 
during skin regeneration by keratinocyte growth factor. J Exp Med 179: 831- 
840.
Poli, G., Leonarduzzi, G., Biasi, F., and Chiarpotto, E. (2004). Oxidative 
stress and cell signalling. Curr Med Chem 11: 1163-1182.
Popp, J.A., and Martin, J.T. (1984). Surface topography and distribution of 
cell types in the rat nasal respiratory epithelium: scanning electron 
microscopic observations. Am J Anat 169: 425-436.
Presland, R.B., and Dale, B.A. (2000). Epithelial structural proteins of the 
skin and oral cavity: function in health and disease. Crit Rev Oral Biol Med 11: 
383-408.
Presland, R.B., and Jurevic, R.J. (2002). Making sense of the epithelial 
barrier: what molecular biology and genetics tell us about the functions of oral 
mucosal and epidermal tissues. J Dent Educ 66: 564-574.
Prosperi, M.T., Ferbus, D., Karczinski, I., and Goubin, G. (1993). A human 
cDNA corresponding to a gene overexpressed during cell proliferation 
encodes a product sharing homology with amoebic and bacterial proteins. J 
Biol Chem 268: 11050-11056.
Proud, D. (2008). The pulmonary epithelium in health and disease. John 
Wiley and Sons Ltd.
Prussin, C., and Metcalfe, D.D. (2003). 4. IgE, mast cells, basophils, and 
eosinophils. J Allergy Clin Immunol 111: S486-494.
2 1 0
R e f e r e n c e s
Pryor, W.A., and Stone, K. (1993). Oxidants in cigarette smoke. Radicals, 
hydrogen peroxide, peroxynitrate, and peroxynitrite. Annals of the New York 
Academy of Sciences 686: 12-27; discussion 27-18.
Prytherch, Z.C. (2010). An in vitro NHBE model of the human bronchial 
epithelium for toxicological testing Thesis.
Puchelle, E., Zahm, J.M., Tournier, J.M., and Coraux, C. (2006). Airway 
epithelial repair, regeneration, and remodeling after injury in chronic 
obstructive pulmonary disease. Proceedings of the American Thoracic Society 
3: 726-733.
Puntmann, V.O. (2009). How-to guide on biomarkers: biomarker definitions, 
validation and applications with examples from cardiovascular disease. 
Postgrad Med J 85: 538-545.
Rabilloud, T., Heller, M., Gasnier, F., Luche, S., Rey, C., Aebersold, R., 
Benahmed, M., Louisot, P., and Lunardi, J. (2002). Proteomics analysis of 
cellular response to oxidative stress. Evidence for in vivo overoxidation of 
peroxiredoxins at their active site. J Biol Chem 277: 19396-19401.
Raherison, C., and Girodet, P.O. (2009). Epidemiology of COPD. Eur Respir 
Rev 18: 213-221.
Rahman, I. (2006). Antioxidant therapies in COPD. Int J Chron Obstruct 
Pulmon Dis 1: 15-29.
Rahman, I., and Adcock, I.M. (2006). Oxidative stress and redox regulation 
of lung inflammation in COPD. Eur Respir J 28: 219-242.
Rahman, I., Biswas, S.K., and Kode, A. (2006). Oxidant and antioxidant 
balance in the airways and airway diseases. Eur J Pharmacol 533: 222-239.
2 1 1
R e f e r e n c e s
Rahman, I., and MacNee, W. (1998). Role of transcription factors in 
inflammatory lung diseases. Thorax 53: 601-612.
Randell, S.H. (2006). Airway epithelial stem cells and the pathophysiology of 
chronic obstructive pulmonary disease. Proceedings of the American Thoracic 
Society 3: 718-725.
Rennard, S.l. (1999). Inflammation and repair processes in chronic 
obstructive pulmonary disease. American Journal of Respiratory and Critical 
Care Medicine 160: S12-16.
Rennard, S.l. (2007). Inflammation in COPD: a link to systemic comorbidities. 
Eur Respir Rev 16: 91-97.
Repine, J.E., Bast, A., and Lankhorst, I. (1997). Oxidative stress in chronic 
obstructive pulmonary disease. Oxidative Stress Study Group. Am J Respir 
Crit Care Med 156: 341-357.
Reynolds, S.D., and Malkinson, A.M. (2010). Clara cell: progenitor for the 
bronchiolar epithelium. The international journal of biochemistry & cell biology 
42: 1-4.
Rhee, S.G. (2006). Cell signaling. H20 2, a necessary evil for cell signaling. 
Science 312: 1882-1883.
Rhee, S.G., Bae, Y.S., Lee, S.R., and Kwon, J. (2000). Hydrogen peroxide: 
a key messenger that modulates protein phosphorylation through cysteine 
oxidation. Sci STKE 2000: PE1.
Rhee, S.G., Chae, H.Z., and Kim, K. (2005a). Peroxiredoxins: a historical 
overview and speculative preview of novel mechanisms and emerging 
concepts in cell signaling. Free Radic Biol Med 38: 1543-1552.
2 1 2
R e f e r e n c e s
Rhee, S.G., Chang, T.S., Bae, Y.S., Lee, S.R., and Kang, S.W. (2003). 
Cellular regulation by hydrogen peroxide. J Am Soc Nephrol 14: S211-215.
Rhee, S.G., Kang, S.W., Chang, T.S., Jeong, W., and Kim, K. (2001). 
Peroxiredoxin, a novel family of peroxidases. IUBMB Life 52: 35-41.
Rhee, S.G., Kang, S.W., Jeong, W., Chang, T.S., Yang, K.S., and Woo, 
H.A. (2005b). Intracellular messenger function of hydrogen peroxide and its 
regulation by peroxiredoxins. Curr Opin Cell Biol 17: 183-189.
Rhee, S.G., Yang, K.S., Kang, S.W., Woo, H.A., and Chang, T.S. (2005c). 
Controlled elimination of intracellular H(2)0(2): regulation of peroxiredoxin, 
catalase, and glutathione peroxidase via post-translational modification. 
Antioxid Redox Signal 7: 619-626.
Rhodin, J.A. (1966). The ciliated cell. Ultrastructure and function of the 
human tracheal mucosa. Am Rev Respir Dis 93: Suppl:1-15.
Rinalducci, S., D'Amici, G.M., Blasi, B., and Zolla, L. (2011). Oxidative 
stress-dependent oligomeric status of erythrocyte peroxiredoxin II (Prxll) 
during storage under standard blood banking conditions. Biochimie 93: 845- 
853.
Rogers, D.F. (2003). The airway goblet cell. Int J Biochem Cell Biol 35: 1-6.
Rose, M.C., and Voynow, J.A. (2006). Respiratory tract mucin genes and 
mucin glycoproteins in health and disease. Physiol Rev 86: 245-278.
Rothen-Rutishauser, B.M., Kiama, S.G., and Gehr, P. (2005). A three- 
dimensional cellular model of the human respiratory tract to study the 
interaction with particles. American journal of respiratory cell and molecular 
biology 32: 281-289.
213
R e f e r e n c e s
Rozman, K.K., and Doull, J. (2003). Scientific foundations of hormesis. Part
2. Maturation, strengths, limitations, and possible applications in toxicology, 
pharmacology, and epidemiology. Crit Rev Toxicol 33: 451-462.
Russell, W., and Burch, R. (1959). The principles of humane experimental 
technique.
Rytila, P., Plataki, M., Bucchieri, F., Uddin, M., Nong, G., Kinnula, V.L., 
and Djukanovic, R. (2006). Airway neutrophilia in COPD is not associated 
with increased neutrophil survival. The European respiratory journal : official 
journal of the European Society for Clinical Respiratory Physiology 28: 1163- 
1169.
Saetta, M. (1999). Airway inflammation in chronic obstructive pulmonary 
disease. Am J Respir Crit Care Med 160: S17-20.
Saetta, M., Turato, G., Baraldo, S., Zanin, A., Braccioni, F., Mapp, C.E., 
Maestrelli, P., Cavallesco, G., Papi, A., and Fabbri, L.M. (2000). Goblet cell 
hyperplasia and epithelial inflammation in peripheral airways of smokers with 
both symptoms of chronic bronchitis and chronic airflow limitation. American 
Journal of Respiratory and Critical Care Medicine 161: 1016-1021.
Scheuch, G., Kohlhaeufl, M.J., Brand, P., and Siekmeier, R. (2006). 
Clinical perspectives on pulmonary systemic and macromolecular delivery. 
Adv Drug Deliv Rev 58: 996-1008.
Schneeberger, E.E., and Lynch, R.D. (1992). Structure, function, and 
regulation of cellular tight junctions. Am J Physiol 262: L647-661.
Schroder, E., and Ponting, C.P. (1998). Evidence that peroxiredoxins are 
novel members of the thioredoxin fold superfamily. Protein Sci 7: 2465-2468.
Scotton, C.J. (2011). A breath of fresh air for tissue engineering? Materials 
Today 14: 212-216.
214
R e f e r e n c e s
Seethala, R. (2001). Handbook of drug screening.
Seo, M.S., Kang, S.W., Kim, K., Baines, I.C., Lee, T.H., and Rhee, S.G.
(2000). Identification of a new type of mammalian peroxiredoxin that forms an 
intramolecular disulfide as a reaction intermediate. J Biol Chem 275: 20346- 
20354.
Sexton, K. (2009). Identification of intelligent biomarkers of exposure in the 
respiratory epithelia to tobacco smoke components Thesis.
Sexton, K., Balharry, D., and BeruBe, K.A. (2008). Genomic biomarkers of 
pulmonary exposure to tobacco smoke components. Pharmacogenet Genom 
18: 853-860.
Shau, H., and Kim, A. (1994). Identification of natural killer enhancing factor 
as a major antioxidant in human red blood cells. Biochem Biophys Res 
Commun 199: 83-88.
Shier, D., Butler, J., and Lewis, R. (2004). Hole's human anatomy and 
physiology. McGraw-Hill.
Shoyele, S.A., and Cawthorne, S. (2006). Particle engineering techniques 
for inhaled biopharmaceuticals. Adv Drug Deliv Rev 58: 1009-1029.
Siafakas, N.M., and Tzortzaki, E.G. (2002). Few smokers develop COPD. 
Why? Respiratory Medicine 96: 615-624.
Simet, S.M., Sisson, J.H., Pavlik, J.A., Devasure, J.M., Boyer, C., Liu, X., 
Kawasaki, S., Sharp, J.G., Rennard, S.I., and Wyatt, T.A. (2010). Long­
term cigarette smoke exposure in a mouse model of ciliated epithelial cell 
function. American journal of respiratory cell and molecular biology 43: 635- 
640.
215
R e f e r e n c e s
Sin, D.D., Anthonisen, N.R., Soriano, J.B., and Agusti, A.G. (2006). 
Mortality in COPD: Role of comorbidities. Eur Respir J 28: 1245-1257.
Singh, G., and Katyal, S.L. (2000). Clara cell proteins. Annals of the New 
York Academy of Sciences 923: 43-58.
Sisson, J.H., Papi, A., Beckmann, J.D., Leise, K.L., Wisecarver, J., 
Brodersen, B.W., Kelling, C.L., Spurzem, J.R., and Rennard, S.l. (1994). 
Smoke and viral infection cause cilia loss detectable by bronchoalveolar 
lavage cytology and dynein ELISA. American Journal of Respiratory and 
Critical Care Medicine 149: 205-213.
Sleigh, M.A. (1990). Ciliary adaptations for the propulsion of mucus. 
Biorheology 27: 527-532.
Snider, G.L. (1989). Chronic Obstructive Pulmonary-Disease - Risk-Factors, 
Patho-Physiology and Pathogenesis. Annual Review of Medicine 40: 411 - 
429.
Snoeck-Stroband, J.B., Lapperre, T.S., Gosman, M.M., Boezen, H.M., 
Timens, W., ten Hacken, N.H., Sont, J.K., Sterk, P.J., and Hiemstra, P.S.
(2008). Chronic bronchitis sub-phenotype within COPD: inflammation in 
sputum and biopsies. The European respiratory journal : official journal of the 
European Society for Clinical Respiratory Physiology 31: 70-77.
Steimer, A., Haltner, E., and Lehr, C.M. (2005). Cell culture models of the 
respiratory tract relevant to pulmonary drug delivery. J Aerosol Med 18: 137- 
182.
Stoller, J.K., and Aboussouan, L.S. (2005). [alpha] 1-antitrypsin deficiency. 
The Lancet 365: 2225-2236.
Szilasi, M., Dolinay, T., Nemes, Z., and Strausz, J. (2006). Pathology of 
chronic obstructive pulmonary disease. Pathol Oncol Res 12: 52-60.
216
R e f e r e n c e s
Takeyama, K., Dabbagh, K., Jeong Shim, J., Dao-Pick, T., Ueki, I.F., and 
Nadel, J.A. (2000). Oxidative stress causes mucin synthesis via 
transactivation of epidermal growth factor receptor: role of neutrophils. Journal 
of Immunology 164: 1546-1552.
Takeyama, K., Dabbagh, K., Lee, H.M., Agusti, C., Lausier, J.A., Ueki, I.F., 
Grattan, K.M., and Nadel, J.A. (1999). Epidermal growth factor system 
regulates mucin production in airways. Proceedings of the National Academy 
of Sciences of the United States of America 96: 3081-3086.
Takeyama, K., Fahy, J.V., and Nadel, J.A. (2001). Relationship of epidermal 
growth factor receptors to goblet cell production in human bronchi. American 
Journal of Respiratory and Critical Care Medicine 163: 511-516.
Takizawa, H., Tanaka, M., Takami, K., Ohtoshi, T., Ito, K., Satoh, M., 
Okada, Y., Yamasawa, F., and Umeda, A. (2000). Increased expression of 
inflammatory mediators in small-airway epithelium from tobacco smokers. Am 
J Physiol Lung Cell Mol Physiol 278: L906-913.
Tanikawa, K., and Torimura, T. (2006). Studies on oxidative stress in liver 
diseases: important future trends in liver research. Med Mol Morphol 39: 22- 
27.
Taylor, J.D. (2010). COPD and the response of the lung to tobacco smoke 
exposure. Pulm Pharmacol Ther 23: 376-383.
Teramoto, S., Tomita, T., Matsui, H., Ohga, E., Matsuse, T., and Ouchi, Y.
(1999). Hydrogen peroxide induced apoptosis and necrosis in human lung 
fibroblasts: protective roles of glutathione. Jpn J Pharmocol 73: 33-40.
Tetley, T.D. (2002). Macrophages and the pathogenesis of COPD. Chest 
121: 156S-159S.
217
R e f e r e n c e s
Thannickal, V.J., Day, R.M., Klinz, S.G., Bastien, M.C., Larios, J.M., and 
Fanburg, B.L. (2000). Ras-dependent and -independent regulation of 
reactive oxygen species by mitogenic growth factors and TGF-beta1. Faseb J 
14: 1741-1748.
Thannickal, V.J., and Fanburg, B.L. (1995). Activation of an H202- 
generating NADH oxidase in human lung fibroblasts by transforming growth 
factor beta 1. J Biol Chem 270: 30334-30338.
Thannickal, V.J., and Fanburg, B.L. (2000). Reactive oxygen species in cell 
signaling. Am J Physiol Lung Cell Mol Physiol 279: L1005-1028.
Therond, P., Bonnefont-Rousselot, D., Davit-Spraul, A., Conti, M., and 
Legrand, A. (2000). Biomarkers of oxidative stress: an analytical approach. 
Curr Opin Clin Nutr Metab Care 3: 373-384.
Thomassen, D.G., and Nettesheim, P. (1990). Biology, toxicology and 
carcinogenesis of respiratory epithelium. Hemisphere Publishing Corporation.
Thornton, D.J., and Sheehan, J.K. (2004). From mucins to mucus: toward a 
more coherent understanding of this essential barrier. Proceedings of the 
American Thoracic Society 1: 54-61.
Tonello, A., and Poli, G. (2011). Rethinking chronic obstructive pulmonary 
disease. Med Hypotheses 76: 358-360.
Torres, M., and Forman, H.J. (2003). Redox signaling and the MAP kinase 
pathways. Biofactors 17: 287-296.
Travis, C.C. (1991). Interspecies extrapolation in risk analysis. Ann 1st Super 
Sanita 27: 581-593.
218
R e f e r e n c e s
Travis, S.M., Singh, P.K., and Welsh, M.J. (2001). Antimicrobial peptides 
and proteins in the innate defense of the airway surface. Curr Opin Immunol 
13: 89-95.
Tsuji, K., Copeland, N.G., Jenkins, N.A., and Obinata, M. (1995). 
Mammalian antioxidant protein complements alkylhydroperoxide reductase 
(ahpC) mutation in Escherichia coli. Biochem J 307 ( Pt 2): 377-381.
Turner, J., Roger, J., Fitau, J., Combe, D., Giddings, J., Heeke, G.V., and 
Jones, C.E. (2011). Goblet cells are derived from a FOXJ1-expressing 
progenitor in a human airway epithelium. American journal of respiratory cell 
and molecular biology 44: 276-284.
Valko, M., Leibfritz, D., Moncol, J., Cronin, M.T., Mazur, M., and Telser, J.
(2007). Free radicals and antioxidants in normal physiological functions and 
human disease. The international journal of biochemistry & cell biology 39: 
44-84.
Van der Vliet, A., Eiserich, J.P., Halliwell, B., and Cross, C.E. (1997). 
Formation of reactive nitrogen species during peroxidase-catalyzed oxidation 
of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. 
The Journal of biological chemistry 272: 7617-7625.
VanGuilder, H.D., Vrana, K.E., and Freeman, W.M. (2008). Twenty-five 
years of quantitative PCR for gene expression analysis. Biotechniques 44: 
619-626.
Veranth, J.M., Kaser, E.G., Veranth, M.M., Koch, M., and Yost, G.S.
(2007). Cytokine responses of human lung cells (BEAS-2B) treated with 
micron-sized and nanoparticles of metal oxides compared to soil dusts. Part 
Fibre Toxicol 4: 2.
Veranth, J.M., Reilly, C.A., Veranth, M.M., Moss, T.A., Langelier, C.R., 
Lanza, D.L., and Yost, G.S. (2004). Inflammatory cytokines and cell death in
219
R e f e r e n c e s
BEAS-2B lung cells treated with soil dust, lipopolysaccharide, and surface- 
modified particles. Toxicol Sci 82: 88-96.
W.A.G. (2010). Early stage development fund for a small pilot study to realise 
the development of the 'Metabo-Lung'. Welsh Assembly Government: Pilot 
study.
Waris, G., and Ahsan, H. (2006). Reactive oxygen species: role in the 
development of cancer and various chronic conditions. J Carcinog 5: 14.
Waskiewicz, A.J., and Cooper, J.A. (1995). Mitogen and stress response 
pathways: MAP kinase cascades and phosphatase regulation in mammals 
and yeast. Curr Opin Cell Biol 7: 798-805.
Watabe, S., Kohno, H., Kouyama, H., Hiroi, T., Yago, N., and Nakazawa,
T. (1994). Purification and characterization of a substrate protein for 
mitochondrial ATP-dependent protease in bovine adrenal cortex. J Biochem 
115: 648-654.
West, J.B. (1995). Respiratory physiology. Williams & Wilkins.
West, J.B., and Mathieu-Costello, O. (1999). Structure, strength, failure, and 
remodeling of the pulmonary blood-gas barrier. Annu Rev Physiol 61: 543- 
572.
Westermeier, R. (2005). Electrophoresis in practice.
Westmoreland, C., Walker, T., Matthews, J., and Murdock, J. (1999). 
Preliminary Investigations into the use of a Human Bronchial Cell Line 
(16HBE14o-) to Screen for Respiratory Toxins In Vitro. Toxicol In Vitro 13: 
761-764.
White, S.H., Wimley, W.C., and Selsted, M.E. (1995). Structure, function, 
and membrane integration of defensins. Curr Opin Struct Biol 5: 521-527.
2 2 0
R e f e r e n c e s
Widdicombe, J.H. (2002). Regulation of the depth and composition of airway 
surface liquid. J Anat 201: 313-318.
Wilson, R., and Turner, A.P.F. (1992). Glucose oxidase: An ideal enzyme. 
Biosens Bioelect 7: 165-185.
Winterbourn, C.C., and Hampton, M.B. (2008). Thiol chemistry and 
specificity in redox signaling. Free radical biology & medicine 45: 549-561.
Woo, H.A., Chae, H.Z., Hwang, S.C., Yang, K.S., Kang, S.W., Kim, K., and 
Rhee, S.G. (2003a). Reversing the inactivation of peroxiredoxins caused by 
cysteine sulfinic acid formation. Science 300: 653-656.
Woo, H.A., Kang, S.W., Kim, H.K., Yang, K.S., Chae, H.Z., and Rhee, S.G.
(2003b). Reversible oxidation of the active site cysteine of peroxiredoxins to 
cysteine sulfinic acid. Immunoblot detection with antibodies specific for the 
hyperoxidized cysteine-containing sequence. J Biol Chem 278: 47361-47364.
Wood, Z.A., Poole, L.B., Hantgan, R.R., and Karplus, P.A. (2002). Dimers 
to doughnuts: redox-sensitive oligomerization of 2-cysteine peroxiredoxins. 
Biochemistry 4 1 : 5493-5504.
Wood, Z.A., Poole, L.B., and Karplus, P.A. (2003a). Peroxiredoxin evolution 
and the regulation of hydrogen peroxide signaling. Science 300: 650-653.
Wood, Z.A., Schroder, E., Robin Harris, J., and Poole, L.B. (2003b). 
Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 
28: 32-40.
Wottrich, R., Diabate, S., and Krug, H.F. (2004). Biological effects of 
ultrafine model particles in human macrophages and epithelial cells in mono- 
and co-culture. Int J Hyg Environ Health 207: 353-361.
2 2 1
R e f e r e n c e s
Yamamoto, T., Matsui, Y., Natori, S., and Obinata, M. (1989). Cloning of a 
housekeeping-type gene (MER5) preferentially expressed in murine 
erythroleukemia cells. Gene 80: 337-343.
Yang, K.S., Kang, S.W., Woo, H.A., Hwang, S.C., Chae, H.Z., Kim, K., and 
Rhee, S.G. (2002). Inactivation of human peroxiredoxin I during catalysis as 
the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. 
J Biol Chem 277: 38029-38036.
Ye, L., Wang, X., and Jin, M. (2009). Role of airway epithelial cells in 
development of chronic obstructive pulmonary disease. J Epithelial Biol 
Pharmacol 2: 44-50.
Yoshida, Y., Yoshikawa, A., Kinumi, T., Ogawa, Y., Saito, Y., Ohara, K., 
Yamamoto, H., Imai, Y., and Niki, E. (2009). Hydroxyoctadecadienoic acid 
and oxidatively modified peroxiredoxins in the blood of Alzheimer's disease 
patients and their potential as biomarkers. Neurobiol Aging 30: 174-185.
Yoshisue, H., Puddicombe, S.M., Wilson, S.J., Haitchi, H.M., Powell, R.M., 
Wilson, D.I., Pandit, A., Berger, A.E., Davies, D.E., Holgate, S.T., and 
Holloway, J.W. (2004). Characterization of ciliated bronchial epithelium 1, a 
ciliated cell-associated gene induced during mucociliary differentiation. 
American journal of respiratory cell and molecular biology 31: 491-500.
2 2 2
A p p e n d ix
A p p e n d ix
------------------------------------------------------------------------------- A p p e n d ix --------------------------------------------------------------------------
A p p e n d i x  I
Protocol provided by Lonza
Recipe for Bronchial Epithelial Growth Medium (BEGM)
For every 10ml of Bronchial Epithelial Basal Medium (BEBM) the following 
growth supplements were added in order to make 10ml BEGM:
V o l u m e S u p p l e m e n t
40pl Bovine Pituitary Extract
10 pi Insulin
10 pi Hydrocortisone
10 Ml Transferrin
10 Ml Triodothronin
10 Ml Epinepherine
10 Ml Epidermal Growth Factor
10 Ml Gentamicin/Amphoteracin
10 Ml Retanoic Acid
------------------------------------------------------------------------------- A p p e n d ix --------------------------------
A p p e n d i x  II
Recipe for Air-Liquid Interface (ALI) growth medium 
For every 20ml of ALI the following recipe was followed:
V o l u m e S u p p l e m e n t
10ml BEBM
10ml DMEM
80pl Bovine Pituitary Extract
20 pi Insulin
20 pi Hydrocortisone
20 Ml Transferrin
20 Ml Triodothronin
20 Ml Epinepherine
20 Ml Epidermal Growth Factor
20 Ml Gentamicin/Amphoteracin
20 Ml Retanoic Acid
